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ABSTRACT  
Anecdotal evidence from clinical observations and evidence in rodents after vertical sleeve 
gastrectomy (VSG) suggest a shift in food preferences. Direct measures of behaviour to study the 
effects of VSG on the food preferences are unknown. This study aimed to investigate (1) Changes in 
eating behaviour and meal patterns after VSG, (2) Changes in sweet taste detection thresholds after 
VSG, (3) Changes in appetitive behaviour as a marker of changes in reward after VSG, and (4) 
Changes in consummatory behaviour as a marker of changes in reward after VSG in adolescents' 
subjects.  
The project recruited 50 adolescents after VSG and 35 as controls. The ages were  
15 ± 0.27 and 14 ± 0.28 for the subjects after VSG and controls respectively. 42 % of the subjects 
were females and 58 % males, with the mean BMI of (51.1 ± 1.0) for VSG and (31.9 ± 1.1) for control 
subject. The parameters recorded for each aim included; Aim 1: Meal duration, meal size, pre-meal 
hunger and post-meal satiation that were assessed before and after VSG. Attitudes to foods, 24h 
recall method and FFQ were measured. Aim 2: The intensity of sweet taste stimuli assessed before 
and after VSG, using the constant stimuli methods. Aim 3: The appetitive reward of fat and sweet 
taste stimuli was assessed before and after VSG, using the Progressive Ratio Task.  Aim 4: The 
consummatory reward of fat and sweet taste stimuli was assessed before and after VSG, using taste 
reactivity by recording and analysing facial expressions to determine the ingestive behaviour in 
response to stimulants.  
The results demonstrated; Aim 1: Changes in food preferences towards healthier choices, eating 
behaviour and meal pattern after VSG (all p <0.05). Aim 2: No changes in sucrose detection threshold 
after VSG (p= 0.6). Aim 3: Appetitive reward value as measured by the breakpoint of the tastant 
decreased after VSG (p=0.02).  Aim 4: Consummatory reward value of the tastant as measured by 
behaviours associated with positive ingestive behaviours decreased after VSG as well (p= 0.03).  
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In conclusion obese adolescents after VSG have a shift in food preferences to healthier food choices, 
as well as eating behaviour and meal patterns. VSG changed the Hedonic value of high fat and sugary 
food as suggested by changes in Appetitive and Consummatory behaviour in response. However VSG 
had no effect on the sensory domain as regards sweet sensitivity. Taken together VSG may improve 
the quality of food selected after surgery by reducing the reward value of high fat and sugary foods. 
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1.1 Introduction      
Body fat is mainly composed of adipose tissue in the form of triglycerides, and its measurement is  
a major challenge to researchers and clinicians. Fat is mainly stored in subcutaneous tissue and intra-
abdominal structures, and a substantial amount of fat can also exist in muscles, particularly in the 
elderly (1). The term obesity is often used to refer to an excess of body fat, which usually accounts 
for up to 25% of body weight in women and 18% in men (2). A number of methods can be used to 
quantify the proportion of fat in our body, but due to its low cost and simplicity, obesity is now 
defined in relation to the calculated body mass index [BMI = weight in kilograms divided by the 
height in meters squared (kg/m²)] (3). BMI has replaced the more traditional measure of percentage 
excess weight, or the proportion by which an individual’s weight exceeds the weight considered ideal 
for gender and age (4). Overweight and obesity are defined in adults using BMI cut-offs of ≥25 and 
≥30 kg/m2, respectively. According to the Centres for Disease Control and Prevention (CDC) 
definitions, children and adolescents with a BMI ≥85th and ≥95th percentiles are considered 
overweight, and  obese, respectively (5;6). Obesity is a multifactorial disease, which results from an 
interaction between the genetic tendency of a person and numerous environmental factors including 
diet and lifestyle. Several studies have attempted to determine the relative contributions of genetic 
and environmental factors in the aetiology of obesity. Genetic factors have been suggested to 
contribute 70%, and environmental factors 30% (7). However, what is much more certain is the 
interaction between the environment and genetics (7). Genes may also contribute to the differences 
between individuals in resting metabolic rate (RMR), weight gain in response to overfeeding, and 
body fat distribution (8-10). RMR, as the largest component of daily energy expenditure, has been 
shown to have a strong genetic component (9;11). However, the influence of a low RMR on the 
aetiology of obesity remains controversial. Stunkard et al. found that the genotype of some 
individuals who are genetically prone to developing obesity, might be expressed only under certain 
adverse environmental conditions, such as exposure to, and consumption of, high-fat diets, and  
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engaging in sedentary lifestyles (7). Risk factors for obesity also include social factors, parental 
obesity, high birth weight, early maturation, and other behavioural and psychological factors (12). 
Portion size might be another reason for increased consumption and hence greater energy intake 
(13;14). The mechanisms preventing an obese person from losing weight and maintaining weight loss 
have only been partly elucidated (15). 
 
1.2 Obesity Epidemiology 
Obesity is considered the “disease of the 21st century”, and results in physical and psychological  
co-morbidities, as well as poor quality of life (QoL) (16). The global prevalence of obesity has 
increased dramatically over the last three decades, among adults and children, across urban  
and rural areas, and within both developing and developed countries. Over 400 million people are 
presently diagnosed as obese (BMI ≥30 kg/m²) and almost 1.6 billion are overweight  
(BMI 25-29.9 kg/m²) (17). 
1.2.1 Adult obesity worldwide 
Linear regression models have been employed to explain the average annual increase and future 
projections for prevalence. Worldwide, the proportion of adults with overweight (BMI ≥25 kg/m²) 
increased between 1980 and 2013 from 28·8% to 36·9% in men and from 29·8% to 38·0% in women 
(18). The prevalence of obesity in adults has increased from 13% to 32% between the 1960s  
and 2004. Presently, 66% of adults are considered overweight or obese (5). In some developed 
countries, the estimated prevalence of obesity among adults exceeds 50%, although the increase has 
slowed since 2006 (18). Annual increases in prevalence have ranged from 0.3 to 0.9%.  
The prevalence of obesity has been predicted to reach 44.2% by 2020 (19), with a predicted 41% of 
adults obese and 75% overweight or obese by 2030 (5), with a linear increase thereafter. Trends also 
suggest 65 million more obese adults in the USA and 11 million more obese adults in the UK by 2030 
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(20). About one-third of the people in the United States (US) are currently classified as obese 
(18;21;22). Similarly, more than 25% and 50% of adults in the UK are respectively considered obese  
and overweight (18). The prevalence of obesity and overweight between US children and adults has 
more than doubled since the 1970s, and the rate continues to rise (5). Between 1960 and 1980  
the prevalence of obesity was relatively stable, after which it began to increase again, more than 
doubling from 15% in 1980 to 34% in 2006 (Figure ‎1.2.3-1) (3;23). Despite this, the prevalence of 
obesity in this age group remains higher in the US than most European Countries (18;24).  
Excess weight has also increased considerably in children and adolescents within developed 
countries; an estimated 23·8% of boys and 22·6% of girls were overweight or obese in 2013. 
Increases have  been observed among children and adolescents in developing countries in 2013, 
from 8·1% to 12·9% for boys and from 8·4% to 13·4% in girls (18). The Middle Eastern countries of 
Egypt, Libya, Iran, Turkey, and gulf region countries, such as Saudi Arabia (SA), now have some of  
the highest prevalences of obesity in adults and young people (18;25;26), which may in part be 
explained in SA by cultural views, customs and traditions of internal marriages.  
1.2.2 Child obesity worldwide 
Over the past century, a large proportion of the nutrition research and policy relating to the 
developing world, focused on undernutrition and poverty-related problems. More recently there is 
growing concern regarding worrying overweight and obesity trends in these societies (27). Defined as 
a BMI at or above the 99th percentile, childhood obesity is one of the most serious public health and 
medical problems in the US, Europe, Middle East and the Gulf area. Worldwide, over 22 million 
children under the age of 5 years are overweight, as are 155 million children of school age. 
Overweight prevalence in Africa and Asia is below 10%, while in the Americas and Europe it is above 
20% (28). Other estimates suggest that 16% of children and adolescents are overweight and 34% are 
at risk of becoming overweight (5). It is of great importance to understand the trends in childhood 
obesity because of the many adverse effects on health it can impose, both during childhood and  
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through adulthood (29).  Wang has presented a unique comparative study examining data from  
4 countries and representing approximately one-third of the global population. This study shows  
the trends in childhood and adolescent underweight and overweight status (30). The prevalence of 
overweight increased in 3 of the 4 countries between the survey periods of each country  
(1971-1999), tripling in Brazil, almost doubling in the US, and increasing by a fifth in China. On the 
contrary, the prevalence of overweight in Russia was reported to have decreased from 15.6% to 
9.0%. This was during a period of great economic stress and a marked reduction in the energy 
density of the typical diet (27;31).  Europe’s obesity estimates vary from 3-21% depending on how 
obesity is defined (32), with an estimated 10-17% in England (33;34). Some suggest that the 
prevalence of childhood obesity has already tripled across the past 30 years in the US, and the health 
implications and related medical costs of the disease are marked (35).  Annual hospital-related costs 
linked to treating obese young people have increased from 35 million US dollars (USD) in 1979 to 
more than 127 million USD in 1997-1999, based on the 2001 USD value (36). 
1.2.3 Obesity in the Middle East - Saudi Arabia 
The rapid socio-cultural changes that have occurred in the Arabian Gulf region, since the discovery of 
oil reserves and the economic boom during the 1970s and 1980s, have resulted in a rapid and 
alarming increase in obesity (37;38).  Among the factors contributing to obesity in SA, is significant 
change to dietary behaviours, in terms of quantity and quality, both of which have become more 
“Westernised” (39).  Recent studies have revealed that consumption of animal products and refined 
foods have increased, at the expense of fruit and vegetables (40;41).El-Bayoumy et al. suggested that 
the Gulf region prevalence of overweight and obesity ranges from 18% to 30 % and 15% to 19%, 
respectively, among children and adolescents(42;43). SA covers around two thirds of the Arabian 
Peninsula and has a population of 30.8 million people, of which 20.7 million are Saudis (44).  
According to a 2007 survey, 37% of the population are ≤15 years(45).  Between 1995 and 2000,  
Al Nozha and his research group conducted a 5-year National Epidemiological Health Survey to study 
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Coronary Artery Disease (CAD) and its risk factors. 20,000 Saudis between men and women aged  
30-70 years in rural and urban areas of the Kingdom were studied. The data showed an overall 
obesity prevalence of 35.6% and an additional overweight prevalence of 36.9%, suggesting that  
a total of 72.5% Saudis are either overweight or obese (18;46).   
 
Figure  1.2.3-1 Prevalence of obesity across selected countries grouped in quartiles (2009) (47). 
 
 
An alarmingly high obesity rate was noted in both Saudi Arabia and Kuwait. The prevalence of obesity 
is considered to be extremely high among Kuwaiti and Saudi pre-school children (8-9%), and Kuwait’s 
prevalences of overweight and obesity in adolescents were among the highest in the world at  
40-46% (48). In studies conducted in different regions of SA, examining children and adolescents ≤ 20 
years old across both genders, 10.7-23.0% were overweight, 3.4-24.5% were considered obese, and 
approximately 28% in total were considered either overweight or obese (Appendix 1) (49).  
More than 50% of children in SA between ages 14 and 18 years had weight above the 85th percentile 
(49).  
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Among young people in Saudi Arabia, overweight and obesity were estimated to be around 27.5% 
among boys (11.7% overweight and 15.8% obese) between 6 and 18 years of age in 1996 (18;50), 
28.0% among girls between 12 and 19 years in 1999 (51) and 37.4% for girls ≤ 20 years in 2013 (18). 
El Mouzan et al.   used the 2005 Saudi reference dataset to calculate the BMI of children aged 5 to 18 
years (52). Using the 2007 WHO definitions, the prevalence of overweight, obesity  
and severe obesity were defined as the proportion of children with a BMI standard deviation score 
more than +1, +2 and +3, respectively (53). The 2000 CDC definitions were used as a comparison (54). 
Their target population comprised 19,317 healthy young people between 5 to 18 years of age, 50.8% 
of whom were boys. The overall prevalence of overweight, obesity and severe obesity in all age 
groups was 23.1%, 9.3% and 2%, respectively. A significantly lower prevalence of overweight  
(23.8 vs. 20.4; p<0.001) and obesity (9.5 vs. 5.7; p<0.001) was observed when the CDC reference was 
used (55). In another study, carried by Al-Hazzaa, between 1988 and 2005, examined school boys 
between the age of 6 and 14 years old, and showed that during these 17 years the mean BMI 
increased from 16.5 to 18kg/m2, and fat percentage increased from 13.2 to 19.7%, indicating a rising 
trend toward overweight and obesity among school aged children(56). Upward trends in the 
prevalence of non-communicable diseases may impact negatively upon individuals, health systems, 
social systems and public economies. The timeframe within which this impact is observed may be 
relatively rapid in countries with comparatively young populations (57). The occurrence of obesity in 
young people represents a major concern, since obesity at this age represents a frustrating  
and difficult disease to treat. However, it is suggested that treatment of obesity in young people 
should start at an early age (58). Those below 20 years of age represent the majority of the Saudi 
population and should be targeted with extensive efforts prevent obesity later in life (45;59). 
1.2.4 Risk Factors for Obesity 
Chronic risk factors 
Obesity is associated with an increased risk of death. In a prospective cohort of more than 500,000 
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US men and women, across 10 years of follow up, Adams et al. estimated the mortality risk of death 
to increase by 20% to 40% in overweight patients and as much as 200% to 300% in obese patients, 
compared with those who are normal-weight with no smoking history (60). Obesity is also associated 
with increased risk for many chronic diseases, including type 2 diabetes mellitus (T2DM), 
hypertension, heart disease, and stroke (61). In addition, obesity is linked to numerous digestive 
diseases, including gastro-oesophageal reflux disease (GORD) and its complications (e.g. erosive 
oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma), colorectal polyps and cancer, 
liver disease (e.g. non-alcoholic fatty liver disease, cirrhosis and hepatocellular carcinoma) (62). 
Childhood obesity has been considered a major public health problem because an obese child will 
usually carry their obesity into adulthood, along with the attendant increased risks of morbidity  
and mortality (63-67), independently of adult BMI (65;68). Specific concern surrounds of  
its association with risk factors for disease and diseases themselves, such as hypertension, 
dyslipidaemia, chronic inflammation, hyperinsulinaemia, and orthopaedic problems (69-73), as well 
as considerable psychosocial consequences. Obese children are usually stereotyped as unhealthy, 
academically unsuccessful, socially incompetent, and even lazy (74). In addition, low self-esteem  
and behavioural problems are commonly associated with obesity (75) . 
1.3 Cost 
The obesity epidemic places a major financial burden on the economy worldwide.  
The US Department of Health and Human Services has estimated the total economic cost of 
overweight and obesity in the United States to be close to $117 billion dollars between  
1995-2001(76). Furthermore, because of the increasing prevalence of overweight and obesity since 
1995, the costs today are likely to be significantly higher than earlier estimates (77). According to 
analyses by Wang et al., based on nationally representative data collected over the past three 
decades, an alarming picture emerges of the ongoing obesity epidemic and related challenges for the 
future in terms of increasing rates and increasing health cost. Their forecasts predict that within  
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15 years, 80% of all adults in the US will be overweight or obese, based on current trends. Moreover, 
the direct health-care costs attributable to obesity and overweight will double every decade to reach 
an expected health care expenditure of between 860.7 and 956.9 billion US dollars by 2030 (19). 
What these data fail to state is the fact that every person, not just the obese, will be affected by this 
epidemic (78;79). Increased health care costs (80;81) will affect not only the health care industry, but 
also other economic sectors that have no direct relationship to health care (82). 
 
1.4 Obesity Treatment 
1.4.1 Non-Surgical treatment 
Optimal strategies and policies to address the obesity epidemic have not yet been established (83). 
Diet and exercise are examples of strategies for obesity treatment, and considered useful for losing 
weight in moderately obese adults. However, it appears that, even among those individuals who 
successfully lose weight with these methods, most are unable to maintain the loss for long periods 
(84). Unfortunately, there are no acknowledged rules to guide interventions endorsing behaviour  
and lifestyle changes for an effective and permanent weight loss (83).  
1.4.1.1 Diet induced weight loss 
It is commonly believed that weight loss achieved at a slow rate is better preserved than if the weight 
is lost faster. However, the literature contradicts this, showing that early weight loss long-term 
weight maintenance (85). Several studies have shown that a greater initial weight loss, which is 
usually achieved in the first 2–4 weeks of treatment, is associated with a better long-term outcome 
(86;87). The importance of the dietary composition in the prevention and management of obesity is 
debated. Some have found that ad libitum consumption of low-fat diets results in short-term weight 
loss (88), and that a  low-carbohydrate, high-protein, and high-fat diets (e.g. the Atkins diet) may 
result in considerable weight loss, as compared with that achieved through other types of diet (89). 
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Progressive weight loss rarely continues beyond 1 year (90), and weight regain in general will be 
unnoticed in short-term studies because it occurs rather more slowly  than weight loss in over 80% of 
individuals who lose weight through various weight loss programs (91). About two thirds of lost 
weight will be regained within 1 year among those who lose weight through dietary restriction and 
behavioural modification, and almost all of the lost weight will be regained by the end of 5 years (92). 
No medical condition has produced as many potential therapeutic approaches as obesity (Appendix 
2)(93). All diets have their respective proponents and followers, but solid data on the efficacy of 
specific diets are almost unanimously lacking. Sacks et al. have reported the results of a large,  
long-term trial that tested the efficacy of weight-loss diets that were high or low in carbohydrates, 
protein, or fat. Twenty years ago, high carbohydrate, low-fat diets became very popular, based upon 
the belief that calories from carbohydrates were less fattening than the same number of calories 
from fat. Subsequently, a high-fat, low-carbohydrate diet was promoted by Dr. Robert Atkins in the 
1970s, which also enjoyed a recent revival. The appeal of high-protein diets is that protein is thought 
to offer more satiation per calorie than fat or carbohydrates (94). From an epidemiologic 
perspective, a positive health benefit has been reported to occur when protein intake is high (95). 
Clinical intervention studies have established evidence that an ad libitum high-protein diet from  
a variety of food sources in free-living overweight persons increases the amount of weight lost in  
a 6 month weight-loss programme (by 3.8 kg) by increasing satiety compared with a high-
carbohydrate diet (96). Furthermore, weight-loss studies in overweight women have revealed that a 
high ratio of protein to carbohydrate has positive effects on markers of disease risk, including body 
composition, blood lipids, and glucose homeostasis. Protein’s effects of increased satiety and lower 
glycaemic load, due to a lesser carbohydrate intake, may be responsible for these benefits (97).  
In a study comparing two contrasting diets, participants were assigned to a high-protein, low 
glycaemic index diet or a low-protein, high glycaemic index diet, with no restriction on energy intake. 
Compliance with the diet was better among participants following the high-protein diet, as was 
maintenance of weight loss. In addition, participants who followed the high-protein, low glycaemic 
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index diet continued to lose weight after the initial weight loss period. The higher protein content 
was attained by reducing the carbohydrate content, which supports the notion that reducing the 
glycaemic load (defined as carbohydrate content multiplied by glycaemic index) is essential for 
controlling body weight in obese people (96;98). Weight regain in the study was comparatively low 
(0.56 kg), and the general weight loss in all participants who completed the intervention was, 
consequently, fairly high (10.6 kg), compared with the total weight loss in most studies of similar 
length. As a result, researchers have concluded that because of the high rate of completion  
and weight maintenance in most subjects, the studied high-protein, low glycaemic index diet appears 
to be preferrable for the prevention of weight regain (99). Considering the growing prevalence of 
obesity in young people, assessments of novel therapeutic interventions are necessary. For example, 
very low–carbohydrate (ketogenic), low-carbohydrate (LC) and low-fat (LF) diets have shown some 
success and have been well tolerated in promoting short-term weight loss, both in children  
and adults (100;101). Researchers have concluded that the LC diet appears to be an effective 
technique for short-term weight loss in overweight adolescents and does not detrimentally affect the 
lipid profile  (102). Astrup et al. were mainly interested in determining the nature of dietary 
components in subjects who consume fat and carbohydrate and demonstrate a positive energy 
balance. Participants who were exposed to high-fat foods for several weeks tended to over consume 
energy, explained by the relatively energy-dense nature of high-fat foods, compared lower fat foods. 
This overeating effect has been termed passive overconsumption (103). The stimulatory effect of 
fatty foods on energy intake depends not only on their high energy density, but also on the possible 
effect fat has in the mouth. The passive overconsumption effect of dietary fat on energy intake 
occurs during consumption (i.e. it is an intra-meal effect). Therefore, explaining why fat has  
a comparatively weaker effect on satiety than other foods for a given amount of energy consumed. 
Many short-term studies on appetite and energy intake clearly corroborate this, showing that fat is 
less satiating than carbohydrate and protein, and that high-fat foods are more likely to encourage 
passive overconsumption and weight gain than low-fat foods (104). The comparative contributions of 
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carbohydrate sources in the diet may have possible implications for body weight regulation  
and obesity. The main dietary alteration in recent times has been the increase in fat intake at the 
expense of carbohydrates. An inverse relationship between dietary fat and carbohydrate has been 
established in several cross-sectional studies in countries of widely varying socio-economic status.  
In addition, modern diets tend to include more simple sugars, at the expense of more complex 
carbohydrates, which tend to balance the fat energy of the diet. This phenomenon has been called 
the ‘fat–sugar seesaw.  The Scottish part of the Monica Survey has delivered the largest dataset 
related to this, which clearly showed an inverse relationship between sugar intake and obesity (105). 
It has long been argued that a reduction in total fat intake occur hand-in-hand with a rise in 
carbohydrate intake, and this may lead to an increase in plasma triglycerides and a decrease in 
plasma HDL-cholesterol, in turn increasing the risk of coronary heart disease (CHD). It has also been 
proposed that mono-unsaturated fat has a more positive effect on risk factors for CHD than 
carbohydrate does. However, the carbohydrate source and the glycaemic index might have  
an important role for the effect on risk factors. Both observational and interventional studies 
demonstrate that a low glycaemic index diet exerts more beneficial effects than a high glycaemic 
index diet in terms of insulin resistance, LDL- and HDL-cholesterol, and plasminogen activator 
inhibitor-1 activity (106;107). Therefore, the high carbohydrate content of low-fat diets should come 
mainly from the complex carbohydrates such as vegetables, fruits and whole grains, which are more 
satiating and contain fewer calories than fatty foods. At the same time they offer a good source of 
vitamins, minerals, trace elements and fibre. A high fibre diet can not only improve the satiating 
effect of the diet, but also delivers a beneficial effect on blood lipids and blood pressure levels, 
especially if the diet is rich in soluble fibre, such as oat bran, legumes, barley and most fruits  
and vegetables (104). A large body of experimental data still suggest that protein exerts a greater 
satiating power per calorie than carbohydrate and fat in adults. So, in conclusion, the available 
evidence suggests that a diet with a protein content representing up to 25% of energy may be helpful 
for weight regulation in adults (104). 
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1.4.1.2 Diets and Exercise 
Many studies (Appendix 2) (93), including Curioni and Lourenco have examined diet and exercise (83) 
and their systematic review; which evaluated a total of 33 trials evaluating diet, exercise, or diet an 
exercise in combination. Only 6 studies were found that directly compared diet and exercise with 
diet alone. The active intervention period ranged between 10 and 52 weeks across studies  
and a 20% greater initial weight loss was achieved by the diet and exercise group of studies  
(13.0 kg vs. 9.9 kg). The combined intervention also resulted in a 20% greater sustained weight loss 
after 1 year (6.7 kg vs. 4.5 kg), than diet alone. In both groups, almost half of the initial weight loss 
(50%) was regained after a year (83). 
1.4.1.3 Psychological Cognitive Behaviour Therapy (CBT) 
Lately a new cognitive behavioural therapy (CBT) method for the treatment of obesity has been 
developed, which is comparable in style and strategy to CBT for Bulimia Nervosa (108;109). It targets 
those patients who overeat and have a low level of activity, emphasising processes that help in 
weight maintenance (110-112). As per Cooper et al., most of the participants lost weight and then 
regained it (110;112). For people with obesity it is remarkably hard to maintain weight loss. Though  
evidence of weight loss maintenance exists (113;114), it is uncommon, and no convincing 
explanation exists. Persistent changes to behaviour are  hard to achieve in people with obesity,  
as compared to people with eating disorders (115). Binge eating disorders in patients with obesity 
improved significantly in a combined approach, comprising diet, exercise and CBT. Exercise appears 
to offer added value to the nutritional CBT, leading to improved mood, recovery from eating 
disorders and weight loss (116). Additional studies and long-term data are needed to determine 
whether psychological treatments for obesity are truly effective. 
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1.4.1.4 Anti-obesity drugs and supporting diets 
In the 1990s, the combination of fenfluramine and dexfenfluramine proved that significant weight 
loss and weight loss maintenance is possible with medication. However, the combination was 
withdrawn from the market due to increased risk of damage to heart valves (117). In 2000, the 
European Medicines Agency (EMA) withdrew phentermine, diethylpropion, and mazindol, because of 
a perceived unfavourable risk-to-benefit ratio (118). The first selective CB1 receptor antagonist, 
rimonabant was licensed in 56 countries from 2006, but it was never approved by the U.S. Food  
and Drug Administration (FDA) because of unfavourable psychiatric events, such as depression, 
anxiety, and suicidal ideation (119). Rimonabant was withdrawn from the European market in 2009. 
Sibutramine was approved by the U.S. FDA in 1997, but was withdrawn in October 2010, due to its 
association with increased cardiovascular risk and stroke in patients with established cardiovascular 
disease as demonstrated by the results of the SCOUT trial (120). This was disappointing as the SCOUT 
trial specifically recruited patients that were, until that point, contra-indicated from treatment with 
sibutramine and there was no evidence of harm in the group of patients that were treated according 
to the licence of the drug. This left orlistat as the only approved pharmaceutical option for obesity for 
several years. After initial concerns in 2011 regarding possible cardiovascular risks (121), the FDA 
approved the combination of bupropion and naltrexone (Contrave) in September 2014 for obesity 
management (122). In 2013, the FDA approved Qsymia a combination of phentermine  
and topiramate extended-release (123). They also approved liraglutide a GLP-1 analogue for weight 
loss especially as the drug was already approved for the treatment of T2DM. The evaluation of the 
long-term safety and efficacy of newly-developed drugs for obesity is proving difficult. Obesity 
frequently needs continuous treatment to achieve and maintain weight loss, although the inflexibility 
of the regulatory system for the endorsement of novel anti-obesity drugs and the regulatory 
guidelines for anti-obesity treatment are limiting drug development. Given the poor safety track 
record of obesity drugs, the approach of regulatory bodies is understandable, but frustrating (121).  
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Orlistat 
Orlistat is a reversible gastrointestinal lipase inhibitor which reduces calorie absorption by 
attenuating hydrolysation of dietary fat in the gut (124). A meta-analysis of twenty nine studies 
showed that orlistat decreased body weight by only 2.6 kg at six months and 2.9 kg at twelve months 
(125). Waist circumference, blood pressure, total cholesterol, and LDL-C were reduced, while 
glycaemia and insulin resistance were improved (126-128). The effects of a high fat diet, when taken 
in combination with orlistat, are unpleasant and include diarrhea, steatorrhoea, flatulence, bloating, 
dyspepsia and abdominal pain (129). It is important to note these effects, particularly in discussion 
with patients, since understanding this crucial information may help to avoid poor compliance among 
patients upon early negative experiences of side effects. If explained appropriately, then the drug 
may result in a change from “mindless eating” to “mindful eating” with patients changing their diet 
to consume fewer calories from fat and avoid steatorrhoea. A deficiency of the fat-soluble vitamins 
(vitamin A, D, E, and K) is rare and, although no evidence exists to show either positive or negative 
effects, definitive data on long term cardiovascular outcomes are still awaited (130). In combination 
with a low fat diet, orlistat reduces weight and prevents weight regain, while also improving some 
obesity comorbidities (131). The XENDOS (Xenical in the Prevention of Diabetes in Obese Subjects) 
study compared weight loss and new incidence of T2DM over four years in patients with obesity  
and impaired glucose tolerance. Patients were randomised to lifestyle changes plus either orlistat or 
placebo (126). Orlistat combined with lifestyle modification was better for weight loss and T2DM 
prevention, compared with lifestyle modification alone (126). The X-PERT study showed good weight 
loss and reductions of the components of the metabolic syndrome when lifestyle changes were 
combined with diverse dietary interventions and orlistat (132). A systematic review and meta-
analysis of ten studies to assess the effects of orlistat on cardiometabolic risk factors (133) offered 
similar findings to those of a multicentre randomized double-blind placebo-controlled study (RCT) 
comparing orlistat to placebo. All groups had a nutritionally balanced diet with a 600-kcal energy 
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deficit. The orlistat groups lost significantly more weight and maintained the weight loss over two 
years (134). 
Orlistat drug interactions 
Vitamin K absorption may be impaired, and hence warfarin anticoagulation may be potentiated,  
as a result of orlistat therapy (135). Patients on stable warfarin doses who start orlistat should have 
more frequent international normalized ratio (INR) monitoring initially. Other possible drug 
interactions include a decrease in the absorption of amiodarone (136) and cyclosporine (137). 
Contrave® 
Contrave® is a combination of naltrexone sustained-release (SR) and bupropion (SR), which are  
a norepinephrine/dopamine reuptake inhibitor and an opioid receptor antagonist, respectively. 
These drugs are licenced separately for depression and smoking cessation, but both have been 
associated with weight loss (121). In almost all studies, the Contrave® group demonstrated  
a significant weight reduction and improvement in cardiometabolic markers when compared to the 
placebo group. The COR-Diabetes trial showed, that after 56 weeks patients with T2DM  
and overweight or obesity lost more weight and achieved better improvement in glycaemic control 
than those who were treated with a placebo (138). All these patients had simultaneous intensive 
behaviour modification (BMOD), portion size control, calorie counting, detailed daily food intake 
recording and increased physical activity. Patients were instructed to consume a balanced low calorie 
diet with 15–20% of energy from protein, 30% or less energy from fat and 50% from carbohydrate. 
Group sessions were conducted by dietitians, behavioural psychologists, or exercise specialists 
weekly during the first four months of the study, followed by monthly sessions thereafter.  
A combination of Contrave® with the intensive BMOD produced significantly greater weight loss than 
BMOD alone (139). 
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Qsymia 
Qsymia (Qnexa®) is a combination of low-dose phentermine and the antiepileptic agent 
topiramate(140). The combination has been shown to maintain an approximately 10% body weight 
loss. The drug is intended to complement lifestyle modification, a low fat diet, exercise, behavioural 
changes and surgical approaches (123;141). Within trial settings, the drug has been combined with 
the LEARN (Lifestyle, Exercise, Attitudes, Relationship, and Nutrition) Program for weight 
management (142), which included a balanced 500kcal reduced diet. Patients were also offered 
nutritional and lifestyle modification counselling (141-145). 
Liraglutide 
Liraglutide is a glucagon-like peptide-1 (GLP-1) analogue that was first used to treat T2DM. As GLP-1 
suppresses appetite and delays gastric emptying, it was found that liraglutide reduces body weight in 
non-diabetic patients (146). Higher doses of this drug can produce better weight loss, which may 
reach 10 kg in 2 years (146;147). The drug was combined with a 500 kcal reduced diet (30% of energy 
from fat, 20% from protein and 50% from carbohydrates) alongside increased physical activity (148). 
Diet to support anti-obesity drug 
Pharmacotherapy can be useful for treating obesity as a part of a comprehensive approach, which 
includes lifestyle modification (149;150), diet, exercise, and behavioural therapy (132). The most 
successful strategy to use alongside pharmacotherapy initially is the low calorie diet (LCD), 
comprising an intake of 800 to 1500 kcal/day, or a balanced-deficit diet typically around 1500 
kcal/day, which can result in approximately 8% body weight loss over six months. An Expert Panel, 
convened through the National Institutes of Health/National Heart, Lung, and Blood Institute, on the 
Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, suggested a 500 to 
1000 kcal/day deficit diet for people with obesity, aiming at 0.5 - 1 kg weight loss per week. However 
it remains challenging to determine patients’ daily energy requirements and thus calorie-intake 
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guidelines are often based on a patient’s original body weight(151). Regular adjustment of the calorie 
content of any prescribed diet is needed in response to a patient’s weight-loss response and 
treatment goals. Low-fat diet was the typical approach (152), but an increase in proteins and low 
glycaemic index carbohydrates, may be equally helpful (88). It has been shown that people with 
obesity who achieve long-term weight maintenance consume only 25% of their calorific intake from 
fats (153). A low carbohydrate ketogenic diet (LCKD) has been shown to lead to improvements 
comparable with those of orlistat plus low-fat diet (O+LFD) (154;155).  
This LCKD restricted carbohydrate (CHO) intake at first to less than 20 g/d (154;155). This diet 
permitted high fat intake, with patients allowed ad libitum to eat meat, eggs, hard cheese, low-
carbohydrate vegetables (e.g. leafy greens), and moderate-carbohydrate vegetables (e.g. broccoli, 
asparagus) daily, with no restrictions on calorie intake. Approximately five grams from other CHO 
was added to their intake per day each week as they approached their target weight or if cravings 
threatened their compliance. A second group received orlistat (120 mg orally 3 times before meals 
per day), plus a LFD, with fat constituting <30% of daily energy, saturated fat <10% and containing 
<300 mg cholesterol per day. The study showed that both the very high-fat (i.e. the LCKD) and the 
very low-fat diet had similar health benefits. Brinkworth et al. (156) also confirmed that compliance 
with a low-carbohydrate diet can be maintained for 1 year. The combination of orlistat with a LCKD 
has not been tested. Weight loss was considerably greater in patients who regularly attended group 
sessions. This selected population may represent the more motivated patients, or it may be that 
sessions had a positive motivational effect upon patients attending, or indeed a combination. 
Incorporating intensive weight loss programs into medical practice and identifying suitable patients 
requires extra effort from healthcare providers, which may not always be possible (157). Reduction 
in energy intake is the cornerstone for reducing weight, while appropriate nutrition counselling, 
behaviour modification therapy and lifestyle changes could aid weight loss maintenance, adding 
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medications to reduce long term calorie intake might have additional benefits, such as improving 
T2DM, cardiovascular risk, hyperlipidaemia, and sleep apnoea (158). 
1.4.2 Surgical Treatment 
1.4.2.1 Types of bariatric surgery 
Bariatric surgery, like all other surgical interventions, was developed through the contribution of 
many experts (159). The first breakthrough that was led by Drs. Arnold Kremen and Richard Varco, 
surgeons at the University of Minnesota, who recognised that severe obesity, was a disease 
dangerous enough to warrant surgery. Based on the understanding they gained from their 
experience with the “short gut” syndrome, they were able to develop the intestinal bypass,  
a technique that eliminates the majority of the small intestine from interaction with food. They 
established, across numerous procedures, that an end-to-end anastomosis from 36 cm along the 
jejunum to the final 10cm of ileum, with the excluded segment draining into the sigmoid colon, 
provided the greatest expected weight loss. The second major breakthrough came with the cautious 
investigations of Dr. Edward Mason, also a member of the Minnesota group, who recognised that 
weight loss could be attained just as successfully, and far more safely, through two gastric 
procedures, the gastric band and the gastric bypass(160). These two operations continue as the most 
broadly performed bariatric procedures in the world today (161). The third innovation was  
the documentation by Pories et al. (162) and MacDonald et al. (163), with very impressive  
95% follow-up of 608 patients for up to 16 years, that the gastric bypass procedure not only led to 
weight loss of more than 45 kg, but also controlled comorbidities, including T2DM, and reduced 
mortality. A fourth main development was the demonstration in 1994, by Wittgrove and Clark (164), 
that the gastric bypass, as an invasive abdominal surgical operation, could be performed using  
a laparoscopic approach, improving its safety and reducing the associated trauma. The fifth 
remarkable shift was the introduction of quality control of bariatric surgery on a national basis and 
the demonstration that these operations can be done with very low rates of mortality and morbidity 
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in centres with high capacity and experience. An example of this is the American Society for Bariatric 
and Metabolic Surgery (ASMBS), which rolled out a program for the certification of Bariatric Centres 
of Excellence (165). Bariatric surgical procedures that modify the anatomy of the gastrointestinal 
tract reduce caloric intake as a result. Operations have historically and possibly wrongly been 
categorised as either ‘restrictive’ or ‘malabsorptive’. ‘Restrictive’ procedures were said to work by 
limiting the food intake by means of reduction in the volume of the gastric reservoir, along with  
a narrow outlet to delay emptying, such as in the case of the gastric band. “Malabsorptive” 
procedures bypass varying portions of the small intestine, where nutrient absorption take place 
(166), and were therefore thought to reduce the proportion of calories that could be extracted from 
ingested food. Procedures thought to limit intake and produce malabsorption concurrently, were 
classified as ‘mixed’ procedures, such as the gastric bypass and duodenal switch(167).  
 
Figure  1.4.2-1 Types of Bariatric Surgery 
 
Bariatric Surgery a. Roux-en-Y gastric bypass, b. Adjustable gastric banding and c. Vertical sleeve 
gastrectomy. 
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Restrictive procedures include gastric stapling (gastroplasty) and adjustable gastric banding or  
a combination of these two approaches. Adjustable gastric banding (AGB) is performed by wrapping 
a synthetic, expandable band around the stomach to create a small pouch with a narrow outlet.  
It also includes the insertion of a subcutaneous reservoir, continuous with an inflatable portion of the 
band, so that gastric restriction can be adjusted by means of saline injections. AGB is performed 
laparoscopically, and the band is removed during a second laparoscopic procedure (Figure ‎1.4.2-1-b) 
(168). Another more recently developed procedure is the vertical sleeve gastrectomy (VSG)  
(Figure ‎1.4.2-1-c), in which resection of much of the gastric body along its greater curvature, leaving  
a narrow tube of stomach as an alimentary channel, with around 75% of the stomach removed (166). 
Proximal Roux-en-Y gastric bypass (RYGB) (Figure  1.4.2-1-a) is often referred to as a mixed 
procedure. It includes stapled transection of the stomach to produce a small (~25 ml) upper gastric 
pouch.  
The small intestine is divided approximately 70-100 cm along the jejunum, and the distal portion 
(called the alimentary, or Roux limb) is anastomosed to the gastric pouch as a gastrojejunal (GJ) 
anastomosis. The proximal part of the jejunum remains in continuity with the duodenum and distal 
part of the stomach, as the biliopancreatic limb. This limb drains digestive juices from the stomach, 
liver, gallbladder and pancreas downstream, where its end is anastomosed, end-to-side, to the 
jejunum of the alimentary limb as a jejuno-jejunal (JJ) anastomosis, approximately a further  
70-100cm distal to the GJ anastomosis. The result is a Y-shaped Roux construction – referred to as 
the Roux-en-Y construction - whereby undiluted gastric, biliary and pancreatic secretions meet 
ingested food approximately 150 to 200cm along the jejunum at the JJ anastomosis. The intestine 
beyond the JJ anastomosis is referred to as the common channel. The shorter this common channel 
is (and therefore the longer the Roux limb), the greater the effect is likely to be on weight loss, but 
also micronutrient deficiency (169). A balance must, therefore, be struck. True calorie malabsorptive 
procedures include biliopancreatic diversion (BPD), often performed as a variant procedure called 
duodenal switch (DS), which incorporates a vertical sleeve gastrectomy. Some surgeons perform  
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a sleeve gastrectomy as phase one of a two-staged operation, performing a Roux-en-Y gastric byass 
procedure after initial weight loss has made surgery less challenging and reduced the operative risk 
(166). It was stated that in 2008 worldwide approximately, 344,200 bariatric surgery operations were 
performed by 4,680 bariatric surgeons; approximately 220,000 of these operations were performed 
in USA and Canada by 1,625 surgeons. At the time the most commonly performed procedures were 
LAGB with 42.3%, laparoscopic RYGB with 39.7%, and vertical sleeve gastrectomy (SG) with 4.5%, and 
over 90% of all procedures were performed laparoscopically (170). These trends have now changed 
with the gastric band becoming less popular and the sleeve gastrectomy more popular. Bariatric 
surgery has increasingly been identified as metabolic surgery, as all procedures for weight loss, 
whether described as restrictive, malabsorptive, mixed, or other, involve neuro-hormonal 
mechanisms. Buchwald proposed a definition of metabolic surgery in 1978 as: "the operative 
manipulation of a normal organ or organ system to achieve a biological result for a potential health 
gain" (170).  
Bariatric surgery’s primary goal is the improvement of obesity-related medical problems.  
Its outcomes should be evaluated in terms of both significant weight loss and improvement of 
obesity related medical disorders (171). It has been documented that bariatric surgery in morbidly 
obese patients' reverses, eliminates, or significantly improves diabetes, hypertension, 
hyperlipidaemia, and obstructive sleep apnoea. These benefits will take place in most patients who 
undergo weight loss surgery (172). Two studies by Schauer et al. (173) and Sugerman et al. (174), 
have reported almost matching rates of resolution  of T2DM as in a meta-analysis did; 83% and 86%, 
respectively. In addition, after 2 years of follow-up, a 60% reduction in plasma insulin and  
a 20% reduction in the plasma glucose were seen in the surgical weight loss group of the Swedish 
Obesity Subjects study (SOS) (175). The control group at 2 years had a 3.7-fold higher risk of diabetes 
onset. Diabetes often resolves in days following bariatric surgery, even before noticeable weight loss 
occurs (162). In addition, improvement or resolution of hypertension is also observed. In the present 
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analysis, improvement in obstructive sleep apnoea was 80% or even higher range. Overall wellbeing, 
social function, self-confidence, body self-image, ability to interact with others, and spending time  
in recreational and physical activities also improve after successful bariatric surgery. Productivity  
and economic opportunities are better, with new employment and greater employment satisfaction. 
Generally all therapeutic interventions balance effectiveness against risk. In such evaluation, bariatric 
surgery fares extremely well. The operative 30-day mortality rate is around 0.1% for restrictive 
procedures, 0.5% for gastric bypass, and 1.1% for biliopancreatic diversion or duodenal switch 
associate positively with the accepted operative mortality rates as compared with other major 
surgical procedures (172). After 2 years, most patients reach their maximum weight loss. Thereafter, 
patients often experience a slight regain of weight by the fifth year, in the order of 5–7%, followed  
a steady reduction again over the subsequent years (161). According to Evola et al. and other groups, 
it was concluded that bariatric surgery is capable of resolving pathology that has previously been 
considered irreversible by endocrinology specialists, dieticians, internists and psychologists. Despite 
this, it is essential to study the potential complications of bariatric surgery. It is important to point 
out that some patients require a further operation following bariatric surgery, often for internal 
hernia, or gallstone disease. In a very small group, reversal of procedure is required for uncontrolled 
nutritional deficiency, although this is generally restricted to the more aggressive, less common 
procedures such as BPD(176). The standardization of bariatric surgical procedures and care has likely 
contributed to a reduction in mortality rates. Nevertheless, the complications after bariatric surgery 
can be lethal and may require urgent treatment by suitably experienced surgeons, familiar with these 
complications. These complications can be classified into two groups: acute and long-term. Acute 
complications, which may occur in 5–10% of the patients, depend upon the procedure, patient age, 
and other pre-operative risk factors, and are similar those encountered after other abdominal 
operations, i.e. haemorrhage, anastomotic leak, infection, obstruction, arrhythmia, and pulmonary 
emboli. Because of excess weight, rhabdomyolysis may also see, particularly after prolonged 
operations. 
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Surgeons with limited experience of long-term complications after bariatric surgery may struggle in 
managing them. Such long-term complications include neuropathies due to nutritional deficiencies, 
internal hernia, anastomotic stenosis, and emotional disorders. Though a daily chewable multi-
vitamin and mineral supplements will help in avoiding potential nutritional deficits (167). 
1.4.2.2 Bariatric surgery in adolescents 
Bariatric surgery is now being considered as a possible paediatric intervention, for the same reasons 
that it has proven effective in adults. The dramatic increase in obesity prevalence has occurred not 
only in adults, but also in young people (177), illustrating the need for effective preventive measures, 
and beginning early in life to improve dietary habits and increase physical activity. Bariatric surgery  
is presently considered as a “rescue” approach for patients with severe obesity (178). Previously,  
18 to 65 years was the age limit for such surgery, but recent data have showed that adolescents and 
the elderly (≥70 years) may also benefit from this kind of surgery, with little or no increase in risk 
(167). Most of the evidence proves that nonsurgical methods such as diet and exercise for weight 
control have failed to achieve sustained weight loss in young people with severe obesity (179). 
Available studies with hypocaloric diets, very-low calorie regimens, exercise, behaviour modification 
and pharmacological agents have demonstrated ineffectiveness. Studies that have lasted for longer 
than 1 year have been few in the literature until recently. In a study of 1,187 young people, 
evaluating a hypo-caloric diet and orlistat (180) of the subjects receiving a hypo-caloric diet alone, 
295 withdrew within 4 weeks of the start of the programme. Of the remaining 892 subjects, 668 
received orlistat plus the hypo-caloric diet, only 306 (46%) of whom completed the study. From the 
limited group of subjects completing the study, an average of 5.56 kg was lost across 2 years (181). 
As per Inge et al. the initial experiences with surgical treatment for adult obesity were first published 
in the late 1960s (182;183). During the 1970s and 1980s the bariatric procedures for young people 
with severe obesity were first described. Bariatric procedures such as jejuno– ileal bypass were 
performed on at least 20 young people (age range 11–20 years) with a preoperative weight of  
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≥120 kg (184;185). The procedures resulted in 34–36% weight reduction among these subjects. 
Significantly improvements in T2DM, hypertriglyceridemia and general quality of life were also 
reported. However, fat soluble vitamin deficiencies, electrolyte abnormalities and diarrhoea also 
were common. Reversal of the jejuno–ileal bypass was necessary for many patients in response to 
these nutritional complications(184;186). As a result of the high risks associated, this procedure is no 
longer used (187) in the treatment of adult and adolescent obesity (188-190). Biliopancreatic 
diversion (BPD) was also performed for small number of young people, involving a partial 
gastrectomy and bypass of a large portion of the small bowel. However, this operation carries a high 
risk of postoperative protein and micronutrient deficiency (191). Specific complications have 
included hypoalbuminaemia, deficiencies of vitamins A, D and folic acid. It was suggested that such 
malabsorptive procedures should not be considered first-line among weight loss procedures for 
young people. Between the early 1980s and mid 1990s surgeons developed the vertical-banded 
gastroplasty (VBG) as an alternative procedure (160;192;193). Following on from the VBG, the 
vertical sleeve gastrectomy (VSG) was subsequently developed and is increasingly being used both in 
adults and adolescents. Mean BMI decreased by 25% at 5 years and 22% at 10 years after VBG (160). 
Adult patients who have undergone VSG alone have lost significant weight (approximately 25%) over 
a 6-month period, with few nutritional side effects (194). Longer-term follow-up is needed to 
determine the relative benefits and risks of the VSG compared with other procedures (195).  
RYGB has been used for weight loss in the US since 1960s for adults and the 1980s for young people 
(191;192;196). The largest retrospective study of adolescent bariatric surgery with the longest 
follow-up to date was provided by Sugerman et al. over a 21-year period between 1981 and 2002, 
thirty-three adolescents underwent different types of procedures including 30 with RYGB and 3 with 
horizontal or vertical gastroplasty (197). Mean preoperative BMI was 52 kg/m2 with mean age of 16 
years. Major complications observed within a month of the procedure comprised one major wound 
infection, one pulmonary embolism, three stomal stenoses requiring endoscopic dilation and four 
ulcers within the Roux limb-treated medically. Late (beyond one month) complications comprised 
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one small bowel obstruction and six incisional hernias. Two late deaths occurred, one at 1 year and 
one at 6 years. Although post-mortem was not performed after either of these sudden deaths, it was 
thought that these deaths were unconnected to the surgical procedure. Results have also shown that 
all preoperative comorbidities had resolved at 1 year except for gastroesophageal reflux and 
hypertension in two patients each. Mean BMI, measured at 1, 5, 10 and 14 years after surgery, was 
36, 33, 34 and 38 kg/m2, respectively. Only five patients (15%) regained all or most of their lost 
weight at 5–10 years after surgery (197). Generally, in young people who have completed linear 
growth, a BMI of 40 kg/m2, or 35 kg/m2 with obesity-related co-morbidities, can be used as eligibility 
criteria for surgical intervention for obesity (198).  
AGB is another procedure explored in the treatment of obesity (199). An Australian adolescent series 
is considered the largest to date, consisting of 41 young people (age range 12– 19 years) with a mean 
weight of 125 kg, and a mean BMI 42 kg/m2. Weight loss in the region of 30% was reported 3 years 
postoperatively among the 18 patients, with 3-year data available. All patients’ comorbidities 
improved and few complications were reported during follow-up. One patient experienced gastric 
prolapse (band slippage) needing band repositioning, and one experienced a leak from the tubing 
requiring a revision procedure. RYGB achieves greater weight loss and comorbidity resolution, as 
compared to AGB, at 1–3 years (200;201), although comparable weight loss has been shown at later 
(5 year) time intervals 33 (198). Tsai et al. have recently examined the temporal trends in utilization 
of bariatric surgery in young people, using the National Inpatient Sample, a large US administrative 
database (202). Over 3000 bariatric procedures were carried out for young people between 1996 and 
2003. Around 200 cases per year were initiated between 1996 and 2000. From 2000 to 2003 
however, the use of weight loss procedures in young people increased up to three-fold, with gastric 
bypass accounting for around 90% (203). Since then, VSG has begun to catch up with RYGB in 
popularity. While there appears to be a good foundation to support bariatric surgery in young 
people, the associated nutritional risks must also be considered and explored in the long term (204). 
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There is potential for inadequate absorption of calcium, iron, folate, vitamins B1, B6, B12, A and 
vitamin D, especially in the absence of micronutrient supplements (205-208).  Even procedures which 
cause no micronutrient malabsorption might result in reduced consumption of macro and 
micronutrients with possible risks for young people. Up-to-date supplementation practices are often 
founded upon standards established in adults, in whom regimens often differ from one surgical 
centre to another. Reliable evidence to inform doses and types of nutritional supplementation is 
lacking. The increased length of time the young people are expected to live with altered physiology 
and anatomy, as well as perceived poor compliance during this critical developmental period 
represent additional difficulties that are not usually seen among adult bariatric candidates. Optimum 
supplementation regimens must be determined (198).   
1.4.2.3 Safety and ethics of bariatric surgery in adolescents 
The performance of bariatric surgery in paediatric patients raises significant ethical questions. The 
central ethical matters before deciding on a bariatric procedure for an adolescent obese patient are 
whether the patient’s health is being compromised by morbid obesity, and whether comorbidities 
are treatable by less invasive means. Surgery is generally not considered in adolescents unless the 
patient has tried conservative measures but failed. An additional important consideration is the 
patient’s ability to demonstrate decisional capacity (177). The adolescent patient with obesity  
and their family should receive extensive preoperative counselling and give informed consent. 
Additionally, the bariatric team should have a comprehensive system of short-and long-term care in 
place (209). Capacity to make decision is not determined strictly by chronologic age. A 13 year-old 
adolescent obese patient, if developmentally normal, might be able to make informed decisions. 
Thereafter the multidisciplinary bariatric team should determine collectively whether they believe 
the patient has capacity, clearly documenting as such. Patients with decisional capacity must be 
allowed to contribute to decisions regarding their care (177). 
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1.4.2.4 Vertical Sleeve Gastrectomy 
VSG is a relatively recent procedure, with an advanced learning curve. In a randomized prospective 
study comparing the results of AGB and VSG after 1 and 3 years of follow-up (210), the median 
weight loss after 1 year was 14 kg for AGB and 26 kg for VSG; and after 3 years  17 kg for AGB and 
29.5 kg for VSG. The median decrease in BMI after 1 year was 15.5 kg/m2 for AGB and 25.0 kg/m2 for 
VSG; and after 3 years were 18.0 kg/m2 for AGB and 27.5 kg/m2 for VSG. The percentage excess 
weight loss (%EWL) at 1 year was 41.4% after AGB and 57.7% after VSG; and at 3 years was 48% after 
AGB and 66% after VSG. The improvement in feelings of hunger after 1 year was noted in 42.5% of 
the patients with AGB and 75% of the patients with VSG; and after 3 years this decreased to 2.9%  
in the AGB group and 46.7% after VSG. Craving for sweet eating was improved, albeit not significantly 
so, after 1 year in 35% within the AGB group and in 50% in the VSG group; and after 3 years these 
numbers decreased to 2.9% in the AGB group and 23.3% in the VSG group. These study results  
at 1 year after VSG are comparable to those reported by Langer (211), Baltasar (212) and Johnston 
(213). The first factor accounting for the differences between the two procedures in terms of weight 
loss and of improvement in hunger sensation is the difference in hormonal effects between  
the procedures. Ghrelin, an acylated upper gastrointestinal peptide, is an orexigenic hormone whose 
circulating levels rise before meals, stimulating hunger, and fall after eating, with a corresponding 
cessation of hunger (214). VSG also contributes to reduced stimulation of the hunger centre because 
of removal of the gastric fundus. One limitation of restrictive surgery is related to “sweet eating”, 
which seems to continue after the procedure. Craving for sweets has been shown to return after  
3 years, moreso for AGB than for VSG (210). VSG is intended to reduce appetite by decreasing the 
volume of the stomach, producing a sense of fullness after reduced oral intake (166;212;215-217). 
Initially, gastrectomy was performed for the resection of gastric neoplasms, before its subsequent 
adaption for  bariatric surgery, taking advantage of the significant weight loss observed as a side 
effect (218).  Johnston et al. (213) described a similar gastric division without resection for weight 
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loss that was called the Magenstrasse and Mill procedure. As a weight loss procedure, VSG was first 
defined by Hess and Marceau et al. (219;220) as part of the biliopancreatic diversion – duodenal 
switch (BPD/DS) surgery. In 2000, Ren et al. (221) desribed performing this surgery completely 
laparoscopically, and subsequently defined VSG as the first of two stages for high-risk obese patients 
(222). It was later proposed that VSG constitutes an easier, faster, and hence safer procedure in 
these high-risk patients than RYGB, BPD or DS (223). Baltasar et al. suggested that good candidates 
for VSG include the super-obese (BMI>55), as a first stage for the laparoscopic DS; class III obese 
patients (BMI ≥40) with severe medical disease such as cirrhosis, or Crohn’s disease; patients with 
lower classes of obesity profoundly affected by co-morbid conditions; patients who have previously 
undergone AGB and subsequent band removal; and, finally, the morbidly obese adolescent. 
Following VSG, it is possible that the remnant stomach may expand or that gastric emptying may 
slow down again. In this situation, performing a second sleeve gastrectomy is still an option (224), 
although many bariatric teams would consider RYGB as the next option. A large body of evidence 
determined that VSG may be a definitive weight loss procedure for some patients. It is typically 
considered a technically less challenging procedure than RYGB and BPD/DS, and can achieve both 
impressive weight loss and reversal of obesity-related comorbidities. Since VSG is a restrictive 
procedure, so it appears to lead to fewer nutritional concerns compared with more malabsorptive 
weight loss procedures and many patients do not appear to need additional procedures. VSG is been 
increasingly performed around the world and, as evidence builds regarding its long-term effects on 
weight loss and its maintenance, researchers have suggested that this surgery will be broadly 
adopted in the future (223).  
Numerous advantages for the VSG have been presented in the literature: 1) stomach volume reduces 
without significant impact on function, so most food items can be consumed, though in lesser 
amounts; 2) the stomach portion that is believed to be associated with the hunger stimulating 
hormone, ghrelin, is removed; 3) dumping syndrome doesn’t occur since the pylorus is preserved; 
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 4) the chance of developing a peptic ulcer is reduced; 5) avoiding the intestinal bypass helps reduce 
risks of intestinal obstruction, osteoporosis, anaemia, protein and vitamin deficiencies; 6) it is an 
effective first-stage procedure for patients with high BMI (BMI>55 kg/m2); 7) It seems, according to 
the limited results in the literature, to be a promising standalone procedure for patients with low 
BMI (BMI 35-45 kg/m2); 8) it is a tempting choice for people with existing anaemia, Crohn’s disease 
or other conditions that increase the risk of intestinal bypass procedures; 9) it can be performed 
laparoscopically in patients that are >225 kg of weight; 10) no foreign body is introduced; 11)  
the operative time is relatively short compared to other procedures; 12) patients recover easily; 13) 
relatively few associated side-effects; 14) it is a substitute for the AGB and gastric balloon that need 
recurrent adjustments and are foreign bodies as well; 15) in the case of inadequate weight loss, 
progression to RYGB or DS are still feasible 16) it is a very good procedure for morbidly and super-
obese young people, in whom some would argue more aggressive surgery should be avoided 
(224;225). On the other hand some disadvantages of the VSG have been recognised: 1) the possibility 
of insufficient weight loss or weight regain (although this may occur in all weight reduction 
procedures, especially with operations that do not involve an intestinal bypass); 2) patients with 
higher BMI may require a second-stage operation in the future to help them lose the remaining 
excess weight. This may be safer for high BMI patients than performing a single operation with  
a greater physiological burden; 3) soft, easily absorbed calorie-dense foods, such as milkshakes, ice 
cream and melted chocolate, can be still consumed in high volumes, conteracting weight loss effects; 
4) gastric staple line leakage and other complications associated with stapling may take a place; 5) 
the procedure is non-reversible because of stomach removal, but practically it can be converted to 
any other weight loss procedure; 6) some surgeons and insurance companies still considers it as 
investigational procedure;  finally 7) results from long-term follow-up are not available yet (224;225). 
1.4.2.5 Vertical Sleeve Gastrectomy in adolescents 
VSG is emerging as a standalone procedure in adolescents (222). From 1997 to 2003, the volume of 
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adolescent bariatric surgery performed in the United States was projected to have increased 5-fold, 
from 51 to 282 (226). Data from a global survey indicated an increase in the use of VSG from 0% of all 
procedures in 2003 to 5.4% in 2008 (170). Results from 15 studies of VSG including 940 adult subjects 
revealed excess weight losses (EWL) of 46% to 83% 1 year after surgery (227), with reports of weight 
loss maintenance up to 5 years after surgery (228). A 6-year follow-up for a total of 30 patients who 
underwent VSG showed a mean (EWL) of > 50% (229). The majority of studies reporting 
consequences after VSG involve adult patients. VSG for treating severe obesity in young people has 
been reported. A small study of adolescents patients (n=7) revealed weight loss in 6 of 7 patients, 
improvement in comorbid conditions and no operative complications (230). Another small study 
(n=4) established similar findings with no postoperative malnutrition or vitamin deficiency (231-235)   
Nineteen young patients in the USA, aged 13-17, underwent vertical banded gastroplasty or RYGB 
between the period between May 1990 and August 2001. The average BMI was 49 kg/m² and almost 
all patients had one or more co-morbidities. Follow-up was completed to 10 years. Treatment was 
considered to have failed in only one participant, who failed to lose sufficient weight. In addition, two 
patients required surgical revision, but no mortality or morbidity was reported. The emerging body of 
evidence suggests that an early surgical intervention must be accessible to a larger number of young 
people to minimize the emotional and physical consequences of morbid obesity (181). A recent study 
of a larger series of young people undergoing VSG between March 2008 through February 2011  
was published by Al Qahtani et al. the group reported data from 108 patients aged 5 through 21 
years. Patients attended follow-up visits at 3 (n = 88), 6 (n = 76), 12 (n = 41), and 24 (n = 8) months 
postoperatively and experienced median EWL of 28.9%, 48.1%, 61.3%, and 62.3%, respectively.  
No serious postoperative complications were reported. Available co-morbidity data pointed out 
improvement of dyslipidemia in 70%, hypertension in 75%, prehypertension in 83%, obstructive 
sleep apnoea in 91%, diabetes in 94%, and prediabetes in 100% (236). Al Qahtani published a recent 
updated data for 226 paediatric patients and concluded that VSG resulted in successful short-term 
weight loss among paediatric patients. Additionally, improvement or remission of 90.3% of 
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comorbidities was reported, 64.9% of which were within the first 12 weeks‎ after surgery. No further 
improvement or remission was observed beyond 2 years, and there was no recurrence up to 3 years 
in patients who were seen in follow-up. The loss to follow-up in each of the 3 years was 4.2%, 7.6%, 
and 15.3%, respectively (237). Long-term data are needed for better understanding and evaluation of 
the maintenance of weight loss, especially into adulthood (236;237). The most up to date study was 
published by Al Sabah et al., with a total of 135 adolescent patients underwent VSG were followed up 
for an average of twenty months. The patients had a median age of 19 years (range 12-21) and  
a mean BMI of 48.5 kg/m². The %EWL at 2 years for males and females was 84 and 77%, respectively. 
All  patients with T2DM and 75 % of those with hypertension demonstrated complete resolution  
at 2 years (238). Al Qahtani and colleagues described several concerns and disagreements 
surrounding the use of bariatric surgery for weight loss in severely obese young people. In a recent 
report of a randomized controlled trial (RCT) comparing LAGB with lifestyle changes in adolescents, 
O’Brien et al (239) encourage the reversible LAGB over irreversible procedures, stating that “better 
therapies are likely to become available during the active life of the adolescent”. 
Al Qahtani’s review voiced disagreement with this opinion, suggesting that the damage of waiting 
may be greater than the benefit that could be achieved in patients who lose less weight and 
experience exacerbation of their co-morbidities. Inge and Xanthakos (240) urged caution around 
using VSG in very young people and concluded that “there is good reason to believe [it] may be 
contraindicated” in growing children. They rightly highlight possible physiological consequences of 
gastrectomy that might influence normal growth and bone development in pre pubertal children. 
However, the same team stated that this is a research area with many unanswered questions. 
Disagreement exists surrounding the effects of obesity itself on bone development. Several authors 
have reported advanced bone age and mineral density in obese young people (241). Al Qahtani 
suggested that, as paediatric obesity is increasing in prevalence and severity, the increasing problem 
of super obesity in youth now requires the attention of all paediatric health-care providers, along 
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with cautious study of all rational interventions at the societal as well as individual level. In this 
regard, accumulating evidence proposes that young people who are currently undergoing bariatric 
surgery should expect significant improvements in obesity status and associated comorbidities. It is 
also promising that improvements in health and psychosocial wellbeing may go beyond course of 
these young people with extreme obesity, after co-morbidities could be expected  that which would 
be anticipated if weight loss surgery were postponed until later in the life course of these young 
people with extreme obesity, after co-morbidities could be expected to have progressed. Following 
increasing numbers of reports of positive outcomes in both medical literature and an increasing 
overall acceptance in the global media, it seems likely that greater numbers of young people will 
pursue surgical interventions for obesity in the future (198). 
 
1.5 Mechanisms of weight loss following bariatric surgery: lessons learned from RYGB 
The Roux-en-Y gastric bypass (RYGB) includes a small gastric pouch (15-30 mL) on the lesser gastric 
curvature (242;243), which is completely divided from the gastric remnant and then anastomosed to 
the jejunum (leaving an alimentary or Roux limb of typically 70-100 cm). The size of the gastro-jejunal 
anastomosis is controversial as initially it was thought that an element of restriction may be helpful 
in slowing the progress of food from the esophagus into the jejunum, but more recently the aim has 
been rapid transit of food into the jejunum to generate the gut signals to reduce meal size (244). 
Bowel continuity is restored by an entero-enteral anastomosis between the excluded biliopancreatic 
limb (BPL) and the alimentary limb. This anastomosis is usually performed 70-100 cm distal to the 
gastro-jejunostomy, although it has also been performed up to 250 cm distally in an attempt to 
induce calorie malabsorption (242). Recognising the potential of operations such as the 
biliopancreatic diversion or mini-gastric bypass to employ a longer BPL and achieve greater reduction 
in insulin resistance, renewed interest has emerged surrounding in the length of the biliopancreatic 
limb BPL (245). Operative times vary from around 45 to over 120 minutes depending on the specific 
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technique and surgeon, and the average hospital stay is usually 1 to 3 days, although successful 
same-day discharge following RYGB procedure has been reported (246). Early complications, within 
30 days after surgery, occur in approximately 4% of patients and include bleeding, anastomotic 
leakage and visceral perforation, each of which may require surgical re-intervention (195). Late 
complications, such as significant abdominal pain, small bowel obstruction, anastomotic stenosis or 
marginal ulceration, can occur in 15-20% of patients from 30 days after surgery onward and surgery 
or endoscopic treatment are often used both for diagnosis and treatment (247). Even though RYGB 
does not address some of the aetiological factors of morbid obesity, such as the obesogenic 
environment we live in, it does successfully achieve 20-30% weight loss and maintenance across  
2 years or more (248-250). It also offers improvement or remission of much obesity-related co-
morbidity (251-255), such as hypertension, T2DM, obstructive sleep apnoea (OSA), and 
musculoskeletal pain. Approximately 40% of obese patients with T2DM go into remission within days 
or weeks after RYGB (256). RYGB is the most extensively studied procedure regarding underlying 
weight loss mechanisms. Below is a description of the mechanisms through which RYGB surgery 
enables weight loss for obese patients, which helps in understanding its complications following 
studies in both humans and animal.  
1.5.1 Food intake 
1.5.1.1 Research studies 
Hunger and fullness  
Lifestyle changes involving a lower calorie diet can be effective at initiating weight loss. However, 
most of the results from randomized controlled trials (RCT) are disappointing regarding long term 
weight loss maintenance (257;258). Approximately 70-80% of patients fail to maintain their initial 
lifestyle-induced weight loss and this is thought to be due to physiological compensatory responses 
that defend the previous weight “set point” (259). Whilst on a long-term low-calorie diet, patients 
usually report an increase in hunger, a decrease in satiety and pre-occupation with energy-dense 
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fatty and sweet food (260;261). This may be part of a normal physiological response, rather than 
being due to lack of motivation. Reduced calorie intake after RYGB is usually a consequence of 
significantly smaller meal sizes, and reduced calorie content of food eaten (262), compensated only 
partially by increased meal frequency (263). Enhanced satiety is the dominant contributing factor 
(264). A dramatic decrease in daily energy intake, to around 600-700 Kcal (262;265), during the first 
month post-surgery is followed by an increase in intake to 1000-1800 Kcal over the first year 
(262;266-272). An average reduction of 1800 kcal per day from pre-operative intake can be sustained 
for several years (272;273). Protein intake during the first year after surgery is often lower than 
recommended, at 0.5g/kg, rather than the recommendation of at least 1.5gm/kg/day (274;275).  
The mechanisms are unclear, but this may be due to a temporary intolerance of higher protein diet 
and dairy foods (262;265;267;276-278). The relative intake of fat and carbohydrates decreases 
during the first year post-surgery, but returns to baseline levels after one year (262), although the 
contribution of high and low glycaemic index carbohydrates may change. Many patients reduce their 
intake of high glycaemic index carbohydrates and increase their intake of lower glycaemic index 
carbohydrates. Changes in behaviour associated with eating after RYGB were reported in the 1970s 
using structured interviews, which suggested that patients reached satiety more quickly, the most 
common reason given as a “lack of desire” for food (279). 
1.5.2 Potential Mediators  
1.5.2.1 Increased transit of food into the mid gut through the gastric pouch 
Whether the size of the gastric pouch and stoma in RYGB surgery affects food intake and body 
weight is contested. It remains controversial in both the human and animal literature whether  
a larger gastric pouch and stoma causes less weight loss (280;281;281-284). The stoma may initially 
cause food to be “stored” in the pouch and not empty rapidly enough, but appears to become more 
“compliant” with time, allowing food to transit more easily from the pouch into the alimentary limb. 
Thus, the initial diameter of the anastomosis may not affect weight loss in the long term (285). To 
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study the effects of RYGB stoma size, a high pressure manometer was used, which showed that  
a large stoma with a small pouch was associated with a lower pressure in the pouch (immediately 
proximal to the gastrojejunal anastomosis) compared with the alimentary limb (286). This suggests 
there was no restriction at the level of the stoma, because of the absence of a high-pressure zone 
proximal to the pouch. Insertion of a gastric balloon into the alimentary limb and inflation of the 
balloon to a pressure of 20 cm water demonstrated that patients with the highest pressure 
generated by the alimentary limb had the smallest meal volume during an ad libitum meal.  
In contrast, those with the lowest pressure in the alimentary limb took longer to terminate their 
meal. Mechanoreceptors within the alimentary limb may be important determinants of meal size if 
food rapidly transits through the pouch to reach the alimentary limb in a less digested state than 
usual. The component that determines caloric intake may be the alimentary limb and not the pouch 
size or stoma diameter. 
1.5.2.2 Hormonal 
RYGB alters endogenous gut hormone responses to a meal. Glucagon like peptide-1 (GLP-1), peptide 
YY (PYY), and ghrelin have been the best studied candidates in the context of reduced food intake 
and sustained weight loss after RYGB. GLP-1 and PYY responses to mixed meals or oral glucose have 
been at the centre of interest of several studies investigating patients six weeks to 10 years after 
RYGB (287-292). Significantly elevated responses are seen in GLP-1 and PYY as early as 2 days after 
RYGB (293) and may remain elevated for more than a decade after RYGB (294). Patients who lost the 
most weight after RYGB also had the highest levels of these postprandial satiety gut hormones 
(295;296). Blocking the release of these hormones in humans and rats with octreotide increased food 
intake after RYGB, but not after adjustable gastric banding (AGB) surgery in humans (292) or sham 
operations in rats (297). Mechanistic studies in rodents have suggested the physiological significance 
of PYY, because weight loss in PYY-knockout mice after a RYGB variant was lower than in wild-type 
mice (298). Exogenous PYY specific antibodies also increased food intake in rats after bypass type 
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procedures (292). Physiologically, PYY has been shown to delay gut transit time, but probably does 
not increase energy expenditure in human (299).  GLP-1 responses are very similar to those of PYY 
after RYGB, but have additionally been linked with increases in insulin secretion (300;301). 
Postprandial responses of GLP-1 before surgery do not correlate with change in weight loss after 
surgery, suggesting that pre-operative gut hormone responses are not prognostic (302). Enhanced 
GLP-1 signaling on its own is also not sufficient to reduce body weight after RYGB suggesting that it is 
multiple gut hormone responses that mediate the increased satiation after a meal (303). Reduced 
ghrelin was the first proposed hormonal mechanism to explain weight loss after RYGB. At first ghrelin 
levels were thought to be lower compared to diet-induced weight loss, which increased ghrelin in  
a control group subjects (304). It was postulated that this decrease was partially responsible for 
reduced hunger after RYGB. Subsequent studies in patients after RYGB were more controversial, 
reporting a reduction in fasting and postprandial ghrelin levels (291;305-311), no alteration in fasting 
and postprandial levels (292;293;312-320), and a rise in fasting ghrelin levels (321-325). Considering 
all the data and variability, it is likely that RYGB results in a comparative ghrelin deficiency 
considering that ghrelin normally increases after diet-induced weight loss, but the magnitude of this 
contribution is unclear (326;327).  
1.5.2.3 Neural 
The vagal afferent fibers in the gastric and proximal small bowel mucosa are known to be sensitive to 
mechanical stretch in order to detect the volume of ingested food (328). The vagus nerve, with both 
the ventral and dorsal gastric branches on the large gastric remnant, is transected during the 
formation of the gastric pouch. The vagal fibers to the gastric pouch are thus intact and these could 
mediate satiety as food passes through the pouch. The vagal denervation more distally may 
attenuate signaling. Taken together, this may play a role in satiation (329). Visceral sensory 
information from the gut is communicated centrally using the afferent (sensory) vagus nerve 
signaling to the nucleus of the tractus solitarius (NTS). Here, visceral sensory information, hormonal 
61 
 
and metabolic inputs are integrated together with neuronal inputs from other brainstem areas (330) 
and may well be the most important way in which RYGB signals to the brain. Transmission of these 
signals involving gut hormones, such as ghrelin, may be impaired after vagotomy (331). RYGB 
appears to have the potential to alter neural responses (332) to reduce hedonic behaviour associated 
with eating highly palatable and calorie dense foods. These changes in reward value of food may 
alter the amount of food consumed (279;333-335). 
1.5.2.4 Change in bile acids  
Bile acids are agonists for the cell-membrane G protein-coupled receptors, TGR5, which in turn 
enhance the release of GLP-1 and PYY. Bile acids also bind the farnesoid X receptor (FXR) (336). The 
anatomical changes after RYGB result in bile progressing down the biliopancreatic limb to the distal L 
cells without mixing with food. As a result the availability of undiluted bile acids in the distal intestine 
may enhance stimulation of TGR5 receptors on L cells (337). Serum bile acid concentration is raised 
after RYGB (338) and is associated with increased energy expenditure possibly through signaling via 
the cyclic adenosine monophosphate cAMP-dependent thyroid hormone triggering enzyme type 2 
iodothyronine deiodinase (339). Fibroblast growth factor (FGF) 19 is increased and binds to 
Fibroblast Growth Factor Receptor (FGFR4), activating fibroblast growth factor Receptor c-kit 
(FGRR1c) in the presence of co-receptor β Klotho (340). The result is increased protein synthesis in 
the liver (341). FGF19 also plays a role in enhanced mitochondria activity (341). Activation of the FXR 
receptor may facilitate the effects of bile acids on energy homeostasis through FGF19, which is 
released from ileal enterocytes and can lead to an increase in metabolic rate and a decrease in 
adiposity (342;343). Bile acids, after a mixed test meal in human subjects, correlated positively with 
circulating GLP-1 and PYY, but negatively with ghrelin (344). Pournaras et al. demonstrated that total 
plasma bile acids are elevated after RYGB (345) and suggested that they may be partly responsible 
for the intestinal hypertrophy, anorexigenic hormone secretion and alterations in gut microbiota 
(346). 
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1.5.2.5 Change in gut microbiota 
Obesity is associated with low-grade inflammation, increased Firmicutes and decreased 
Bacteroidetes in animals (347), and humans (348-350). The intestinal microbiota has also been 
shown to utilise energy from food and thus increase the host's energy-harvesting capacity (351). 
Proteobacteria have been shown to increase after RYGB in humans (352), with the major contributor 
being Enterobacter hormaechei. The significant improvement of weight, inflammation and metabolic 
status after surgery was associated with increased bacterial variety. An association was observed 
between adipose tissue gene expression and bacterial genes at baseline with a 10-fold increase three 
months after surgery, and this may suggest a restored cross talk between both the gut microbiota 
and the host (353). After RYGB, acidity was reduced in the alimentary limb, leading to a decrease of 
hydrochloric acid flux in the gut, while bile acids were increased in the biliopancreatic limb.  
Bacteroidetes growth was attenuated at lower pH, whereas E. coli increased at a higher pH. Gut 
microbiota quickly adapt in a “starvation-like state” created by RYGB and rapidly and sustainably 
increase. Changes in microbiota in mice after RYGB were independent of weight alteration and 
caloric restriction (354). Transfer of the gut microbiota from RYGB-treated mice to non-operated, 
germ-free mice resulted in weight loss and reduced fat mass in the recipient animal. The altered 
microbial production of short-chain fatty acids that increases may offer a partial explanation (354). 
Although RYGB did not change gut microbiota from the “obese state” to the “lean state” it did create 
a “third state” which, on balance, appeared to be associated with many of the beneficial 
characteristics of RYGB. 
1.5.3 Food preferences 
1.5.3.1 Observations 
Weight gain has been linked to a preference for both sweet and/or high-fat foods (355;356), which 
may partly explain why obese people regain body weight frequently after “dieting” (357;358). The 
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common view summarised previously by Pangborn and Simone is: “In the mind of a normal person, 
sugar and sweets are ‘fattening’ and most overweight people have a ‘sweet tooth’” (359). Hedonism 
associated with palatable foods is considered a significant factor, which increases the prevalence of 
obesity. A motivational factor that is referred to as “hedonic hunger” (360) may be a trigger for 
overeating (361). After RYGB, patients tend to increase the intake of fruit and vegetables, as well as 
low fat food (362;363). The dumping syndrome was thought to induce these changes in food 
preference (364), and it is often considered as a useful characteristic of the RYGB  to “teach” patients 
to avoid calorie-dense foods and thus consume fewer calories (365). However, patients after RYGB 
also appear to make healthier food choices and adopt a more balanced diet, even when they do not 
experience dumping (362;366), and have considerable reduction in energy intake (EI) and energy 
density. In a comparison of food groups eaten by a group of patients after RYGB, the total number of 
servings from fat, grains and sweetened beverages was reduced and remained reduced in the longer 
term. Meats, dairy products, fruits, and sweets, however, were reduced in the short term, but then 
returned to baseline by twelve months (262). When energy intake was reduced to 1300 Kcal,  
60% and 25% of patients, respectively, were consuming less than one serving per day from both 
fruits and vegetables. Intake of whole grains increased from 25% to 40% within the first three 
months, but then returned to baseline at twelve months (262). The association between reduced diet 
energy density and weight loss is controversial as some studies describe no association (367), while 
others show shifts in food preferences to be partially responsible for the decreased calorie intake 
and weight loss after RYGB (368).  RYGB in humans appears to alter taste through both unconditional 
and conditional mechanisms (264;369-371), leading to the concept of “behaviour surgery” (364).   
In 1987 Sugerman et. al. reported that “sweet-eaters” did particularly well after RYGB (372;373). 
Some of the initial findings were confounded by intolerance to sweets related to symptoms of the 
dumping syndrome (279;372-374). Conditioned taste aversion may thus be a factor in some patients. 
These initial assumptions resulted in many clinicians thinking that the RYGB works by “punishing” the 
“poor behaviours” of obese patients. The notion that RYGB becomes an external enforcer that goes 
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against the free will of the patient has led to some authors questioning the morality of RYGB as a tool 
that changes patients’ behaviour, against patients’ natural wishes (375). This misconception may 
have reduced the wider acceptance of RYGB as a valid physiological treatment for the pathology that 
results in obesity. Classical conditioned food aversion is, however, an unlikely explanation as most 
patients with severe dumping still report that they enjoy the taste of sweet foods, but that they have 
learned to consume only small quantities that do not cause negative visceral symptoms, or to 
consume sweets at night before bedtime, suggesting a conditioned food avoidance to be a more 
likely explanation. Distinguishing between the terms is important, because avoidance implies that 
the palatability of sweet or fat didn’t change when small quantities are consumed, but that the 
subject “learns” to stop consuming the food sooner (earlier avoidance), because large quantities may 
have negative visceral consequences (376-378).  
1.5.4 Mediators 
RYGB could be exerting its effects on food selection and preference through any one of the taste 
function domains important in normal physiology, such as sensory-discriminative (stimulus 
identification), hedonic (ingestive motivation) and physiological (digestive preparation) (379;380). 
Affective responses to taste stimuli, which can be considered an example of ingestive motivation, can 
be both conditioned and unconditioned. It remains controversial which of these three domains are 
involved and what their interactions are to determine food preferences after RYGB surgery. For 
example, RYGB could have effects directly on the central gustatory pathways related with feeding 
and reward through gut hormonal mediators. Alternatively, changes in the sensory signals could alter 
the intensity or the quality of tastants, but also lead to an unconditioned change in palatability.  
If RYGB causes visceral malaise after ingestion of fat, then it is possible that the palatability of fat 
could alter through a process of learning (conditioned response) (381). Although there are 
suggestions in animal models that the hedonic properties of sweet and fat stimuli may change after 
RYGB (263;381-385), less work has been done in humans. Miras et al., using the progressive
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ratio task, showed that RYGB resulted in the selective decrease of the reward value of a sweet and 
fat tastant, but not vegetables (386). Further support comes from studies of brain reward cognitive 
systems linked to eating behaviour, as studied by functional MRI (fMRI), where brain hedonic 
responses to calorie-dense food are lower after RYGB compared to patients who have lost similar 
amounts of weight after adjustable gastric banding (369). 
1.5.4.1 Energy expenditure 
According to the laws of thermodynamics, energy that enters a system (energy intake) must either 
be stored (body energy gain) or be used (activity, heat or faecal energy loss). Energy expenditure (EE) 
is usually decreased during food restriction, a phenomenon known as the “starvation response” 
(387). Weight loss in rodent models of RYGB is associated with preservation of lean body mass and 
increased EE (387). Humans demonstrate decreased basal metabolic rate, but increased meal-
induced thermogenesis after RYGB (272;363;388-394).  
Evidence is now also emerging to suggest that the metabolic rate of the small bowel is increased 
after RYGB with a greater carbohydrate consumption, which may explain the changes observed in 
respiratory quotient after these operations (395). Reduced resting energy expenditure (REE) or basal 
metabolic rate after RYGB (363;388;396-398), may be attenuated due to relative lean mass 
preservation. Patients who regain the weight they lost two years after RYGB have lower REE (390), 
suggesting that elevating REE after RYGB may enhance weight loss. Physical activity may further help 
increase activity-related EE and also preserve lean mass, and therefore REE, after RYGB (399).  
1.5.4.2 Calorie malabsorption 
Several bariatric operations were designed to result in malabsorption of calories (400). The exclusion 
of the approximately 10% of the bowel (70-100 cm of BPL) after RYGB is unlikely to result in calorie 
malabsorption. Moreover, the exaggerated gut hormone responses that reduce gut transit after 
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RYGB do not alter oro-caecal transit time or functional enterocyte mass (256). RYGB may, however, 
impair pancreatic exocrine function, which could contribute to a small degree of fat malabsorption, 
the magnitude of which is probably too small to contribute substantially to weight loss (401-403).  
 
1.6 Mechanisms of complications 
The rise in the number of RYGB procedures (404) has also increased the absolute number of comp- 
lications associated with this procedure, even though the percentage of patients with complications 
has reduced due to better surgical experience (405) Postprandial hypoglycaemia, even in patients 
without T2DM, can occur several hours after a meal and is distinct from early dumping syndrome, 
which occurs within minutes after eating (406;407). Early dumping is a consequence of rapid 
emptying of food into the jejunum due to the lack of a pylorus presumably causing neural activation 
in the proximal alimentary limb (408). Late dumping or “postprandial hypoglycaemia” occurs  
1-3 hours after ingesting a meal and is a result of the exaggerated insulin response to high glycaemic 
index carbohydrates in the meal. The proposed mechanisms involve increased β-cell mass, improved 
β-cell function and non-β-cell mechanisms, which may include a lack of ghrelin (a counter regulatory 
measure to hypoglycaemia) (304;409). In addition, the sustained weight loss can reduce insulin 
resistance, which renders the previous insulin responses needed pre surgery to suddenly become 
excessive. The aetiology of hypoglycaemia is likely to be different for individual patients and is also 
probably a mixture of the anatomic, hormonal, and metabolic changes after RYGB (410). Although 
treatment of this complication can be difficult, pancreatectomy is no longer advised (411). Rather,  
a multimodal medical approach is favored (412).  
1.6.1 Unexplained abdominal pain 
Up to 10% of the patients complain of unexplained chronic abdominal pain which can be difficult for 
both the treating clinician and patient to acknowledge (413;414). Mild abdominal pain is reported by 
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up to 95% of patients at some point after RYGB (413;415-417). Symptom severity fluctuates between 
vague discomfort to severe colicky pain (418). Vomiting and nausea, especially if prolonged, are 
symptoms of pathology and are not part of the normal postoperative course after RYGB, yet some 
reports suggests up to 80% of patients report the symptoms at some point after surgery (413;415). 
Abdominal pain may be recurrent and it should be remembered that internal hernias may 
spontaneously reduce, causing pain to be intermittent. Early investigation of acute symptoms of 
abdominal pain is mandatory at first presentation due to the risk of obstruction, volvulus and 
ischaemia of the herniated bowel (413;419). Cross-sectional imaging is often unhelpful and the use of 
laparoscopy is frequently required for diagnosis. Management protocols for chronic unexplained 
abdominal pain are not clearly defined, but the jejunal-jejunal anastomosis is currently receiving 
more attention as a possible cause for these chronic problems.  
1.6.2 Anastomotic stenosis 
When the circular stapler technique is used, anastomotic stenosis can be a common complication, 
with a reported incidence of up to 27% and a recurrence rate of up to 33% (142;420). If dysphagia 
occurs, it is usually within 6 months of surgery. Endoscopy can often be used both as a diagnostic and 
an interventional tool.  
1.6.3 Vitamin deficiencies: iron, vitamin B12, folic acid, vitamin D, and calcium 
Iron deficiency occurs in up to 49% of patients after RYGB (421). Reduced acid production in the 
stomach pouch decreases iron absorption (422). For iron to be absorbed, the ferric iron in foods has 
to be reduced to the ferrous state, but because the volume of hydrochloric acid produced is lower 
after RYGB, this process is attenuated (423). Reduced intake of iron-rich foods after RYGB such as red 
meat may also contribute (424;425). In the stomach, both pepsin and hydrochloric acid are required 
for absorption of vitamin B12. Deficiencies of vitamin B12 occur in up to 70% of patients after RYGB 
(425-427) because of achlorhydria, reduced vitamin B12 absorption from foods and reduced ingestion 
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of meat, and insufficient secretion of intrinsic factor after surgery (423). Folic acid deficiency affects 
up to 35% of patients after RYGB. The proximal third of the small bowel is most important in folate 
absorption, which is reliant upon hydrochloric acid (427). Vitamin B12 also acts as a coenzyme in the 
conversion of methyltetrahydrofolate to tetrahydrofolate. Thus, folate deficiency might result from 
achlorhydria, bypassing of the proximal small bowel, vitamin B12 deficiency and/or decreased folate 
ingestion (425-428). Hypocalcaemia occurs in up to 10% and low serum 25-hydroxy vitamin D levels 
in up to half of RYGB patients (429). Nevertheless, a study has shown most patients with obesity had 
significantly lower basal 25-hydroxyvitamin D concentrations and higher parathyroid hormone 
concentrations as compared to age-matched lean controls (430). Deficiencies may occur because 
calcium is typically absorbed in the proximal small bowel, which is bypassed after RYGB. Intolerances 
can also develop to important calcium-rich dietary sources, such as milk, especially if the fat content 
is high. Calcium can be released from bone, as is evident from an increased bone turnover and 
subsequent reduced bone mass after RYGB (431;432). The higher bone turnover in the RYGB patients 
could be partly due to weight loss in these patients (433), but animal studies suggest that bone loss 
exceeds that which would be expected from weight loss alone (434).   
1.6.4 Loss of bone density  
Many patients with obesity have a higher than normal bone density before surgery, due to long-term 
excessive weight bearing. This may be protective and partly explains the question of why the loss of 
bone density after RYGB does not cause more bone fractures (435;436). Multiple mechanisms may 
contribute to RYGB reducing bone density, including physiologically reduced mechanical load related 
to weight loss after surgery, hyperparathyroidism due to insufficient calcium consumption, or 
reduced intestinal calcium and vitamin D absorption. Humoral factors from adipose tissue 
(oestradiol, leptin, adiponectin), pancreas (e.g., insulin, amylin), or the gut (ghrelin, glucagon-like 
peptide-2, glucose-dependent insulinotropic peptide) may also play a role (437;438), by connecting  
a web of consistent regulatory pathways (437). 
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1.6.5 Kidney stones 
Hyperoxaluria is common after RYGB, but the incidence of renal calculi is much lower than after 
jejunal-ileal bypass (JIB) (439-441). Comparison with the JIB is important, because the incidence, as 
well as the potential mechanisms, may be different after RYGB. The lithogenic effects after RYGB may 
stem from reduced calcium binding to oxalate in the intestinal lumen. The excess oxalate is then 
cleared by the kidneys resulting in hyperoxaluria and calcium oxalate nephrolithiasis. Five years after 
JIB, which causes significant malabsorption, almost 21% of patients developed kidney stones (442), 
but the incidence of kidney stones after RYGB appears to depend on a combination of other factors , 
such as hydration status and urine volume (441).Patients in high stone-forming areas of the world 
demonstrate an increased susceptibility to stones while those in low stone-forming countries may 
have an incidence similar to the background population (443). Thus RYGB alone is not enough to 
cause kidney stones, but it does potentiate other predisposing factors. 
 
1.7 Mechanism for weight loss post bariatric surgery: VSG vs. RYGB  
1.7.1 Food intake and underlying mechanisms 
Lifestyle changes with a low-calorie diet can be effective at initiating weight loss. However, most of 
the results from randomized controlled trials (RCT) are disappointing regarding long term weight loss 
maintenance (257;258). Approximately 70-80% of patients fail to maintain their initial weight loss 
thought to be due to physiologically compensatory responses that defend the previous weight “set 
point” (259). Whilst on a low-calorie diet, patients usually report an increase in hunger, a decrease in 
satiety and a pre-occupation with energy-dense fatty and sweet food (260;261). This may be part of a 
normal physiological response and not due to lack of motivation. 
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Reduced calorie intake after bariatric surgery, such as VSG and RYGB, is usually a consequence of 
significantly reduced meal size, compensated only partially by increased meal frequency (263), with 
increased satiety being the dominant contributing factor (264). Changes in behaviour associated with 
eating after RYGB were reported in the 1970s using structured interviews. These suggested that 
patients reached satiety more quickly than when compared to before RYGB, with the commonest 
reason given as a “lack of desire” (279). 
1.7.1.1 Hypothalamic signaling 
The expression of AgRP, which works by increasing appetite and decreasing metabolism and energy 
expenditure, remained unchanged in rats undergoing VSG (444). This finding might suggest that the 
rats with calorie restriction were hungry and the VSG rats were not. However, in the same 
experiment, there was no change in the expression of pro-opiomelanocortin or neuropeptide Y 
following VSG. There is little evidence to suggest that VSG or RYGB decrease the weight ‘set point’ by 
changing the expression of key signaling elements in the hypothalamic nuclei (264). 
1.7.1.2 Hormones 
RYGB and VSG might change the signals from the gut to the hypothalamus and brainstem. The 
postprandial release of the anorexigenic hormone peptide YY (PYY) is increased after both VSG and 
RYGB, but not after AGB or caloric restriction (260;290;292;314). Glucagon-like peptide-1 (GLP-1) 
responses are comparable to those of PYY after both VSG and RYGB (301). GLP-1 is secreted by the  
L-cells of the small bowel, together with PYY, with higher concentrations in the distal ileum and 
colon(445). Whether GLP-1 is essential for VSG-induced weight loss has been questioned, as the 
procedure was similarly effective in both GLP-1 receptor wild-type and knockout mice (446). The 
rapid delivery of nutrients to the distal ileum following RYGB may be responsible for the exaggerated 
increase of both PYY and GLP-1 levels (447). In the absence of a ‘shortened’ small bowel in VSG, the 
rise in levels of these gut hormones has been credited to the rapid gastric emptying (448). It is likely 
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that the proximal small bowel, upon sensing the arrival of nutrients, is able to signal to the distal 
small bowel to release gut hormones as well (449). GLP-1 and PYY responses to mixed meals or oral 
glucose have been at the center of interest of several studies investigating patients, six weeks to  
10 years after RYGB (287-292). Significantly elevated responses are seen as early as 2 days after RYGB 
(293) and may remain elevated for more than a decade after RYGB (294). Patients who lost the most 
weight after RYGB also had the highest levels of postprandial satiety gut hormones (295;296). 
Blocking the release of the postprandial satiety gut hormones in humans and rats with octreotide 
increased food intake in rats and patients with RYGB, but not in patients after AGB surgery (292) or 
rats with sham operations (450). Ghrelin levels are reduced after eating, with carbohydrates causing 
a more rapid suppressive effect than protein and lipids (451). Ghrelin levels are reduced after VSG 
(452) and increased after AGB (453), while after RYGB they may be either decreased, increased or 
remain unchanged (304;454). It is not clear whether ghrelin is the key physiological player in VSG, as 
the procedure is similarly effective in ghrelin-deficient and ghrelin-intact mice (455), both surgical 
and nonsurgical caloric restriction cause fat mass loss and reductions in plasma leptin levels 
(260;316). The expression of leptin receptors was equally reduced after VSG surgery or pair-feeding 
and, therefore, surgery does not appear to have  a greater effect on central leptin sensitivity (444). 
There is a considerable amount of data to suggest that both GLP-1 and PYY are significant mediators 
of weight loss after RYGB, although the evidence is less developed for VSG. PYY acts to reduce food 
intake and, therefore, maintain weight loss (456). GLP-1 acts to reduce food intake, increase glucose 
stimulated insulin secretion, improve insulin sensitivity, and may preserve islet integrity (457). 
1.7.1.3 Vagal signalling 
The contribution of the vagus nerve to weight loss after VSG and RYGB has not been sufficiently 
explored so far (264). 
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1.7.2 Mechanical factors 
Controversy exists as to whether the gastric sleeve volume in VSG and the size of the gastric pouch 
and stoma in RYGB surgery affect food intake and body weight (264). Some studies have shown that 
the larger the gastric pouch and stoma diameter the less weight is lost, both in human and animal 
models (280-282). Others, however, have not shown correlation between the two variables 
(281;283;284). Equally conflicting results have been found concerning the volume of the gastric 
sleeve after VSG (211;458-460). The various methods used to measure gastric volume, patient 
characteristics and other notable confounders, along with the unclear association between gastric 
volume and weight loss suggest that the physiological role of this factor might be minimal. Gastric 
emptying and intestinal transit actually seem to be faster after VSG (448;461-463), which go some 
way to explaining why the release of anorexigenic gut hormones post VSG is comparable in 
magnitude to RYGB (264). 
1.7.2.1 Caloric malabsorption 
An 8%, statistically insignificant increase in faecal caloric density has been established in animal 
models of VSG (464), but no studies have measured it post VSG in humans. Therefore, the 
contribution of caloric malabsorption to weight loss post VSG and RYGB appears to be minimal (264). 
 
1.8 Food preferences in obese 
High dense food; sweets and fats 
Studies have indicated that feeding laboratory animals a variety of calorie dense foods, high in fat 
and sugar, in addition to their standard chow will induce overeating and obesity (465).  
The palatability of fat and sugar rich foods may be responsible for a preference for, and the over 
consumption of certain foods, i.e. the hedonic response to their flavour (466;467). Human obesity 
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and weight gain have been linked to an elevated preference for both sweet and/or high-fat diet 
(355;356). The increased appetite for sweet or high-fat foods may explain why obese people gain and 
regain body weight frequently (357;358). For example, these two energy rich components account 
for around 60% of the daily energy content of the typical American diet (22% from sugar and 37% 
from fats) (468). There is a discrepancy between the published studies that have investigated 
whether people with obesity have a higher preference for sweet-tasting foods, or have a different 
threshold for sweetness compared to the non-obese (469-478). The common view about sweetness 
and obesity was summarized by Pangborn and Simone as: ‘In the mind of a normal person, sugar and 
sweets are ‘fattening’ and most overweight people have a ‘sweet tooth’ (359). Some individuals 
show a continuous increase in taste satisfaction as sweetness concentration was raised (i.e. the 
sweeter the better), while in others, satisfaction increases to a maximum level and then decreased 
again as sweetness became overpowering (479). In a third group, the satisfaction decreased with 
increasing sweetness (480). However, the original conclusion of Pangborn and Simone was supported 
by the majority of evidence from the literature, which suggests that body weight has nothing to do 
with the perception of, and preference for, sweetness (470;472;473;476;481-483). Neither threshold 
(473;474;483), nor suprathreshold was different (474-476;482-484) when linked to body weight as 
well. (2) Higher BMI is linked to a lower perceived sweetness. Therefore, it is necessary to correct 
comparisons of ‘liking for sweet’ to account for perceived sweetness. Plotting the liking as a function 
of sweetness shows that sweet liking is greater among individuals with obesity. This is done by 
scaling the sweet taste and liking with the gLMS. (3) A lower perception of sweetness is linked with  
a greater difference between an individual’s likings of fat foods compared to liking sweet foods. 
Bartoshuk and colleagues argued in their review, most of the literature describing those with obesity 
experiencing less sweetness than those without obesity is compromised by the psychophysical errors 
described above. The expression of taste loss in patients with obesity may provide researchers with 
new ways to think concerning liking for sweet and fat tastes in the obese population, with the 
research team concluding that liking of both sweet and fat tastes increase as BMI increases (471). 
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This assumption that body weight has no influence of preference for sweetness has prevailed for 
almost 50 years, justifying the failure of the earlier studies to find sensory or hedonic differences 
(475), but new data has suggested that there are sensory differences related to body mass index 
(BMI), challenging the previous assumption (471). It was found that people with a higher BMI tend to 
find candy less sweet. This novel finding is a result of the use of the general labeled magnitude scale 
(gLMS) within certain studies, discussed in more detail later herein. Elsewhere, data have shown that 
obese people tend to favour sugar more than underweight individuals do. Multiple regression 
analysis demonstrated that individuals with a higher BMI liked sugar more than those with a lower 
BMI (471). It also demonstrated that this liking increases as a function of sweetness as BMI increases 
and, as a result, liking increases as BMI increases for the same perceived sweetness. Moskowitz 
suggested that studying and analysing the liking of sweet tastes in the conditions of the perceived 
intensity of sweetness is helpful for learning more about obesity (485). The common view regarding 
fat is comparable to that for sugar; it is presumed that people with obesity show greater liking for 
high-fat foods. Though, contrary to the evidence relating to sugar, studies on preference and obesity 
support this general view (357;486;487). In these studies, mixing fat with other dietary components 
was of special interest for researchers. Drewnowski and his colleagues conducted a study that used 
dairy products with diverse sugar and fat content to study more about this mixture between fat and 
sugar and how palatable it is. Data have shown that women with obesity preferred a higher ratio of 
fat to sweet, and that a mixture of sweet and fat establishes palatability (357). Moreover,  
an assessment of food preferences found that obese women tend to prefer sweet–fat foods, while 
obese men tend to favour savoury–fat foods (488). It’s not clear yet, why this liking for sweet and fat 
increases as BMI increases. The relationship between orosensory experience and post-ingestive 
effects of sweet and fat foods contributes to liking (489), and, indeed, that the hedonism associated 
with foods is considered a significant factor in the increased prevalence of obesity. In addition, a 
substantial body of literature has verified the differences in reward behaviours and neural reward 
functions between obese and lean animals and humans (361;384;490-501). It has not been shown, 
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however, whether such differences exist before the development of obesity, and are causative, or 
are a result of obese condition (502). There is much to be learned about the relationship between 
liking and consuming foods in the near future (471). 
1.8.1 Low glycaemic index carbohydrates, including fruits and vegetables 
Many researchers have examined the effects of macronutrient measures on satiety, food intake and 
body weight. Fruit and vegetables are usually considered together as they are often associated in 
dietary advice, for example “eat more fruit and vegetables”. Even though they may vary greatly in 
their sensory and nutritional profiles, both are low in fat and high in both fiber and water, which 
makes them low in energy density (kcal/gram). These properties could be beneficial for weight 
management by virtue of a contribution to increased satiety and reduced food intake. By adding fruit 
and vegetables to the diet, overall energy density will be reduced and the quantity of food that can 
therefore be consumed within a given calorie limit will be greater (503). Satiation is considered by 
measuring consumption when foods are freely available. Energy density effect satiation i.e. lower 
energy density equates to enhanced satiation (504-508), and that the amount and type of 
carbohydrates in fruits and vegetables might also effect satiety and therefore food intake (509). 
Carbohydrates, when digested, are converted to glucose, and the rate of this conversion process can 
be determined by measuring plasma glucose concentrations over time (i.e., the glycaemic response). 
The glycaemic response across two hours after ingesting a portion of food that contains 50g 
carbohydrate is used to analyse the food by creating an “index”. High glycemic index (GI) food causes 
a quick but short-lived rise in blood glucose levels, whereas low GI food causes a slower, more 
sustained rise (503). Satiety is proposed to be greater in foods with a low GI than those with a high 
GI,  although a strong relationship between GI and satiety, food intake, or body weight has not been 
established (510;511). 
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1.9 Determinants of food preferences 
Social, cultural and genetic factors contribute to the development, preservation and alteration of 
dietary patterns and food preferences, taste, and food choices (512;513). Interpersonal relationships, 
such as family and friendship groups, influence eating behaviour and exert direct or indirect social 
influences (e.g. beliefs, cooking traditions, food rules that a family may teach their children). Taste 
and other sensory properties of foods (e.g. smell and texture) are partly responsible for the selection 
of one food over another. In addition, the hedonic value of food is strongly linked to the functional 
taste domain, which may be a driving force behind food consumption (514). 
1.9.1 The taste system 
Taste detection thresholds are only one basic aspect of taste function in general and have been 
shown to vary as a function of genetics, pharmacological treatment, and neural manipulations (515). 
The concepts of taste hedonics and alterations in reward responses have not been fully explored as  
a potential mechanism for the development of obesity. The search for the neural basis of any 
behavioural or sensory process must begin with a clear articulation of the principles of function. With 
this in mind, there is ample evidence that the sense of taste serves several functions that can be 
experimentally classified into at least three general domains (379). 
1.9.1.1 Stimulus identification 
Stimulus identification is the detection or discrimination of sensory signals arising from taste cell 
activation in the oral cavity. Stimulus identification involves the discrimination between the sensory 
signals representing different taste stimuli arising from the interactions of chemical compounds with 
taste receptors. 
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1.9.1.2 Ingestive motivation 
Ingestive motivation refers to processes that promote or discourage ingestion of foods and fluids on 
the basis of taste input. Ingestive motivation can be further divided into two functional subclasses: 
Appetitive behaviour (“wanting”) can be defined as actions that lead to contact with the taste 
stimulus (e.g. searching, foraging, and approach to a drinking spout) and reflects how much the 
stimulus is wanted. Consummatory behaviour (“liking”) represents the behaviour that is elicited 
during the contact with the taste stimulus (e.g. oral motor responses, swallowing) and reflects how 
much the stimulus is liked. 
1.9.1.3 Digestive preparation 
Digestive preparation refers to physiological reflexes that fall into a general class referred to as 
cephalic phase responses, which are internal physiological events triggered by stimulus contact with 
any sensory receptor of the head (516). Cephalic phase responses generally prepare to digest, absorb 
and then store nutrients that enter the body through feeding. Cephalic phase reflexes can be both 
intrinsic and learned. For example, most animals readily learn to avoid foods that render them ill 
through conditioned taste preferences and conditioned taste aversions, and rats can be conditioned 
to react aversively to sweet solutions by actively rendering them ill after ingestion. Consequently, 
they will decrease their intake of the sweet solutions when they are exposed to them again.  
The vagus nerve is thought to be an important pathway for cephalic phase responses (517).  
For taste function assessment, it is important to circumvent the influence of post-ingestive factors in 
both animals and humans. Post-ingestive effects can be positive (e.g. satiation, fullness) or negative 
(nausea, visceral pain) and occur after food ingestion. They also include post-absorptive effects. 
Hence, two important methodological features must be considered for the experimental  
protocols: First, only small volumes of taste solutions must be used. Second, immediate responses to 
the taste stimulus should be measured. For animal experiments, the application of these 
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methodological features requires the use of a special stimulus delivery system and a lickometer 
(515). 
 
1.10 Food preferences post bariatric surgery 
Changes in appetite behaviour after obesity surgery were reported in the 1970s. Halmi in a study 
conducted earlier, using structured interviews reported that post gastric bypass patients reached 
satiety much faster compared to before surgery and the reason for reduced food intake was lack of 
“desire”(279). More importantly there was a statistically significant reduction in the intake for high 
fat meats and high calorie carbohydrates six months after surgery. At the same time patients found 
these foods “no longer enjoyable”. In an attempt to explain the changes in high calorie carbohydrate 
eating, dumping syndrome was implicated, although it was not evaluated further (279). These 
findings were simulated by Brown (518), who used food diaries to show that both total fat and 
carbohydrate intake was significantly lower after gastric bypass. Patients stated that they were “not 
interested in sweets or deserts after surgery”, although again this was not officially quantified. Kenler 
was the first to conduct a study comparing gastric bypass and horizontal gastroplasty, recognising 
very early that the superior weight loss after gastric bypass may be due to changes in taste 
preference rather than gastric restriction (368). This study showed, using diet interviews, that gastric 
bypass patients consumed 45% less solid sweets, sweet high-calorie beverages, and 37% less milk or 
ice cream, compared to gastroplasty patients (368). Milk and ice cream consumption increased post-
operatively in the gastroplasty group as these food substances were easier to swallow. Dumping 
syndrome was suggested (but not proven) to be accountable for the changes in sweet consumption 
(368;519). Some patients reported “losing their taste” for milk and ice cream even without having 
unpleasant gastrointestinal symptoms. On this basis the authors recommended gastric bypass as  
a more suitable procedure for sweet and ice cream eaters supporting the findings and 
recommendations of the Sugerman group (373). Olbers et al. compared patients post RYGB  
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and vertical banded gastroplasty in the only such randomised controlled trial. After surgery the 
gastroplasty group consumed a significantly higher proportion of their total calories as fat and 
carbohydrates in contrast to the RYGB group. Interestingly, gastric bypass led to patients preferring 
fruit and vegetables and intentionally avoiding fat, in fact reporting feeling unwell after fat 
consumption, potentially as a result of a dumping phenomenon (363). Furthermore, findings from Le 
Roux’s et al. suggest that changes in fat preference may contribute to long-term maintained weight 
loss after RYGB (383). In addition, a trend was seen toward greater rates of healthy food 
consumption on a daily basis and significantly better food tolerance a year after VSG (520). Leahey et 
al. found that bariatric surgery was connected with major reductions in food cravings and 
consumption of craved foods, with the exclusion of high-fat foods. Despite these decreases, patients' 
cravings did not fully reduce to "normative" levels and are not associated with post-operative weight 
loss (521). Generally, patients' behaviours have a considerable effect on post-operative outcomes 
after bariatric surgery (522). Based on these findings and the terminology used in the literature of the 
time (desire, not interested, or intolerance) it became clear that obesity surgery, and specifically 
gastric bypass, does not just reduce the amount that people eat but also alters the perception of 
food and possibly eating behaviour. This healthy shift away from high calorie fat and sugar foods to 
increased consumption of fruit and vegetables could be explained by alterations in the sense of taste. 
1.10.1 Changes in taste post bariatric surgery 
Bariatric surgery could be exerting its effects on food selection and preference through any one, or  
a combination, of several functional domains: sensory-discriminative (or stimulus identification), 
hedonic (or ingestive motivation) and physiological (or digestive preparation) (379;380). Altered taste 
function in humans can be measured through various means. For example, taste thresholds can be 
assessed by a variety of objective techniques to measure detection thresholds to sucrose (381;523), 
urea (524), and hydrochloric acid (524). Taste threshold measurements, however, do not always 
predict perceived intensity at suprathreshold concentrations (525). The only way to measure 
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suprathreshold sensitivity is through the use of scaling procedures, in which subjects are asked to 
rate the intensity of their sensations. This is usually done using visual analogue scales (VAS) that are 
relatively easy, efficient, and inexpensive. The drawback of VAS in adolescents with morbid obesity is 
that the patient may indicate a result they think the healthcare professional or researcher would like 
to elicit. Thus, underreporting or misreporting may be a major confounder, just as in the case of food 
diaries (526;527). 
1.10.1.1 Sensory Domain 
Direct measures of behaviour can be used to study the effects of gastric bypass surgery on the 
sensory domain of sweet taste in obese patients. A technique incorporating the application of 
constant stimuli to determine detection thresholds has been used to measure taste sensitivity in 
animal models (385). After gastric bypass, patients’ sucrose detection threshold decreased (523), 
suggesting that surgery has consequences on the sensory processing of taste signals generated by 
sucrose (381). In fact, RYGB appears to alter most of the domains involved with taste (364). 
1.10.1.2 Reward domain: appetitive behaviour 
Although there are suggestions in animal models that the rewarding and aversive properties of sweet 
and fat stimuli may change after gastric bypass (263;381-385), very little work has been performed in 
humans to determine whether there are any changes in the hedonic domain of taste function after 
other weight loss surgeries such as VSG. This question has been addressed using the progressive ratio 
schedule of reinforcement, an operant task first developed by Hodos 50 years ago (528) for use in 
animals. During the task, the subject is trained to perform a certain number of responses required to 
obtain a reinforcer (i.e., reward). After delivery of each reward, the response requirement 
progressively increases until it is so great, the subject stops responding. This point is defined as the 
breakpoint. The number of responses completed for the last reward received can be used as a proxy 
of the reward value of the reinforcer and is a pure assessment of appetitive responsiveness driven by 
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the stimulus properties of the reinforcer such as its taste. Miras et al. found that gastric bypass 
surgery (RYGB) resulted in the selective reduction of the reward value of a sweet and fat tastant.  
This application of the progressive ratio task provided an objective and reliable evaluation of taste-
driven motivated behaviour for food stimuli after obesity surgery (386). Anecdotal evidence from 
clinical observation and evidence in rodents after VSG does suggest a shift in food preferences. 
Seeley et al. showed VSG in rats reduced intake of dietary fat and shifted preference toward lower 
caloric-density foods as compared with sham operated rats. Progressive-ratio (PR) and conditioned 
taste aversion paradigms showed changes after VSG in rats. Finally, food choice was compared 
between VSG and  RYGB operated rats, and concluded that these two anatomically different bariatric 
procedures lead to comparable changes in food choice (529). In contrast, another study failed to 
show this shift in food preferences after VSG in rats (464). The trend shows that RYGB in humans 
leads to changes in food preference and possibly fundamental alterations to taste (264;369-371;530). 
Questions remain over whether humans show similar changes to rats after VSG and, indeed, to 
humans after RYGB. 
1.10.1.3 Reward Domain: consummatory behaviour 
Another objective way to study human feeding behaviour, is taste reactivity, as measured by “the 
involuntary, minute movements of the face in response to a stimulus” (531). These can be studied to 
enable an impression of the emotional state of an individual as a consequence of the applied 
stimulus. Taste reactivity studies using facial expression, which looked at infants, apes, new world 
monkeys and rats, concluded that there were two major reaction patterns seen: the positive, 
hedonic reaction - typically to sweet taste - was characterised by lip smacking, tongue protrusion and 
even a smile, while the negative, aversive reaction – to bitter taste - involved grimacing, retracting of 
the lips, wrinkling of the nose and retraction of the head away from the food source. Other tastes, 
such as salt or sour, were found to produce responses with intermediate reactions between those 
described above (532-536). The use of taste reactivity to study the ingestive motivation, 
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consummatory behaviour in adult humans has been less well investigated. Previous work has shown 
that adults do demonstrate facial reactivity, with some promising results (533;535;537;538), 
although these behaviours may be less accurate as a consequence of socialisation and voluntary or 
higher control (535;539). Taste reactivity has not been used for the study of consummatory reward in 
obese adults or adolescents previously. A major limitation to the use of facial reactivity is the 
difficulty in interpretation of these often small and subtle movements (535). A few studies have used 
the Facial Action Coding System (FACS) with trained interpreters (540).  
However, face recognition software packages have recently been developed, which enable a more 
objective assessment of facial reactivity and can determine the duration of the facial reaction, 
providing a better overall feedback on the emotional state of the subject (e.g. FaceReader™). This 
technology is promising and could be further improved in terms of specificity, sensitivity and adapted 
to cultural and social facial reactivity differences. Metabolic mechanisms may facilitate the effect of 
bariatric surgery on taste pathways. It has been shown lately, that high levels of PYY activate brain 
regions related to food reward, including the ventral striatum, orbitofrontal cortex (OFC) and insular 
cortex (541).  Moreover, GLP-1 receptors have also been isolated in brain reward areas (542). GLP-1 
and its receptor have been isolated in taste cells of the taste buds and adjacent intragemmal afferent 
fibers, respectively, interacting in a paracrine manner (543). Accordingly, if bariatric surgery was to 
affect taste hedonics, it may do so through increased GLP-1 and PYY availability and input to the 
taste signal pathways at multiple levels, both proximal and distal. Further studies are needed to 
explore the effect of bariatric surgery on decreasing sweet and fat reward, thus leading to healthier 
food choices after surgery, which contribute to long-term maintained weight loss. The consequence 
of VSG on the complex central reward circuits has not yet been studied. By understanding the 
mechanisms by which VSG decreases consumption of high calorie fat and sweet foods and alters 
taste responses, new surgical and non-surgical therapies could be developed that reproduce these 
processes and so encourage safe and effective weight loss. 
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1.10.2 Eating behaviour and meal patterns 
Little is known about eating behaviour and meal patterns following RYGB and other weight loss 
procedures. RYGB results in early satiety and a reduction in food intake. Bjorklund suggested that the 
Roux limb could also be a significant determinant for regulating food intake after RYGB surgery (544), 
where the thresholds for eliciting distension-induced sensations are strongly and negatively 
associated with preferred meal size (244). Weight loss surgery, including RYGB, changes the acuity 
perception of food and thus eating behaviour, leading to the concept of “behaviour surgery” (364).  
In a study conducted by Furnes et al., eating behaviours were compared between rats that 
underwent VSG and counterparts that underwent RYGB. They found that the food intake and meal 
size were reduced after VSG but not gastric bypass, suggesting that the control of food intake was 
independent of the food reservoir function of the stomach (545). Gastrointestinal function, as well as 
the behaviour of the individual, might be influenced by the psychosocial factors, such as dietary 
counseling, individual food preferences and dislikes, food culture, previous experiences of dieting 
and emotional state (244). It is likely that the changes in gastrointestinal functionality after bariatric 
surgery are the start of a cognitive process, whereby the individual makes preventive changes in 
behaviour in order to avoid dumping syndrome (406). The general relationship to food is part of the 
eating behaviour as well (244). For example, dietary restraint is suggested to have an inconsistent 
role in the development of obesity (546). Loss of control over food intake and a tendency to overeat 
in the presence of emotional distress are additional types of eating behaviour, yet little is known 
about their prevalence after bariatric surgery (547;548). Few studies have considered changes in 
eating behaviour such as meal size and number of meals, and none has studied the effect of VSG on 
both elements. 
1.10.3 Changes in calorie density of food 
Studies have shown that energy intake increases depending on the fat content and energy density of 
the entire diet (549). Dietary energy density (ED) is the amount of energy (calories) in a particular 
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weight of food, generally presented as the number of calories per gram of food (kcal/gram) (103). It 
is likely that fat (9 kcal/g) influences the ED values more than carbohydrate or protein (4 kcal/g) 
because of its very high-energy content, whereas water containing foods, such as fruit and 
vegetables do the opposite, owing to their low ED (550). Small changes in ED may have a significant 
effect on the energy intake (EI), as people have a tendency to eat a constant volume of food (550). 
Diets considered to be of a high dietary quality are usually low in ED (551). Studies that compared 
Diets considered to be of a high dietary quality are usually low in ED (551). Studies that compared 
overweight and obesity, have determined the importance of dietary ED on food intake, concluding 
that lowering ED can reduce energy intake (EI) (549;552). Moreover, Rolls et al. found that ED 
affected satiety or the feeling of fullness when the proportions of macronutrients were constant 
(550). Several studies have revealed that dietary management of obesity depends on establishing a 
low ED diet (553;554). Furthermore, successful weight maintenance programs have also utilized low 
ED diets (555;556). Studies have represented bariatric surgery to be the only currently available 
treatment demonstrating long-term efficacy. Considered to be the gold standard, RYGB achieves not 
only the excellent weight loss described earlier, but also a high level of eating quality. RYGB 
influences food selection, subjects tending to increase their intake of fruit and vegetables, as well as 
low fat food after RYGB (362;363). Previously mentioned factors including taste alteration (364) and 
the dumping syndrome have been considered “useful” characteristics of RYGB because patients learn 
to avoid calorie-dense foods and eat less at each meal (365). Ernst et al. and Thomas et al. showed 
that RYGB resulted in healthier food choices and a more balanced diet than AGB (362;366).  
In addition, Laurenius et al. stated that besides considerable reduction in EI and large difference in 
consumed food weight (FW) after RYGB, patients reported decreased dietary ED over 2 years. 
Although there was no association between the reduction in dietary ED and percentage weight loss, 
changes in food choice were overall nutritionally beneficial (367). To date, no data exists 
representing the effect of VSG on ED and EI for patients after surgery. It is not clear whether the 
observed alteration in perception of food is the result of changes in taste or post-ingestive effects. 
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Whether VSG can influence physiological circuits like the gustatory system is unclear, especially as 
behaviour focused anti-obesity interventions have not succeeded. It is also not clear at what level of 
taste transduction this manipulation take place – the taste bud, the brain or both? These questions 
have raised the interest of obesity and behaviour researchers over the last two decades and have led 
to ground breaking clinical and preclinical experimental work. 
 
1.11 Hypothesis 
The Hypothesis: VSG changes taste, which changes eating behaviour. 
 
1.12 Aims of study 
Aims to test the hypotheses of the study: 
AIM 1. To assess changes in eating behaviour and meal patterns following VSG in adolescents 
Patients have been studied longitudinally before and after surgery, as well as being compared to  
a non-surgical control group. 
SPECIFIC AIM 1.1. To examine whether vertical sleeve gastrectomy (VSG) alters portion size, meal 
duration and rate of eating. 
SPECIFIC AIM 1.2. To evaluate whether pre-meal hunger, post-meal satiation and maintained satiety 
in relation to voluntary food ingestion are different before and after surgery. 
SPECIFIC AIM 1.3. To examine the diurnal distribution and number of meals, examining 24h recall 
using food behaviour questionnaires, before and after surgery. 
SPECIFIC AIM 1.4. To evaluate changes in eating behaviour and meal patterns pre-surgery and at 12 
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and 52 weeks‎ post-surgery in adolescents following VSG. 
AIM  2. To assess longitudinal changes over 52 weeks‎ in taste detection thresholds for sucrose after 
VSG in adolescents, as compared to the non-surgical control group. 
SPECIFIC AIM 2.1. To evaluate sweet taste detection thresholds pre-surgery and at 12 and 52 weeks‎ 
in adolescents following VSG. 
AIM  3. To assess longitudinal changes in appetitive behaviour after VSG in adolescents, as compared 
to the non-surgical control group. 
SPECIFIC AIM 3.1. To evaluate appetitive behaviour pre-surgery and at 12 and 52 weeks‎ in 
adolescents following VSG. 
AIM  4. To assess longitudinal changes in consummatory behaviour after VSG in adolescents, as 
compared to the non-surgical control group. 
SPECIFIC AIM 4.1. To determine changes in “facial expressions” in adolescents when reacting to 
tastant stimulants after VSG. 
SPECIFIC AIM 4.2. To study and evaluate oromotor reflexes, as related to consumatory behaviour 
pre-surgery and after 10 days and 12 weeks‎ in adolescents after VSG. 
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2.1 Subjects 
2.1.1 Sleeve subjects 
Sixty adolescent (aged 12-18 years) Saudi subjects with obesity, scheduled for VSG were selected for 
the study, consisting of fifteen subjects in each arm. All subjects were treated in the obesity surgery 
clinic at King Saud University (KSU) in Riyadh city, KSA. Inclusion criteria were: BMI ≥40 kg/m2 or 
 ≥35 kg/m2 with obesity related co-morbidities, except for T2DM (≥95% body mass index (BMI) on 
Centers for Disease Control (CDC) for adolescents), and consent to proceed with VSG surgery. 
Exclusion criteria included pregnancy, breast-feeding, a diagnosis of T2DM, psychiatric illness,  
an inability to comprehend and comply with treatment requirements and low levels of zinc. The 
laparoscopic VSG was carried out using a technique that has been standardized and remained the 
same since the start of patient enrollment (557). Most observations were conducted approximately  
2 weeks before surgery and again 10 days, 12, and 52 weeks after surgery. All patients continued 
their routine post-surgery hospital visits to the multi-disciplinary obesity surgery clinic including 
dietary counseling. Sleeve subjects were recruited at the obesity clinic in KKUH when attending their 
initial appointment with the team. A twenty-minute interview was conducted with each individual to 
introduce the investigator and discuss the study, giving the patient and parent enough time to ask 
any questions they had. All subjects or their parents provided written informed consent before the 
study began, and received reward vouchers at every visit. Studies took place in a Clinical Research 
Centre (CRC) with a constant room temperature of 21°C for all test sessions. All participants received 
follow up appointment schedules and received a reminder phone call and text message twenty-four 
hours before their appointment. The sample size was determined based on similar studies, which 
had previously shown significant results with 9-15 participants after RYGB (381) within our research 
team at Imperial College London. 
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2.1.2 Control subjects 
A control group of 40 (10 per study arm) non-surgically-treated Saudi adolescents, was recruited 
from the siblings of surgical patients and was matched according to gender and age. These 
individuals represented a broad range of weight categories, from normal weight to obese. Control 
subjects underwent the same experiment 8-12 weeks apart to validate the study (four arms) sample 
size according to each arm methods. Exclusion criteria included pregnancy, breast-feeding,  
a diagnosis of T2DM, psychiatric illness, an inability to comprehend. Control subjects were recruited 
by calling the parents of surgical subjects, involving the same process of interview, consent and 
follow-up as surgical patients' thereafter.Studies took place in a Clinical Research Centre (CRC) with  
a constant room temperature of 21°C for all test sessions. All participants received 2nd appointment 
schedules and received a reminder phone call and text message twenty-four hours before their 
appointment. The sample size was determined based on similar studies, which had previously shown 
significant results with 9-15 participants after RYGB (381) and matching control group within our 
research team at Imperial College London. 
A school campaign to reqruit controls was determined in one of the National schools in Riaydh, KSA. 
It wasn’t easy to recruit subjects because it interfears with the school timimg. An educational lecture, 
brochures and flyers were prepared for this purpose but it didn’t work. Students and parents were 
concerned about being absent from school due to the experiment timing.  
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2.2 Methods (in brief) 
2.2.1 Aim 1: Changes in eating behaviour and meal pattern post VSG in adolescents 
Ten non-obese control subjects were examined twice, while the 17 obese surgical subjects were 
examined before surgery and twice (12 weeks and 52 weeks) after VSG. At these times, subjects 
consumed a standardised ad libitum test meal in the Clinical Research Centre (CRC) in a standardised 
quiet private room. Meal duration and meal size was measured, as well as pre-meal hunger and post-
meal satiation, which was measured twice after the meal. At each study visit, habitual meal patterns 
were recorded using a standardised validated questionnaire for the analysis of meal frequency, 
dietary behaviour and temporal distribution over 24 hours.  
2.2.2 Aim 2: Sweet taste thresholds changes post VSG in adolescents 
Ten non-obese control subjects were examined twice, while the 15 obese surgical subjects were 
examined before surgery and twice (12 weeks and 52 weeks) after VSG. Seven sucrose 
concentrations were used in this study: 2.1, 6.25, 12.5, 25, 50, 100 and 300 mM. Concentrations 
were tested in eight blocks, each block consisting of seven sucrose and seven water stimuli. Sucrose 
and water stimuli were presented in a random order without replacement. Subjects were given  
a period of five seconds to sample the stimulus in the mouth and were asked to indicate whether the 
stimulus was water or not. 
2.2.3 Aim 3: Changes in appetitive behaviour post VSG in adolescents 
Ten non-obese control subjects were examined twice, while the 21 obese surgical subjects were 
examined before surgery and twice (12 weeks and 52 weeks) after VSG. The Progressive Ratio Task 
was performed in this arm with an increasing number of computer mouse clicks needed to earn  
a sweet. The starting ratio to get a reward was 10 clicks, with a geometric incremental increase by  
a factor of 2 (i.e., 10, 20, 40, etc.), until the participant stopped responding, which was deemed the 
breakpoint. 
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2.2.4 Aim 4: Changes in consummatory behaviour post VSG in adolescents 
Within this pilot study, 5 non-obese control subjects were examined twice, while 7 obese sleeve 
subjects were examined before surgery and twice (10 days and 12 weeks) after VSG. A 50 mL 
chocolate milkshake flowed directly and securely into the subjects’ mouths by hanging the milkshake 
in a giving set bag from a 1.5-2 meters stand, using gravity to deliver a rate of 25mL/minute.  When 
the record button on the camera was pressed, the infusion started along with the video recording 
and the investigator left the room for two minutes before the recording stopped. 
 
2.3 Statistics 
Parametric or non-parametric tests depending on the distribution of the data were used. All normally 
distributed data were expressed as mean ± standard error of the mean (SEM) for demographic data 
and 95% confidence intervals (CI) for other variables. One-way analysis of variance (ANOVA) with 
repeated measures and post-hoc Bonferroni tests were used to test for significant differences 
between pre- and post-operative measures. Two-way analysis of variance (ANOVA) with repeated 
measures and post-hoc Bonferroni tests were used to study the effect and interaction of Group and 
Time on different variables. Linear regression models were used to examine associations. Significance 
was determined as p<0.05. Raw data was analyzed using graphpad Prism® software package or SPSS® 
v22 or Mystat® (Systat® 13). 
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CHAPTER 3  
CHANGES IN EATING BEHAVIOUR AND MEAL 
PATTERNS FOLLOWING VERTICAL SLEEVE 
GASTRECTOMY IN OBESE ADOLESCENTS 
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3.1 Introduction 
 Childhood obesity is defined as a BMI at, or above, the 97th percentile and is one of the most serious 
public health and medical problems worldwide, but also specifically in the Gulf area (35).  In the Gulf 
region the usual diet has changed in terms of quantity and quality, with more calories being 
consumed as fat and high glycemic carbohydrates (39).  The overall prevalence of obesity among 
adults in the Kingdom of Saudi Arabia is 35.6%, with a further 36.9% of patients being overweight 
(46).  The prevalence of overweight and obesity among young people, aged ≤20 years old, in Saudi 
Arabia was estimated at 28%, an estimated 11-23% overweight and 3-25% obese. More than 50% of 
children in SA between 14 and 18 years had a weight above the 85th percentile (49).  Obesity at this 
age represents one of the most frustrating and difficult diseases to treat even if interventions are 
started at an early age (58).  Frustratingly, an understanding of the mechanisms preventing an obese 
adolescent or adult from losing weight and maintaining weight loss remains elusive (15). 
 Social, cultural and genetic factors contribute to the development, preservation and alteration of 
dietary patterns and food preferences, taste, and food choices (512;513). Interpersonal relationships 
in family and peer groups influence eating behaviour and exert direct or indirect social influences  
(e.g. beliefs, cooking traditions and food rules, which a family may teach their children). Taste and 
other sensory properties of foods (e.g. smell and texture) are partly responsible for the selection of 
one food over another. The hedonic value of food is strongly linked to the functional taste domain, 
which may be a driving force behind food consumption (514). Weight-loss maintenance after 
changes in lifestyle, diet, and exercise have been disappointing (257).  Bariatric surgery is a successful 
intervention for sustained weight-loss and is cost-effective for morbidly obese people compared with 
non-surgical interventions (558). Although bariatric surgery may not treat the aetiology of morbid 
obesity, it is able to achieve 25-35% long term weight loss maintenance (559),  while also improving 
many co-morbidities (560),  such as disturbed eating behaviour and impaired quality of life (QoL)  
(561).  
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Vertical sleeve gastrectomy (VSG) is effective for weight loss over two-years (229;562), though more 
long term data are awaited. Al Qahtani et al., reported the largest series in the world of VSG in young 
people, which was performed at King Saud University Hospitals, Riyadh, Saudi Arabia. The reported 
outcomes of 108 patients aged between 5 and 21 years showed successful short-term weight loss in 
more than 90% of patients after VSG and resolution of 70% of their co-morbidities within 2 years 
after surgery. Longer-term data are needed to better understand what happens as these patients 
mature into adulthood (236). Anecdotal evidence from clinical observation and evidence in rodents 
after VSG suggest a shift in food preferences. Seeley et al showed VSG in rats reduced intake of 
dietary fat, and shifted preference toward less calorie-dense foods as compared with sham operated 
rats. When food choice was compared between VSG- and RYGB-operated rats, comparable results 
were achieved with these two anatomically different bariatric procedures (529). RYGB in humans 
may lead to changes in food preference and fundamental alterations to taste (264;369-371). This 
research wanted to determine whether humans after VSG change their food preferences and eating 
behaviours. This study aimed to test the hypotheses that there would be changes in meal patterns, 
attitudes to eating and foods selected by adolescents following VSG. Using a prospective approach, 
the specific aims were to evaluate (1) portion size, meal duration and rate of eating, (2) attitudes to 
eating, (3) foods selected and timing patterns of food selection pre VSG and after 12 and 52 weeks‎ in 
adolescents. 
 
3.2 Methods 
Obese adolescent patients older than 12 years, who met eligibility criteria for bariatric surgery  
(BMI greater than 40 kg /m² or 35 kg /m2 with comorbidity), were prospectively included. Patients 
were assessed for VSG in the Multidisciplinary Obesity Clinic for Children at King Saud University 
(KSU), Riyadh, Saudi Arabia. Exclusion criteria for the study included lack of understanding of the test 
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instructions, a diagnosis of diabetes mellitus, pregnancy, breast feeding, substance abuse,  
psychiatric illness, or allergy to the stimulus ingredients. All non-surgical subjects had BMIs >25 kg/m2 
and were relatives of the surgical subjects, in order to control for home environments. 
Anthropometric measurments for all participants were performed before the experiment, weight, 
height and BMI. Written, informed consent was obtained from all subjects. The study was approved 
by the Ethics Committee at KSU (Reference E 12-741). 
3.2.1 Ad libitum meal study 
 Ten non-surgical subjects and 13 VSG subjects completed the study between 11:00 and 14.00. The 
non-surgical subjects were tested twice, 12 weeks‎ apart and the VSG subjects before surgery and 
after VSG, at 12 and 52 weeks‎. All subjects had their usual breakfast two hours before each study 
visit. A customised menu for adolescents from Diet Centre® provided eight choices with comparable 
nutritional components (mean calories per meal was 1530 kcal and mean weight 1000 g). The menu 
included traditional food such as biryani rice with beef or kebsa rice with chicken, but also 
alternatives such as lasagna, spaghetti with tomato and meat, shawarma wraps with beef or chicken, 
and beef or chicken burger with or without cheese. On the day of recruitment the subjects were also 
screened for suitability and asked to choose a meal that they would have to consume at all the 
subsequent visits.  At the experemant day the research room was prepared in a standardised way to 
serve the meal after weighing it using a scale (Appendix 12). The investigator then left the room and 
the subjects had as much time as they needed to consume their meal, and were informed to call the 
invistegator back into the room once they were done with their meal. During this time a stop watch 
was used to calculate the duration of meal consumption. At each visit subjects were seated in a quiet 
private room and consumed their standardised ad libitum test meal with three glasses (750 ml) of 
water. Meal duration and size were determined. All questionnaires were self-administered with the 
supervision of the researcher only provided where needed. All anthropometric measures were taken 
prior to the study each time. Pre-meal hunger and post-meal satiation were measured twice:  
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a) immediately after the meal and b) one hour later to test whether satiation was maintained using 
the VAS (Appendix 12). 
3.2.2 Attitudes to eating 
At each of the above study visits, attitudes towards eating such as cognitive restraint (CR), emotional 
eating (EE) and uncontrolled eating (UE) were measured using validated three-factor eating 
questionnaire (TFEQ-21) (244) (Appendix 12). 
3.2.3 Food choices and patterns of consumption 
Habitual meal patterns over 24 hours were also recorded at each visit using a standardised 
questionnaire that allowed the analysis of temporal distribution of food intake over 24 hours, meal 
frequency and the foods selected at different times of the day (Appendix 12). 24h recall methods 
questionnaire were analysed using the Diet plan б® software. Food   questionnaire were analysed by 
converting the descriptive data into normative data using the serving size from the American 
Dietetics Association (ADA) manual. The sample size was calculated to detect an effect size of VSG of 
0.85 standard deviations (SD) from the mean VAS rating. With 15 patients in each group this was 
predicted to permit greater than 90% power to detecting significant differences at the p<0.05 level, 
using two tailed tests. The effects of sleeve gastrectomy on the study’s outcomes have never been 
examined before. Therefore, the effect size used in the power calculation was informed by similar 
experiments on patients after RYGB using the same behavioural testing methods at Imperial College 
London. Comparisons between and within groups were made using the Mann-Witney and Wilcoxon 
matched pairs test respectively. One-way ANOVA, within the surgical group was performed using 
repeated measures, Benferoni and the Friedman test respectively. Correlations were made using the 
Spearman non-parametric test, but the graphs include a parametric linear regression curve for visual 
comparison. The patient characteristic data were normally distributed and thus t-tests and ANOVA 
were used for within and between group comparisons for age and BMI, whilst gender comparisons 
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were made with Fisher’s exact test. Results are expressed either as mean ±SEM or median 
(interquartile range). GraphPad Prism® version 5 was used for statistical comparisons, and/or SPSS® 
v22 for the Two Way ANOVA data analysis.  
 
3.3 Results 
3.3.1 One Way ANOVA Statistical Analysis 
Table ‎3.3-1 shows the demographics of the participants. All eligible non-surgical participants 
completed the study (n=10). In the surgical group 17 eligible patients were recruited,  
and 13 completed the study (Figure  3.3.1-1). Data from completers are reported for both the surgical 
and non-surgical groups. The mean age within the surgical group was 15.2 ± 0.5 and within the non-
surgical group was 14.2 ±0.5 years (p=0.2) (Figure  3.3.1-2); mean BMI was 50.9 ±2.0 kg/m² and  
31 ±1.8 kg/m², respectively (p=0.0001) (Figure  3.3.1-3). There was no bodyweight change in the non-
surgical group between the two sessions, but the VSG group reduced their weight from 142 ±8 kg, to  
117 ±5.5 kg and 95.4 ±5 kg at 12 and 52 weeks‎ (Figure  3.3.1-4).   
Figure  3.3.1-1 Gender distribution in between the groups, VSG vs. Control 
 
Graph plots the distribution of both male and female in between the groups, VSG vs. Control, they 
are matching. 
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Figure  3.3.1-2 Matching Age for both groups VSG vs. Control 
 
Graph plots the matching age for both groups, VSG vs. Control, they are matching.  
 
 
Figure  3.3.1-3 Change in BMI pre/post VS 
 
Graph plots the changes in BMI through all three interval visits, baseline, 12 and 52 weeks post VSG. 
(A) * 12 weeks, and ** 52 weeks  are significantly decreased as compared to pre-op visit, +52 weeks 
significantly decreased as compared to 12 weeks. (B) Control groups no changes between the two 
visits.  
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Figure  3.3.1-4 Change in Weight pre/post VSG 
 
Graph plots the changes in Weight through all three interval visits, baseline, 12 and 52 weeks post 
VSG. (A) * 12 weeks, and ** 52 weeks  are significantly decreased as compared to pre-op visit, +52 
weeks significantly decreased as compared to 12 weeks. (B) Control groups no changes between the 
two visits.  
 
 
3.3.1.1 Ad libitum meal test  
Compared with baseline the weight of food eaten at 12 and 52 weeks‎ reduced after surgery  
(p ≤ 0.001), as well as being less than the weight of the food eaten by the non-surgical group  
(p ≤ 0.02) (Table ‎3.3-1, Figure  3.3.1-5). Water intake also decreased from 277 ±37 ml to 52 ±13 ml and 
49 ±11 ml after 12 and 52 weeks‎ respectively (p≤0.001) (Table ‎3.3-1, Figure  3.3.1-6), while the non-
surgical group had no changes in water intake between the two sessions (p = 0.2). The rate of eating 
in the VSG group reduced from 37 ±5 g/min, to 14 ±2 g/min and 16±2 g/min at 12 and 52 weeks‎ 
respectively (p<0.001) (Table ‎3.3-1, Figure  3.3.1-7). The rate of eating in the non-surgical group 
changed in the opposite direction by increasing from 26.4 ±3.6 to 34.5 ±3.8 g/min (p ≤ 0.02).  
Table  3.3-1 show the hunger and craving pre-test reduced at 12 and 52 weeks‎ (p ≤ 0.04), while 
craving also decreased at 12 and 52 weeks‎ (p=0.03).   
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Figure  3.3.1-5 Change in Eaten Food Weight pre/post VSG  
 
Graph plots the changes in Eaten Food Weight before and after the experiment session through all 
three interval visits, baseline, 12 and 52 weeks post VSG. (A) * 12 weeks, and ** 52 weeks are 
significantly decreased as compared to pre-op visit. (B) Control groups no changes between the two 
visits. 
 
 
Figure  3.3.1-6 Change in Water Intake pre/post VSG 
 
 
Graph plots the changes in Water Intake before and after the experiment session through all three 
interval visits, baseline, 12 and 52 weeks post VSG. (A) * 12 weeks, and ** 52 weeks are significantly 
decreased as compared to pre-op visit. (B) Control groups no changes between the two visits. 
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Figure  3.3.1-7 Change in Eating Rate pre/post VSG 
 
Graph plots the changes in the Eating Rate before and after the experiment session through all three 
interval visits, baseline, 12 and 52 weeks post VSG. (A) * 12 weeks, and ** 52 weeks are significantly 
decreased as compared to pre-op visit. (B) Control group a significant increase was shown in *2nd 
visit. 
3.3.1.2 Attitude to eating 
 Cognitive restraint (CR), emotional eating (EE) and uncontrolled eating (UE), as assessed by the 
Three-Factor Eating questionnaire (TEFQ-21), were unchanged in the non-surgical group, but in the 
VSG group, both EE (p < 0.001) and UE (p < 0.001) had decreased at 12 and 52 weeks‎, while CR had 
increased (p ≤ 0.02), (Figure  3.3.1-8, Figure  3.3.1-9, Figure  3.3.1-10). 
Figure  3.3.1-8 Change in Cognitive Restrain pre/post VSG  
 
Graph plots the changes in Cognitive Restrain before and after the experiment session through all 
three interval visits, baseline, 12 and 52 weeks post VSG. (A) * 12 weeks is significantly increased as 
compared to pre-op visit. (B) Control groups no changes between the two visits. 
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Figure  3.3.1-9 Change in Emotional Eating pre/post VSG  
 
Graph plots the changes in Emotional Eating before and after the experiment session through all 
three interval visits, baseline, 12 and 52 weeks post VSG. (A) * 12 weeks, and ** 52 weeks are 
significantly decreased as compared to pre-op visit. (B) Control groups no changes between the two 
visits. 
 
 
Figure  3.3.1-10 Change in Unconditional Eating pre/post VSG  
 
Graph plots the changes in Unconditional Eating before and after the experiment session through all 
three interval visits, baseline, 12 and 52 weeks post VSG. (A) * 12 weeks, and ** 52 weeks are 
significantly decreased as compared to pre-op visit. (B) Control groups no changes between the two 
visits. 
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3.3.1.3 24-hour diet recall  
Twenty-four hour calorie intake, according to 24-hour diet recall, decreased after VSG from  
3243 ±819 kcal to 880 ±182 kcal to 1207 ±273 kcal at 12 and 52 weeks‎ respectively (p < 0.001).  
No significant change in 24-hour calorie intake was observed in the non-surgical group  
(2313 ±287 vs. 1962 ±278 kcal) (p = 0.3) (Table ‎3.3-1, Figure  3.3.1-11). The relative percentages of 
macronutrients such as protein, fat, and carbohydrates did not change in either the VSG or  
non-surgical group (Figure  3.3.1-12) (Figure  3.3.1-13) (Figure  3.3.1-14).  
 
Figure  3.3.1-11 Change in Calories consumption pre/post VSG 
 
Graph plots the changes in Calories consumption through all three interval visits, baseline, 12 and 52 
weeks post VSG. (A) * 12 weeks, and ** 52 weeks are significantly decreased as compared to pre-op 
visits. (B) Control groups no changes between the two visits. 
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Figure  3.3.1-12 Change in percentage Protein consumption pre/post VSG 
 
Graph plots changes in percentage Protein consumption. (A) No changes through all three interval 
visits, baseline, 12 and 52 weeks post VSG. (B) Control groups no changes between the two visits. 
 
 
Figure  3.3.1-13 Change in percentage Fat consumption pre/post VSG 
 
Graph plots changes in percentage Fat consumption. (A) No changes through all three interval visits, 
baseline, 12 and 52 weeks post VSG. (B) Control groups no changes between the two visits. 
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Figure  3.3.1-14 Change in percentage Carbohydrate consumption pre/post VSG 
 
Graph plots changes in percentage Carbohydrate consumption. (A) No changes through all three 
interval visits, baseline, 12 and 52 weeks post VSG. (B) Control groups no changes between the two 
visits. 
 
3.3.1.4 Food questionnaires 
Food questionnaires, as previously used for patients before and after bariatric surgery by the 
Swedish Obese Subject Study (563;564), covered most food groups and items, all kind of meats, dairy 
products, grains, fruits, vegetables, beverages, fast food, and sweets. The non-surgical group had no 
changes in their choices, preferences and consumption.   The VSG group reduced their consumption 
of foods at 12 and 52 weeks‎ after surgery, compared with pre-surgery, although the 52 weeks intake 
was greater than 12 weeks intake (Figure  3.3.1-15). Meal size and meal frequency of the main and 
light meals through the weekdays and weekends decreased at 12 and 52 weeks‎ after VSG  
(Figure  3.3.1-16). Portion sizes for fats and high glycaemic index carbohydrates decreased at 12 and 
52 weeks‎ (Figure  3.3.1-17). The contribution of higher glycaemic index carbohydrates to the overall 
calorie intake reduced from 44% to 30% and 37% respectively after 12 and 52 weeks‎after VSG  
(p = 0.0001). While the proportion of lower glycaemic index carbohydrates such as vegetables to the 
overall calorie intake increased from 22% to 38% and 28% after 12 and 52 weeks‎ respectively  
(p = 0.004). To understand the contribution of foods and their marconutrient content was analysed 
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preferences broadly in categories defined as fat, higher glycaemic index carbohydrates, lower 
glycaemic index carbohydrates, proteins and beverages.    
Food preferences for fat:  
Fast food high in fat, sugar and salt decreased after 12 and 52 weeks‎, and fried food prepared in the 
home also decreased at 12 and 52 weeks (Figure  3.3.1-15) (Figure  3.3.1-18). Foods that were 
previously fried were now grilled, baked, or boiled leading to observed as an increase in each of 
these at 12 and 52 weeks‎. The type of fats used in cooking also changed, with less butter, but more 
vegetable oil at 12 and 52 weeks‎. Food preferences for higher glycaemic index carbohydrates: White 
bread was often replaced with whole grain bread as the main source of carbohydrates in their diet  
(Figure  3.3.1-18). 
Food preferences for lower glycaemic index carbohydrates:  
Whole grains and vegetables increased at 12 and 52 weeks‎ (Figure  3.3.1-18).  
Food preferences for protein: 
Cheese, legumes and sea-food increased at 12 weeks‎ and returned to pre surgical levels at 52 weeks‎. 
Intake of red meats and chicken decreased at 12 weeks‎, but returned to pre-surgical levels at 52 
weeks‎ (Figure  3.3.1-18).   
Beverages: 
Carbonated beverage consumption decreased at 12 and 52 weeks‎ and non-carbonated beverages 
increased after 12 and 52 weeks‎ (Figure  3.3.1-19).  
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Figure  3.3.1-15 Change in percentage Total Consumption pre/post VSG 
 
Graph (A) plots the changes in Total consumption through all three interval visits, baseline, 12 and 52 
weeks post VSG. (B) Control groups no changes between the two visits. 
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Figure  3.3.1-16 Change in Main meals portion size and Frequency pre/post VSG 
 
Graph (A) plots the changes in Main meals portion size and frequency and Light meals frequency per 
week through all three interval visits, baseline, 12 and 52 weeks post VSG. (B) Control groups no 
changes between the two visits. 
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Figure  3.3.1-17 Change in portion size for Protein, HGI and LGI pre/post VSG 
 
 
Pie chart (A) plots the changes in the portion size for Protein, HGI and LGI at the main meal for 
patients at 12 and 52 weeks‎ after VSG. Pie chart (B) plots the changes in the portion size for Protein, 
HGI and LGI at the main meal for control adolescents' patients at two separate visits. 
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Figure  3.3.1-18 Changes in different Food Preferences pre/post VSG 
 
Graph (A) plots the changes in Food Preferences through all three interval visits, baseline, 12 and 52 
weeks post VSG. (B) Control groups no changes between the two visits. 
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Figure  3.3.1-19 Changes in consumption of Carbonated beverages vs. Non-carbonated beverages 
pre/post VSG 
 
Graph (A) plots the changes in consumption of carbonated beverages vs. Non-carbonated beverages 
through all three interval visits, baseline, 12 and 52 weeks post VSG. (B) Control groups no changes 
between the two visits. 
 
 
  
112 
 
Table  3.3-1 One Way ANOVA Results 
  
Participant characteristics at baseline and summary of eating behaviour characteristics and visual analogue scale ratings (VAS) at baseline and follow up. 
All patients were tested at baseline and 12 weeks after enrolment (or surgery), and those undergoing vertical sleeve gastrectomy (VSG) were additionally 
tested 52 weeks after surgery. Results are expressed as mean ±SEM or median (interquartile range) depending on normality distribution. 
 
VSG 
PRE-OP 
(N=13) 
VSG 
12 WEEKS 
POST‐OP 
(N=13) 
VSG  
52 WEEKS 
POST‐OP 
(N=13) 
P VALUE 
WITHIN VSG 
GROUP 
CONTROL 
VISIT 1 
(N=10) 
CONTROL 
VISIT 2 
(N=10) 
P VALUE 
WITHIN 
CONTROL 
GROUP 
P VALUE 
BETWEEN 
GROUPS AT 
BASELINE 
Participant Characteristics  
Gender (M/F) 8/5 N/A N/A N/A 7/3 N/A N/A 0.89 
Age (years) 15.2±0.5 N/A N/A N/A 14.2±0.5 N/A N/A 0.18 
BMI (kg/m2) 52.4±2.4 41.5±1.7 33.5±1.5 *0.0001 31.0±1.8 29.9±1.5 0.9 *0.0001 
Food Weight Calculations  
Food wt pre-test (g) 974±102 961±105 974±133 0.73 1087±106 1145±131 0.27 0.44 
Food wt post-test (g) 579±85 907±103 871±134 *0.04 830±122 835±118 0.46 0.08 
Eaten food wt (g) 395±42 55±4.0 103±15.0 *≤0.0001 257±34 310±36 0.25 *0.02 
Eating rate (g/m) 36.7±4.5 13.6±2.1 16.2±1.9 *≤0.0001 26.4±3.6 34.5±3.8 *0.02 0.13 
Water (ml) 277±37 52±13 49±11 *≤0.0001 200±38 171±25 0.57 0.16 
Duration (m) 12.1±1.4 5.2±0.9 6.5±1.0 *0.008 10.8±1.1 9.2±0.7 0.32 0.22 
TFEQ-21 Rating Scale  
Cognitive Restrains 43.9±7.0 66.7±4.0 60.3±3.8 *0.02 57.3±4.0 60.2±3.6 0.43 0.11 
Emotional Eating 33.7±5.5 4.4±2.2 7.2±2.8 *0.0005 21.3±5.3 17.9±7.1 0.29 0.12 
Unconditional Eating 60±5.6 20.6±3.3 16.5±2.4 *0.0001 43.5±5.8 42.2±4.7 0.54 *0.05 
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VSG 
PRE-OP 
(N=13) 
VSG 
12 WEEKS 
POST‐OP 
(N=13) 
VSG  
52 WEEKS 
POST‐OP 
(N=13) 
P VALUE 
WITHIN VSG 
GROUP 
CONTROL 
VISIT 1 
(N=10) 
CONTROL 
VISIT 2 
(N=10) 
P VALUE 
WITHIN 
CONTROL 
GROUP 
P VALUE 
BETWEEN 
GROUPS AT 
BASELINE 
Macronutrients Consumption  From 24h  
Calories  3243±819 880±182 1207±273 *0.0006 2313±287 1962±278 0.27 0.72 
Protein % 12.9±1.5 12.0±1.6 17.9±2.7 0.09 13.8±1.2 13.5±1.2 0.67 0.66 
Fat % 28.1±4.2 26.5±4.5 38.1±5.5 0.58 30.1±2.8 30.0±2.7 0.47 0.70 
Carbohydrates % 64.0±5.1 65.5±4.9 50.6±5.1 0.07 60.7±3.6 60.3±2.9 0.64 0.60 
Visual Analogue Scale Ratings 
Pre-Meal 
 
Crave pre – test (cm) 62.7±6.4 32.0±6.0 51.5±7.4 *0.04 55.7±6.5 65.4±5.7 0.39 0.49 
Hunger pre – test  (cm) 55.7±7.2 32.9±8.5 47.1±7.3 *0.006 41.8±6.5 59.1±7.7 0.05 0.16 
Satisfaction  pre – test (cm) 88.2±5.6 89.5±3.3 75.8±7.1 0.43 81.0±6.3 80.4±8.4 0.91 0.42 
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VSG 
PRE-OP 
(N=13) 
VSG 
12 WEEKS 
POST‐OP 
(N=13) 
VSG  
52 WEEKS 
POST‐OP 
(N=13) 
P VALUE 
WITHIN VSG 
GROUP 
CONTROL 
VISIT 1 
(N=10) 
CONTROL 
VISIT 2 
(N=10) 
P VALUE 
WITHIN 
CONTROL 
GROUP 
P VALUE 
BETWEEN 
GROUPS AT 
BASELINE 
“Food amount”  pre – test (cm) 61.6±6.7 29.3±6.0 40.5±6.6 0.09 47.4±5.8 54.4±6.3 0.52 0.12 
Visual Analogue Scale Ratings 
Post-Meal 
 
Crave post – test (cm) 23.6±8.9 4.5±1.8 2.5±1.5 *0.03 6.1±2.9 7.7±4.9 0.81 0.07 
Hunger  post – test (cm) 8.2±4.9 4.4±1.5 9.7±7.6 0.35 3.9±1.9 5.4±3.3 1.0 0.55 
Satisfaction  post – test (cm) 93.6±2.9 83.2±6.7 77.2±9.6 0.50 91.5±4.4 95.3±2.7 0.57 0.77 
“Food amount”  post – test (cm) 10.6±3.8 3.8±1.3 10.2±4.1 0.90 4.8±2.9 10.2±6.4 0.94 0.26 
"How Good the food" post – test  (cm) 89.3±3.7 88.3±5.2 92.7±3.8 0.42 89.3±4.1 93.6±2.1 0.32 1.0 
Visual Analogue Scale Ratings 1hour Post-
Meal 
 
Crave  1hpost – test (cm) 15.1±5.3 16.1±4.6 21.9±6.6 0.53 11.0±3.6 11.3±4.9 0.64 0.53 
Hunger  1hpost – test (cm) 12.5±4.9 12.9±4.0 16.4±4.1 0.48 17.8±8.4 2.8±1.3 *0.04 1.0 
Satisfaction  1hpost – test (cm) 84.6±5.2 91.6±4.3 87.9±5.5 0.59 93.2±4.1 99.8±0.1 0.06 0.19 
“Food amount”  1hpost – test (cm) 15.2±4.7 12.2±3.2 17.2±5.2 0.67 8.8±3.1 9.0±4.0 0.63 0.26 
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3.3.2 Two Way ANOVA Statistical Analysis 
3.3.2.1 Ad libitum meal test  
The 2-way repeated measures ANOVA used to study the comparison between groups  
(VSG vs. Control) and within Group comparisons to examine the Time effect (pre-op vs post-op) on 
the variables (Table ‎3.3-2). Post hoc effects of Time within each group was illustrate according to the 
Time x Group interaction effect (Table ‎3.3-3). Meal size and eating rate were reduced significantly 
after 12 weeks‎ of surgery in the VSG adolescent patients. The overall repeated measures ANOVA for 
meal size (eaten food): Group F(1,21)= 5.4, p ≤0.01, Time F(1,21)= 4.0 , p ≤0.05, Group x Time  
F(1,21)= 24.4, p ≤0.001. (*p = 0.001) with post-hoc Bonferroni significant differences test  
(Figure  3.3.2-1). The eating rate didn’t show any differences between groups F(1,21)= 2.9, p=0.07 and 
between visits F(1,21)= 0.53, p=0.47, but the interaction between Group and Time presented  
a significant result F(1,21)= 18.17, p ≤0.001. (*p= 0.001) with post-hoc Bonferroni significant 
differences test (Figure  3.3.2-3). The water intake didn’t show any differences between groups 
F(1,21)= 2.4, p=0.11 and between visits F(1,21)= 2.8, p=0.11, but the interaction between Group and 
Time presented a significant result F(1,21)= 4.9, p ≤0.02. (*p = 0.001) with post-hoc Bonferroni 
significant differences test (Figure  3.3.2-2).  
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Figure  3.3.2-1 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Eaten Food Weight 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs. post-op) on Eaten Food Weight, showing the effects of Time within each group, 
according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
 
Figure  3.3.2-2 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Water Intake 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the tTime 
effect (pre-op vs post-op) on Water Intake, showing the effects of time within each group, according 
to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
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Figure  3.3.2-3 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Eating Rate 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs. post-op) on Eating Rate, showing the effects of Time within each group, according 
to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
3.3.2.2 Attitude to eating 
Attitudes towards eating such as cognitive restraint (CR), emotional eating (EE), and uncontrolled 
eating (UE) did show significant differences after 12 weeks‎ in VSG patients. CR increased and was 
different between groups F(1,21)=15, p ≤0.001 (Figure  3.3.2-4), and the (EE) decreased with an 
interaction between groups and visits F(1,21)=6.8, p ≤0.005 only (Figure  3.3.2-5). Uncontrolled eating 
(UE) as well was reduced, and the overall repeated measures ANOVA: Group F(1,21)=4.5, p=0.02, 
Time F(1,21)= 4.2 , p ≤0.05, Group x Time F(1,21)= 9.7, p ≤0.001 (Figure  3.3.2-6). 
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Figure  3.3.2-4 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Cognitive Restrain 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on Cognitive Restrain (CR), showing the effects of Time within each group, 
according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
 
Figure  3.3.2-5 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Emotional Eating 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on Emotional Eating (EE), showing the effects of Time within each group, 
according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
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Figure  3.3.2-6 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Unconditional Eating  
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on Unconditional Eating (UE), showing the effects of Time within each 
group, according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
3.3.2.3 24 four hour diet recall  
The data showed no differences in the macronutrient component of food as proportion for the 
carbohydrates, fat, and protein between groups or visits, and no interaction between the groups and 
time was seen. The overall repeated measures ANOVA for calories intake Group F(1,21)= 1.4, p=0.27 
Time: F(1,21)= 1.3, p=0.28 and Group X Time F(1,21)= 1.9, p=0.17) (Figure  3.3.2-7, Figure  3.3.2-8, 
Figure  3.3.2-9). Given the a priori hypothesis that calories intake will change in the VSG adolescents 
patients groups after surgery, we illustrate post hoc effects of Time within each group, irrespective of 
the Time x Group interaction effect. (*p= 0.002) with post-hoc Bonferroni significant differences test 
(Figure  3.3.2-10). 
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Figure  3.3.2-7 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Calories consumed 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on Calories consumption, showing the effects of Time within each group, 
according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
 
Figure  3.3.2-8 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Percentage Protein consumed 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on percentage protein consumed showing no effects. 
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Figure  3.3.2-9 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Percentage Fat consumed 
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Comparison between groups (VSG vs. Control) and within Group comparisons to examine the Time 
effect (pre-op vs post-op) on percentage Fat consumed showing no effects. 
 
 
Figure  3.3.2-10 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Percentage Carbohydrates consumed 
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Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs. post-op) on percentage Carbohydrates consumed showing no effects. 
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3.3.2.4 Visual Analogue Scale Ratings 
Craving, hunger, satisfaction and wanting all were measured using the VAS. The results showed  
a reduction in their scale when tested before the test meal was served in the VSG patients  
as compared to pre-op and control group. The overall repeated measure for craving, hunger, 
satisfaction and wanting presented a significant interaction between groups and visits, Group X Time 
F(1,21)= 4.7, p ≤0.02, F(1,21)= 4.6, p ≤0.02, F(1,21)= 4.7, p ≤0.02, and F(1,21)= 4.7, p ≤0.02 
respectively, (*p ≤0.01) with post-hoc Bonferroni significant differences test.  AS that was filled 
immediately after they finished their meal didn’t show any differences. One hour after consuming 
their meal, the VSG patients were less satisfied as compared to the controls, Group F(1,21)=25.9,  
p ≤0.001.(*p= 0.06)  with post-hoc Bonferroni significant differences test. 
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Table  3.3-2 Two Way ANOVA Results 
  
Two Way ANOVA results for Participant characteristics at baseline and 12 weeks. A summary of eating behaviour characteristics after Vertical Sleeve 
Gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending on normality distribution. 
 
 
CONTROLS SLEEVE ANOVA 
PRE POST PRE POST GROUP TIME GROUP X TIME 
Number 10 10 13 13 F 
a
 P 
b
 F 
a
 P 
b
 F 
a
 P 
b
 
Participant Characteristics  
Age (years) 14.2±0.5 N/A 15.2±0.5 N/A N/A N/A N/A N/A N/A N/A 
Height (m) 1.64±0.03 1.65±0.03 1.67±0.3 1.68±0.03 0.55 0.46 9.2 0.006 0.08 0.77 
BMI (kg/m2) 30.4±2.3 30.2±1.8 52.4±2 41.5±1.6 37.9 *≤0.001 92.1 *≤0.001 85.3 *≤0.001 
Weight (kg) 82.1±7.4 82.5±5.8 145.8±6.5 117±5.1 31.5 *≤0.001 93.6 *≤0.001 98.9 *≤0.001 
Food Calculations  
Food wt pre-test (g) 1079.4±118.6 1156.2±130.6 973.7±104 961.2±114.5 4.05 *≤0.033 0.065 0.80 0.42 0.66 
Eaten food wt (g) 277±43.5 316±26.1 395±38.1 54.8±22.9 5.4 *≤0.01 4.5 *≤0.05 24.4 *≤0.001 
Eating rate (g/m) 22.7±5.3 35.8±3.4 36.7±4.6 11.6±3 2.94 0.075 0.53 0.47 18.17 *≤0.001 
Water (ml) 203±43.7 162.5±20.6 277.3±38.3 52.1±18.1 2.4 0.11 2.8 0.11 4.9 *0.02 
Duration (m) 10.4±1.5 8.9±0.9 12.1±1.3 5.2±0.8 6.5 *0.006 1.7 0.21 2.6 0.09 
TFEQ-21 Rating Scale  
Cognitive Restrains 56.6±6.5 60.2±4.1 43.9±5.7 66.7±3.6 15 *≤0.001 0.76 0.39 1.5 0.25 
Emotional Eating 21.7±6.3 17.9±5.0 33.7±5.5 4.4±4.4 0.72 0.49 3.2 0.09 6.8 *0.005 
Unconditional Eating 46.6±6.4 42.2±4.2 60±5.7 20.6±3.7 4.5 0.02 4.2 *≤0.05 9.7 *≤0.001 
Macronutrients Consumption  From 
24h 
 
Calories 2483±736 1962±240 3243±646 880±211 1.4 0.27 1.3 0.28 1.9 0.17 
Protein % 0.15±0.016 0.133±0.017 0.128±0.014 0.125±0.014 0.98 0.39 0.3 0.56 0.1 0.88 
Fat % 0.292±0.043 0.309±0.046 0.288±0.036 0.275±0.038 0.97 0.39 0.2 0.67 0.2 0.83 
Carbohydrates % 0.603±0.054 0.606±0.049 0.636±0.045 0.639±0.041 1.43 0.26 0.04 0.84 0.03 0.97 
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CONTROLS SLEEVE ANOVA 
PRE POST PRE POST GROUP TIME GROUP X TIME 
Number 10 10 13 13 F 
a
 P 
b
 F 
a
 P 
b
 F 
a
 P 
b
 
Visual Analogue Scale Pre-Meal  
Crave pre – test (cm) 61.7±6.5 62.5±6.3 62.7±5.7 32±5.5 8 *0.003 1.2 0.3 4.7 *0.02 
Hunger pre – test  (cm) 43.4±7.5 55.5±8.9 55.7±6.6 32.8±7.8 2.3 0.1 0.13 0.7 4.6 *0.02 
Satisfaction pre – test (cm) 50.6±7 50.2±6.2 61.6±6.1 29.3±5.5 4.2 *0.03 1.4 0.3 4.7 *0.02 
“Wanting”  pre – test (cm) 50.6±7 50.2±6.2 61.6±6.1 29.3±5.4 4.2 *0.03 1.4 0.3 4.7 *0.02 
Visual Analogue Scale Post-Meal  
Crave post – test (cm) 7.3±8 7.5±3.9 23.6±7 4.5±3.4 0.86 0.4 0.4 0.5 1.6 0.2 
Hunger  post – test (cm) 4.7±3.9 5±2.7 8.2±3.9 4.4±2.4 0.3 0.8 0.05 0.8 0.2 0.8 
Satisfaction post – test (cm) 89.9±4.2 96.8±6 93.6±3.7 83.2±5.2 22.3 *≤0.001 0.03 0.9 2.5 0.1 
“Food amount”  post – test (cm) 5.8±4 9.2±4.7 10.6±3.5 3.8±4.1 0.3 0.8 0.03 0.9 0.8 0.5 
"How Good the food" post – test  
(cm) 
87.5±5.3 94.9±4.6 89.3±3.9 88.3±4.1 27.3 *≤0.001 0.14 0.72 0.8 0.5 
Visual Analogue Scale 1hour Post-
Meal 
 
Crave 1hpost – test (cm) 12.4±5.3 11.3±5.1 15.1±4.6 16.1±4.4 0.9 0.4 0.001 0.99 0.03 0.97 
Hunger  1hpost – test (cm) 21.4±7.6 2.8±3.6 12.5±6.7 13±3.1 0.4 0.7 0.5 0.5 1.7 0.2 
Satisfaction 1hpost – test (cm) 91.8±5.5 99.8±3.7 84.6±4.8 91.6±3.3 25.9 *≤0.001 0.8 0.4 0.12 0.9 
“ Food amount”  1hpost – test (cm) 10±4.7 9±3.8 15.2±4.1 12.2±3.3 1.0 0.4 0.05 0.8 0.05 0.9 
F a (1, 21) for all ANOVA results. 
P b values for repeated measures ANOVA with Group as between subject factor and Time as within subject factor. 
Data presented as mean ± SEM. 
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Table  3.3-3 Post hoc effects of Time within groups 
  
Post-hoc Bonferroni significant differences test with Two Way ANOVA results for participant characteristics at baseline and 12 weeks.  
A summary of eating behaviour characteristics after Vertical Sleeve Gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile 
range) depending on normality distributionPost hoc effects of Time within each group, according to the Time x Group interaction effect. 
 
CONTROL VS. SLEEVE AT BASELINE CONTROL VS. SLEEVE AT 12 weeks‎ CONTROL BASELINE VS. 12 weeks‎ SLEEVE BASELINE VS. 12 weeks‎ 
Mean Difference P Value Mean Difference P Value Mean Difference P Value Mean Difference P Value 
Participant Characteristics  
Age (years) N/A N/A N/A N/A N/A N/A N/A N/A 
Height (m) N/A N/A N/A N/A N/A N/A N/A N/A 
Weight (kg) -63.8±9.9 *≤0.001 -34.5±7.7 *≤0.001 0.4±2.2 0.86 28.9±1.9 *≤0.001 
BMI (kg/m2) -21.95±3.1 *≤0.001 -11.2±2.4 *≤0.001 0.21±0.9 0.81 10.9±0.8 *≤0.001 
Food Calculations  
Food wt pre-test (g) N/A N/A N/A N/A N/A N/A N/A N/A 
Eaten food wt (g) -117.9±57.8 *≤0.05 261.2±34.7 *≤0.001 39±41 0.35 340.2±36.4 *≤0.001 
Eating rate (g/m) -14.1±7 0.057 24.2±4.5 *≤0.001 13.15±4.8 *≤0.01 25.1±4.2 *≤0.001 
Water (ml) -74.3±58 0.22 110±27.4 *≤0.001 40.5±46.4 0.39 225.2±40.7 *≤0.001 
Duration (m) -1.7±1.69 0.40 3.7±1.2 *0.007 1.5±1.9 0.43 6.8±1.6 *≤0.001 
         
TFEQ-21 Rating Scale         
Cognitive Restrains 12.7±8.7 0.2 -6.5±5.5 0.25 3.6±8.8 0.68 22.8±7.7 *0.008 
Emotional Eating -12±8.4 0.17 13.5±6.7 0.056 3.8±5.4 0.49 29.3±4.8 *≤0.001 
Unconditional Eating -13.4±8.6 0.163 21.6±5.6 *≤0.001 4.4±6.2 0.48 39.4±5.4 *≤0.001 
Macronutrients Consumption  
From 24h 
        
Calories -760±979 0.44 1081±320 *0.003 522+751 0.49 2363±659 *0.002 
Protein % N/A N/A N/A N/A N/A N/A N/A N/A 
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CONTROL VS. SLEEVE AT BASELINE CONTROL VS. SLEEVE AT 12 weeks‎ CONTROL BASELINE VS. 12 weeks‎ SLEEVE BASELINE VS. 12 weeks‎ 
Mean Difference P Value Mean Difference P Value Mean Difference P Value Mean Difference P Value 
Fat % N/A N/A N/A N/A N/A N/A N/A N/A 
Carbohydrates % N/A N/A N/A N/A N/A N/A N/A N/A 
Visual Analogue Scale Pre-
Meal 
 
Crave pre – test (cm) -0.99±8.6 0.9 30.5±8.4 *≤0.001 0.8±7.9 0.9 30.7±7 *≤0.001 
Hunger pre – test  (cm) 12.3±10 0.2 22.7±11.8 0.07 12.1±8.7 0.2 22.8±7.6 *0.007 
Satisfaction  pre – test (cm) -0.11±9.3 0.2 20.9±8.3 *0.02 0.4±8.1 0.9 32.2±7.1 *≤0.001 
“Food amount”  pre – test (cm) -11±9.3 0.2 20.9±8.3 *0.02 0.4±8.1 0.9 32.2±7.1 *≤0.001 
Visual Analogue Scale Post-
Meal 
 
Crave post – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Hunger  post – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Satisfaction  post – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
“Food amount” post – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
"How Good the food" post – 
test  (cm) 
N/A N/A N/A N/A N/A N/A N/A N/A 
Visual Analogue Scale 1hour 
Post-Meal 
 
Crave  1hpost – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Hunger  1hpost – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Satisfaction  1hpost – test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
““Food amount”1hpost – test 
(cm) 
N/A N/A N/A N/A N/A N/A N/A N/A 
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3.4 Discussion 
This study has demonstrated that VSG changes eating behaviour and, specifically, ad libitum meal 
size, meal duration and rate of eating reduce. Emotional eating and unconditioned eating decreased 
postoperatively while cognitive restraint increased. Food preferences, as reported by patients, 
suggest a reduction in fat and high glycaemic index carbohydrates, with an increase in low glycaemic 
index carbohydrates and unchanged protein consumption after VSG.  
Lessons learnt from RYGB 
 Laurenius et al. showed that 2 years after RYGB, in addition to a considerable reduction in overall 
energy intake and large difference in food weight, patients reported decreased dietary energy 
density, with nutritionally beneficial food choices (367).  Laurenius further showed that after RYGB,  
a reduction in ad libitum meal size and rate of eating although meal duration remained the same 
(244). Interactions between eating rate and satiety hormones have also been demonstrated in 
humans after RYGB (565).  VSG resulted in similar observations documented regarding RYGB (268), 
showing that reduced energy intake was the most important dietary factor contributing to weight 
loss. After RYGB subjects tend to increase the intake of fruits and vegetables as well as low fat food 
(362;363).  
3.4.1 Ad libitum meal consumption 
Strengths of this study include that direct measures were obtained of the portion size, meal duration 
and eating rate both preoperatively, and at 12 and 52 weeks‎ after VSG when patients consumed 
healthy palatable low fat popular ready-made meals. A limitation of this study is that the test meals 
were served in a test center setting, which may not reflect habitual eating habits of obese adolescent 
patients, although the methods replicated a previous published protocol (244). Eating rate is 
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positively correlated with BMI (566-568), and reducing eating rate lowers caloric intake and 
increased satiety (569-571).  Possible mechanisms include changes in appetite-regulatory hormones 
leading to reduced hunger, which in turn may reduce eating rate and energy intake (292;293).  Eating 
rate may also be reduced to attenuate the risk of dumping syndrome, which may occur when high 
glycaemic index carbohydrates rapidly reach the proximal small intestinal (406). Reports 
documenting gastric emptying following VSG are inconsistent (461;462),  and it is also unclear how 
often VSG is associated with symptoms of dumping syndrome, but a recent study suggested that 
symptoms of dumping syndrome occur in almost half of patients 6 weeks after VSG (572).  
3.4.2 Attitudes to eating 
 Changes in attitudes to eating may also alter meal frequency, meal size, eating rate (547;573), and 
weight loss maintenance (574-576).  Individuals may be influenced by psychosocial factors, such as 
culture, dietary counseling, food preferences, previous experiences of dieting and emotional state 
(244).  The changes in gastrointestinal physiology after VSG may initiate a cognitive process leading 
the individual to make changes to their behaviour, or leading them to attempt to avoid negative 
consequences of eating specific foods (406). This learning process may increase cognitive restraint, 
although the potential extent of such an impact is controversial (546). Little is known about attitudes 
to eating after VSG (547;548).  Furnes et al. compared eating behaviour in rats that had undergone 
VSG or RYGB and found that the food intake and meal size were reduced after VSG, but not after 
RYGB. This suggested that the control of food intake was independent of the food reservoir function 
of the stomach (545). Seeley et al. demonstrated that reductions in meal size post VSG in rats was 
not a consequence of volume effects, but rather resulted from the activation of satiation pathways in 
response to nutrients, and particularly in response to fat content (577). 
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3.4.3 24 hour recall of food choices 
The shift shown after VSG, towards smaller meals and increased meal frequency, is difficult to 
interpret in the context of inconsistent associations between meal frequency and BMI in both normal 
weight subjects and those with obesity (578-580).  Frequent eating has been associated with poorer 
weight loss after RYGB (581;582), but no data on VSG is currently available. These inconsistent results 
may be explained by the difficulty in distinguishing between snacking on high calorie dense foods and 
having more meals of lower fat and glycaemic index after bariatric surgery(583). 
3.4.4 Food questionnaires 
 Energy intake increases depending on the fat content and energy density of the entire diet (549). 
After VSG, food preferences became healthier, reducing fat and higher glycaemic index carbohydrate 
intake, both of which may be associated with conditioned avoidance. This part of the study is limited 
by the reliance on self-reported data from patient-completed questionnaires, although this method 
has been validated previously. Information was not collect on physical activity and body composition, 
which may have strengthened the association between lifestyle changes and weight loss.  
In conclusion, patients reduced their ad libitum meal size, meal duration and eating rate. Habitual 
meal frequency tended to increase with more meals consumed in the mornings. Emotional and 
unconditional eating decreased while cognitive restraint increased after VSG. Besides a considerable 
reduction in overall energy intake, patients also reported decreased dietary energy density. After 
VSG, adolescents with obesity exhibit eating behaviour that promotes and maintains weight loss. 
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CHAPTER 4  
SUCROSE DETECTION AFTER VERTICAL SLEEVE 
GASTRECTOMY IN OBESE ADOLESCENTS 
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4.1 Introduction 
Obesity in young people is one of the most serious public health problems worldwide, but specifically 
in the Gulf area where more than 27% of children and adolescents are overweight or obese (50;51). 
Obesity at this age is challenging to treat even if treatment is initiated early (58). Moreover the 
mechanisms preventing an obese adolescent from losing and maintaining weight loss have been 
elusive, although bariatric surgery such as vertical sleeve gastrectomy (VSG) is successful at achieving 
long term weight loss (195). Several studies have demonstrated that VSG can be as effective as RYGB 
for weight loss over two-years (229;562), though longer term data are awaited. The largest series in 
the world of VSG in children and adolescents has been performed at King Saud University Hospitals, 
Riyadh, Saudi Arabia and shows that successful medium term weight loss and resolution of  
co-morbidities occur within the first 2-5 years after surgery (236). Longer-term data are needed to 
better understand what happens to these patients as they mature into adulthood (236).   
Roux-en-Y gastric bypass (RYGB) in humans and rodents leads to changes in food preference and 
fundamental alterations in taste sensitivity (264;369-371). After RYGB, patients often report 
idiosyncratic changes in taste perception that involve “sweet” taste, something that may drive 
selective reduction in food with a high sugar content (269;279;363;518;524;584). The gustatory 
system is a prime candidate to explain this observation. It remains unclear, however, whether such 
changes in intake are conditioned or unconditioned. Furthermore, if is unclear whether changes are 
attributable to either an alteration in the intensity of sensory signals generated by food, or by their 
altered evaluation in the so called “reward” circuits of the brain, or a combination of both 
(263;382;384;385). Anecdotal evidence from clinical observation and evidence in rodents after VSG 
suggest a shift in food preferences. Seeley et al. showed that VSG in rats reduced intake of dietary 
fat, and shifted preference toward lower caloric-density foods as compared with sham operated rats. 
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A progressive-ratio (PR) and conditioned taste aversion paradigms demonstrated a reduction in 
appetitive behaviour and reduced intake of calorie dense foods after VSG in rats. Food choice was 
compared between VSG- and RYGB-operated rats, and no differences in food choices were seen 
between these two anatomically  diverse bariatric procedures (529). Taste detection thresholds 
inform us of the functional status of oral sensory receptors and the sensitivity of downstream 
gustatory circuits (379;380).  
Taste detection thresholds are only one basic aspect of taste function and have been shown to vary 
as a function of genetics, pharmacological treatment, and neural manipulations (515). Circumventing 
the influence of post-ingestive factors both in animals and humans is important during assessment of 
taste function. Postingestive effects can be positive (e.g. fullness) or negative (nausea, visceral pain). 
Hence, two important methodological features to consider include; a) only small volumes of taste 
solutions must be used and b) immediate responses to the taste stimulus should be measured. Using 
direct measures of behaviour to study the effects of RYGB on the sensory domain of sweet taste in 
obese patients using a method of constant stimuli determined detection thresholds to sucrose 
showed that sweet taste acuity improves after RYGB (i.e. sweet detection thresholds are reduced) 
(385). The effect of VSG on the sensory domain of sweet taste has not been studied in humans.   
The objective of this study was to determine whether humans after VSG have changes in sucrose 
detection thresholds in the context of previous data that showed humans after RYGB have increased 
sensitivity to sweet. This study examined oral sensory sucrose taste detection thresholds in 
adolescent patients undergoing VSG and non-operated overweight/obese controls that were 
matched for age and gender.  
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4.2 Methods 
This prospective study of obese adolescent patients who fulfilled the criteria for having VSG (BMI 
greater than 40 kg/m² or 35 kg/m2 with comorbidity) recruited patients from the Multidisciplinary 
Obesity Clinic for Children at King Saud University (KSU), Riyadh, Saudi Arabia.   Written, informed 
consent was obtained from all the subjects. The study was approved by the Ethics Committee at KSU 
(Reference E 12-767). Assessment of sucrose detection thresholds in fourteen obese adolescent 
subjects was performed two weeks before and 12, and 52 weeks after VSG. Ten non-surgical subjects 
were tested on two occasions 10-12 weeks apart to ensure no learning occurred in between the test 
that may alter the outcome.  Dietetic advice given to the patients was similar to what was received 
within the non-surgical weight management program and included advice on healthy eating, avoiding 
calorie dense foods and increasing physical activity. The patients were reviewed every 3 months for 
nine months by a clinical dietitian within the multi-disciplinary clinic. The tests were all performed in 
the morning after an overnight fast of at least 10 hours. Room temperature was kept constant at  
21 °C for all test sessions. All solutions were prepared daily using the same distilled still natural 
mineral water (Bambini distilled still natural baby water, Delta Marketing Co. Ltd., Jeddah, KSA) and 
presented at room temperature. As per previously validated protocols (381), seven sucrose (Sigma 
Aldrich, Dorset, UK) concentrations were used in this study: 2.1, 6.25, 12.5, 25, 50, 100 and 300 mM. 
Concentrations were tested in eight blocks, each block consisting of seven sucrose and seven water 
stimuli. Sucrose and water stimuli were presented in random order without replacement  
(Appendix 13). Thus, each of the seven sucrose concentrations was presented once within a block. 
Fifteen millilitres of water or sucrose stimuli were offered in polystyrene cups and subjects were 
given a period of five seconds to sample the stimulus in the mouth. Subjects then expectorated the 
sample and were given additional five seconds to indicate whether the stimulus was water or not by 
answering the investegators question for each trial “Is this water or not?”. 
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Each stimulus was followed by a thorough ten second water rinse with 30 ml of water, which was 
expelled before the next stimulus was offered. To maintain attention to the task, the patients were 
rewarded for correct responses with the presentation of a token and penalized by loss of a token for 
incorrect responses. The sucrose detection study used the method of constant stimuli in which taste 
stimuli are presented randomly and performance is assessed allowing for the derivation of  
a psychometric function. A “hit” was defined as when the subject correctly reported that the 
stimulus was different from water when sucrose was presented. A “false alarm” (FA) was defined 
when the subject incorrectly reported that the stimulus was different from water when water was 
presented. The hit rate for a given sucrose concentration was adjusted for the false alarm rate to 
derive a “corrected hit rate” using the following equation: Corrected Hit Rate =
𝑃(ℎ𝑖𝑡)−𝑃(𝐹𝐴)
1:0−𝑃(𝐹𝐴)
 where  
P (hit) = the proportion of sucrose trials of a given concentration that were hits, and P (FA) = the 
proportion of water trials that were false alarms. Thus, when the uncorrected hit rate is equal to the 
false alarm rate, the corrected hit rate=0. The corrected hit rate values were subjected to two-way 
analyses of variance (ANOVAs). Because there was very little or no variance around the sample 
means for the highest three concentrations for the groups both preoperatively and postoperatively, 
only the scores for the lower 4 concentrations, representing the dynamic range of performance, 
were used in the ANOVAs. In addition, concentration-response curves were fit to the corrected hit 
rate values for each subject preoperatively and postoperatively to derive a family of individual 
psychometric functions using the following logistic equation: f(x) = a / [1+10 ((log10(x)-c) x b)] where 
log10(x) = log10 concentration, a = the upper asymptote of performance, b = slope, and c = the log10 
concentration at 1/2a performance (i.e. EC50). The c parameter was defined as the threshold 
because it represents the inflection point of the psychometric function and thus optimally represents 
lateral shifts in sensitivity. 
135 
 
Only c-values of the individual curve fits for the subjects who had fits that accounted for at least 85% 
of the variance was compared. The shifts in the c parameters were analyzed in a one-way ANOVA. All 
subjects had curve fits that accounted for at least 85% of the variance and all were included in the 
analyses of corrected hit rate described above. All other variables were compared with 
paired/unpaired t-tests or their non-parametric equivalents depending on the normality distribution 
of the data, with p≤0.05 used to define statistical significance.  
The sample size was calculated to detect an effect size of VSG of 0.85 standard deviations (SD) from 
the mean VAS rating. With 15 patients in each group this was predicted to permit greater than 90% 
power to detecting significant differences at the p<0.05 level, using two tailed tests. The effects of 
sleeve gastrectomy on the study’s outcomes have never been examined before. Therefore, the effect 
size used in the power calculation was informed by similar experiments on patients after RYGB using 
the same behavioural testing methods at Imperial College London.  
Comparisons between and within groups were made using the Mann-Witney and Wilcoxon matched 
pairs test respectively. One-way ANOVA, within the surgical group was performed using repeated 
measures, Benferoni and the Friedman test respectively. Correlations were made using the 
Spearman non-parametric test, but the graphs include a parametric linear regression curve for visual 
comparison. The patient characteristic data were normally distributed and thus t-tests and ANOVA 
were used for within and between group comparisons for age and BMI, whilst gender comparisons 
were made with Fisher’s exact test. Results are expressed either as mean ±SEM or median 
(interquartile range). GraphPad Prism® version 5 was used for statistical comparisons and/or SPSS® 
v22 for the Two Way ANOVA data analysis and Mystat® (Systat® 13).  
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4.3 Results 
4.3.1 One Way ANOVA Statistical Analysis 
The 14 adolescent patients (Figure  4.3.1-1, Figure  4.3.1-2) after VSG experienced a reduction in their 
mean body weight from 136.7±5.4 kg to 109.6±5.1 kg and 86.5±4.0 kg after 12 and 52 weeks 
respectively (p<0.001) (Figure  4.3.1-3) resulting in a BMI reduction from 49.6±1.6 to 39.4±1.5 and 
31.0± 0.9 kg/m2 (p<0.001) (Figure  4.3.1-4). There were no nutritional or surgical complications in the 
surgical group. In contrast, the 10 non-surgical subjects had a BMI of 32.0±1.6 kg/m2 and kept their 
body weight stable at 89.9±5.4 kg vs. 90.1±5.6 kg, (p=0.30) as shown in (Table ‎4.3-1).  
 
Figure  4.3.1-1 Gender distribution in between the groups, VSG vs. Control 
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Graph plots the distribution of both male and female in between the groups, VSG vs. Control. 
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Figure  4.3.1-2 Matching Age for both groups, VSG vs. Control 
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Graph plots the matching age for both groups, VSG vs. Control, they are matching. 
 
 
Figure  4.3.1-3 Changes in Weight pre/post VSG 
 
Graph plots the changes in Weight through all three interval visits, baseline, 12 and 52 weeks post 
VSG. (A) * 12 weeks, and ** 52 weeks  are significantly decreased as compared to pre-op visit, +52 
weeks significantly decreased as compared to 12 weeks. (B) Control groups no changes between the 
two visits. 
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Figure  4.3.1-4 Changes in BMI pre/post VSG 
 
Graph plots the changes in BMI through all three interval visits, baseline, 12 and 52 weeks post 
VSG.(A) * 12 weeks, and ** 52 weeks  are significantly decreased as compared to pre-op visit, +52 
weeks significantly decreased as compared to 12 weeks. (B) Control groups no changes between the 
two visits. 
 
 
4.3.1.1 Corrected hit rate analysis for sucrose taste detection. 
The mean corrected hit rates (proportion of sucrose trials adjusted for false alarm rate; see above for 
non-surgical subjects and patients pre- and postoperatively (Figure  4.3.1-5, Figure  4.3.1-6) are 
displayed in (Table  4.3-1). The one-way ANOVA values for comparison of the corrected hit rates  
pre and postoperatively between visits pre, 12 and 52 weeks post- VSG are also shown in  
(Figure  4.3.1-6) along with the two visits for the non-surgical group which occurred 12 weeks apart  
(Figure  4.3.1-6). Preoperatively, there were no differences between controls and patients with no 
significant main effect of groups, neither an interaction between group and concentration, for the 
corrected hit rates (p=0.8). There was also no difference uncorrected hit rate in the non-surgical 
group in-between their two visits (p=0.3), nor for the VSG group between the three visits (p=0.2).  
The c-value, representing the EC50 (the concentration where subjects achieved the mean corrected 
hit rate also did notchange significantly after VSG either at 12 or 52 weeks (Figure  4.3.1-5). 
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Figure  4.3.1-5 Changes in Ec50s pre/post VSG 
 
Graph plots changes in EC50s. (A) No changes through all three interval visits, baseline, 12 and 52 
weeks post VSG. (B) Control groups no changes between the two visits. 
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1Figure  4.3.1-6 Corrected hit rate for sleeve patients pre/op VSG as a function of sucrose 
concentration. 
 
Mean ±SEM corrected hit rate for VSG patients preoperatively and postoperatively as a function of 
sucrose concentration. Curves were fit to the mean data points using Eq. (2) in text. The EC50 was 
derived from the c-parameter in the curve fit and represents the concentration at which the 
corrected hit rate reaches 50% of the maximum asymptote. No significant changes were shown 
between the study groups. 
  
                                                          
1 Pre-op  ______     
   Post-op 12 weeks ………… 
   Post-op 52 weeks  _ _ _ _ _ 
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2Figure  4.3.1-7 Corrected hit rate for controls in 2 visits as a function of sucrose concentration. 
 
Mean ±SEM corrected hit rate for controls at visit 1 and 2, as a function of sucrose concentration. 
Curves were fit to the mean data points using Eq. (2) in text. The EC50 was derived from the c-
parameter in the curve fit and represents the concentration at which the corrected hit rate reaches 
50% of the maximum asymptote. No significant changes were shown between the study groups. 
 
 
  
                                                          
2 Visit 1 _______ 
   Visit 2 _ _ _ _ _  
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Table  4.3-1 One Way ANOVA Results 
Participant characteristics at baseline and sucrose taste detection thresholds at baseline and follow up. Patients were tested 12 nd 52 weeks after 
vertical sleeve gastrectomy (VSG), whilst un-operated obese control participants were tested 10‐12 weeks apart. Results are expressed as mean ± SEM or 
median (interquartile range) depending on normality distribution. Data from all subjects are represented as they all met the criterion of 85% of variance 
accounted for in the curve fits. 
 
VSG 
PRE-OP 
(N=14) 
VSG 
12 WEEKS 
POST‐OP 
(N=14) 
VSG  
52 WEEKS 
POST‐OP 
(N=14) 
P VALUE 
WITHIN 
VSG 
GROUP 
CONTROL 
VISIT 1 
(N=10) 
CONTROL 
VISIT 2 
(N=10) 
P VALUE 
WITHIN 
CONTROL 
GROUP 
P VALUE 
BETWEEN 
GROUPS 
AT 
BASELINE 
Participant Characteristics  
Gender (M/F) 4/10 N/A N/A N/A 6/4 N/A N/A 0.24 
Age (years) 15.2±0.5 N/A N/A N/A 15.1±0.6 N/A N/A 0.92 
BMI (kg/m2) 49.6±1.6 39.6±1.5 31.0±0.9 *≤0.0001 33.1±1.8 32.2±1.8 0.69 *≤0.0001 
Tested sucrose taste detection 
thresholds 
 
EC50s -1.7±0.3 -1.9±0.1 -2.0±0.1 0.60 15.2±0.5 15.1±0.6 0.69 0.38 
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4.3.2 Two Way ANOVA Statistical Analysis 
The 2-way repeated measures ANOVA used to study the comparison between groups  
(VSG vs. Control) and within Group comparisons to examine the Time effect (pre-op vs post-op) on 
the variables (Table ‎4.3-2). A post hoc effect of Time was illustrated within each group, according to 
the Time x Group interaction effect (Table ‎4.3-3). The EC50s showed no differences neither between 
groups nor according to time effect, No interaction Group x Time was seen (Figure ‎4.3.2-1).  
The Overall repeated measures ANOVA: Group F(1,22)=1.3, p=0.27, Time F(1,22)= 0.5, p=0.50,  
Group x Time F(1,22)= 0.3, p=0.57. A two-way repeated measures ANOVA was used in the VSG group 
to study the effect of time (pre-op vs. post-op) and the effect on concentrations of sucrose. There 
was a significant difference between concentrations F(1,12)=95.8, p ≤0.0001, but no differences 
between pre and postoperative visits F(1,12)=1.06, p=0.35, and no interaction between 
concentrations and Time for visits, F(1,12)=0.58, p=0.86 (Figure ‎4.3.2-2).  
Figure  4.3.2-1 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on EC50s 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on EC50s showing no effects. 
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Figure  4.3.2-2 Comparison between concentrations and within visits (pre/post VSG) to examine 
time effect on Concentrations 
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Comparison between Concentrations and Time for visits (pre-op vs. post-op) in the VSG group (only) 
showed: significant differences between Concentrations P≤0.0001, no differences between visits 
P=0.35, with no interaction between Concentrations and Time for visits P=0.86.  
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Table  4.3-2 Two Way ANOVA Results 
Two Way ANOVA results for Participant characteristics at baseline and 12 weeks. A summary of their response to sweet tastant after Vertical Sleeve 
Gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending on normality distribution. 
Data presented as mean ± SEM 
F a (1, 22) for all ANOVA results. 
P b values for repeated measures ANOVA with Group as between subject factor and Time as within subject factor. 
 
 
 
 
CONTROLS SLEEVE ANOVA 
PRE POST PRE POST GROUP TIME GROUP X TIME 
Number 10 10 14 14 F a P b F a P b F a P b 
Participant Characteristics  
Age (years) 15.1±0.6 N/A 15.2±0.5 N/A N/A N/A N/A N/A N/A N/A 
Height (m) 1.68±0.03 1.68±0.03 1.66±0.02 1.66±0.02 0.18 0.66 N/A N/A N/A N/A 
Weight (kg) 88.4±6.2 90.1±9.1 138.9±5.2 101.8±7.7 14.5 *≤0.001 8.6 *0.008 10.3 *0.004 
BMI (kg/m2) 32.0±2.0 32.2±3.1 50.8±1.7 36.7±2.6 23.0 *≤0.001 8.2 *0.009 8.8 *0.007 
Tested sucrose taste detection 
thresholds  
EC50s -2.0±0.3 -2.0±0.1 -1.7±0.2 -1.9±0.1 1.3 0.27 0.50 0.50 0.3 0.57 
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Table  4.3-3 Post hoc effects of Time within groups 
Post-hoc Bonferroni significant differences test with Two Way ANOVA results for participant characteristics at baseline and 12 weeks. A summary of 
response to sweet tastant after Vertical Sleeve Gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending on 
normality distributionPost hoc effects of Time within each group, according to the Time x Group interaction effect. 
 
CONTROL VS. SLEEVE AT 
BASELINE 
CONTROL VS. SLEEVE AT 12 
weeks‎ 
CONTROL BASELINE VS. 12 
weeks‎ 
SLEEVE BASELINE VS. 12 weeks‎ 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Participant Characteristics  
Age (years) N/A N/A N/A N/A N/A N/A N/A N/A 
Height (m) 0.02±0.04 0.7 0.02±0.04 0.7 N/A N/A N/A N/A 
Weight (kg) -50.5±8.1 *≤0.001 -11.7±11.9 0.333 1.7±9.2 0.85 37.1±7.8 *≤0.001 
BMI (kg/m2) -18.8±2.6 *≤0.001 -4.5±4.1 0.27 0.2±3.7 0.95 14.1±3.1 *≤0.001 
Tested sucrose taste detection 
thresholds 
 
EC50s -0.3±0.4 0.38 -0.1±0.1 0.28 0.02±0.3 0.94 0.2±0.2 0.34 
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4.4 Discussion 
This study showed that VSG did not have an effect on the detection threshold for sucrose in 
adolescent patients. This is in contrast to the findings in adults after RYGB where  an increase in 
sensitivity of sucrose have been detection (381). These results suggest that VSG might not 
fundamentally shift the sensory domain of taste, but food preference changes may instead be 
related to other factors such as conditioned avoidance.  
This study utilised the method of constant stimuli, in which sucrose solutions were presented 
randomly and performance was assessed across a set of concentrations allowing for derivation of  
a psychometric function (381). Moreover, adolescent subjects obtained feedback by receiving tokens 
for correct responses and losing tokens for incorrect responses, which appeared to maintain 
subjects' vigilance and motivation in this “game-like competitive setting”. The advantage of this 
technique is that it can also be used to measure taste sensitivity in animal models (385).  Despite the 
fat mass loss, reduction in total body weight, and maintenance of weight loss observed after the VSG, 
changes in taste sensitivity were not observed. Using the same methodology, this data on sucrose 
detection threshold after VSG in adolescents are different to an existing data relating to adult 
patients undergoing RYGB (381). The change in taste detection thresholds for sucrose after RYGB 
remain controversial (585), but most of the available evidence are consistent with our previous 
findings (381). Scruggs et al. reported a trend for sucrose detection and recognition thresholds to 
decrease after RYGB (524). The concentration at which the subjects could correctly identify the 
characteristic taste quality of the stimulus was considered the recognition threshold. This technique, 
however, only stimulates a limited number of taste buds. Burge et al. used a staircase method of 
stimulus presentation and found that sucrose recognition thresholds also decreased after RYGB 
(523). These current results therefore suggest that adolescents after VSG behave in similar ways to 
some adult patients after RYGB.   
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There are reasons other than potential changes in the sensory nature, or unconditioned hedonic 
value of sweets, as to why patients would avoid some sugary or fatty foods and fluids (e.g. learning 
from post-ingestive consequences, nutritional counseling, or both (269;271;275;368;518;586;587). 
The study was limited as it did not have an adult or RYGB control group and therefore it cannot 
directly compare the results of this and the previously published study in adults after RYGB. In this 
study only 14 subjects were studied after VSG, but did not observe even a trend for a reduction in 
sucrose thresholds at either 12 or 52 weeks after VSG, suggesting that it studied a sufficient number 
of subjects to avoid a type II statistical error. The non-operated obese group did not receive any 
intervention and they were not studied at 1 year. Their only function was to ensure that the test 
used in this study provided the same results in subjects that were weight stable, even if they were 
tested on two different occasions. This was important to establish as the non-surgical subjects may 
have learnt how to do the test and this in itself may have altered the results.  
In conclusion, VSG surgery did not decrease the taste detection to sucrose thus there was no 
increased sensitivity to sweets in the surgical group at either 12 or 52 weeks after VSG. Collectively, 
these results, along with previous modest changes observed from RYGB studies, highlight that 
changes in taste-driven motivated behaviour to sucrose after both VSG and RYGB may depend less 
on changes in the sensory domain of taste and relate more to learning. Therefore, studies examining 
conditioned taste avoidance, as a potential mechanism underlying the changes in food preferences 
after VSG, are eagerly awaited. 
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CHAPTER 5  
VERTICAL SLEEVE GASTRECTOMY IN OBESE 
ADOLESCENTS REDUCES THE APPETITIVE REWARD 
VALUE OF A SWEET AND FATTY REINFORCER IN A 
PROGRESSIVE RATIO TASK 
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5.1 Introduction 
Childhood obesity is defined as a patients being above the 95th percentile for BMI. This serious public 
health and medical problems is rapid increasing worldwide (588).Obesity at this age represents one 
of the most challenging diseases to treat even within a multidisciplinary setting and if treated is 
started at an early age (58). A healthy lifestyle including a balanced diet and regular physical activity 
is crucial in the prevention of obesity but offers limited benefit for its treatment in the long term 
(589). Dieting can reduce body weight, but most patients regain the weight they have lost (259). 
Vertical sleeve gastrectomy (VSG)  is an effective weight loss option in adults with long term benefits 
(229;562). The largest series of VSG in children and adolescents was performed at King Saud 
University Hospitals, Riyadh, Saudi Arabia, and reported the outcomes of 291 patients aged between 
5 and 21 years. Successful weight loss and resolution of co-morbidities both occur within the first  
2 years after surgery and continue for 5 years, but longer-term data are needed to better understand 
what happens as these patients mature into adulthood (236;237).   
 Anecdotal evidence from clinical practice and evidence from rodent models of VSG suggest  
a reduction in wanting of foods high in sugar and fat (529). Seeley et al showed that VSG in rats not 
only reduced total caloric intake, but also the proportion of dietary fat, with a shift to preferring 
lower caloric-density foods. These observations were consistent with findings using a progressive-
ratio task (PRT) and conditioned taste aversion paradigm after VSG in rats(529). When food choice 
was compared between two anatomically different bariatric procedures  (VSG and  RYGB) in  rats, 
there were very little difference in macronutrient intake (529). Roux-en-Y Gastric Bypass (RYGB) in 
humans lead to reduced motivation to ingest foods high in sugar and fat (264;369-371). However, 
there are no previous studies on VSG in adults or adolescents. In this study, the aim was to 
determine changes in the motivational reward value of a candy high in sugar and fat after VSG in 
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adolescents. To address this question the progressive ratio schedule of reinforcement was used as  
an operant task in a similar way Hodos did 50 years ago in animals (528). 
  
5.2 Methods 
This was a prospective study of obese adolescents eligible for bariatric surgery (BMI ≥40 kg/m² 
without comorbidity, or ≥35 kg/m2 with comorbidity). Patients where under the care of the 
multidisciplinary obesity clinic for children and underwent VSG at King Saud University (KSU) in 
Riyadh, Saudi Arabia.   The control group included overweight/obese adolescents who were recruited 
from the community and did not have an intervention, but were studied twice (10-12 weeks) to 
confirm the stability of the PRT and exclude learning as a confounder. Written, informed consent was 
obtained from all the subjects. The study was approved by the Ethics Committee at KKUH (Reference 
E 12-740). During the progressive ratio task, the subject performs a certain number of responses to 
obtain a reinforcer (i.e. reward). After delivery of each reward, the response requirement 
progressively increases until it is so great, the subject stops responding. This point is defined as  
the breakpoint. The number of responses “in the last completed ratio” indicates the reward value of 
the reinforcer and this task is a pure assessment of appetitive responsiveness driven by the stimulus 
properties of the reinforcer, such as its taste. Obese adolescents undergoing VSG and the non-
surgical control group were instructed to have their usual breakfast until they felt “comfortably full” 
before starting the test.  Testing occurred 2-3 hours after breakfast in a quiet room within the clinical 
research facility. Room temperature was maintained at 21°C. Participants were blinded to the study 
hypothesis, given exactly the same verbal and written instruction and specifically informed that there 
were no right or wrong responses to the task.   
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A power point presentation in Arabic that explained the Progressive Ratio Task (PRT) program 
provided instructions. Subjects rated their hunger, fullness and desire to eat immediately prior to the 
test starting, using a horizontal 100 mm Visual Analogue Scale (VAS) with the anchors “not at all” and 
“extremely” on either end (Appendix 14).  
Subjects were placed in front of a computer screen and a plate of 20 chocolate candies (M&M® crispy 
candies, Mars UK Limited, Slough UK), each one containing approximately 4 kcal (energy 
contribution: 43.7% sugars, 44.1% fat) (Appendix 14). The following prompt appeared on the screen: 
“You can earn food by clicking on the mouse button. Click as much or as little as you like. When you 
no longer want to continue, press the spacebar to stop the session”. Upon completion of each ratio a 
message box appeared on the screen: “You have earned food. Enjoy your reward and after you have 
swallowed it completely you may click on OK to continue with the programme.” After ingesting the 
reward, the subjects then pressed the OK button in the message box only if they wished to progress 
to the next ratio in order to obtain another chocolate candy (Appendix 14).  The starting ratio was 10 
clicks with a geometric increment of 2 (i.e. 10, 20, 40, 80 etc.).  This progression schedule was chosen 
based on previous experiments within this research group, at Imperial College London, UK (386).  
The instructor ensured that all participants understood the experiment, then left the room and 
subjects were left on their own to complete the task. The instructor was not present during the task 
to reduce any potential influence on the behavioural responses of the participant (386). When the 
effort of repeatedly pressing the mouse button was perceived to be greater than the reward value of 
the chocolate candy, subjects pressed on the space bar to terminate the session indicating the 
breakpoint was reached (Appendix 14). No food or fluid was offered after termination. The same 
numbers of chocolate candies (n=20) were presented to all participants. The number of candies left 
after completion of the experiment was subtracted from 20 to give the total number consumed. This 
was correlated with the number of completed ratios from the computer software to ensure 
participants followed the instructions reliably. Patients due to have VSG underwent testing two 
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weeks pre-operatively and 12 and 52 weeks post-operatively, whereas the control group tested on 
two occasions 8-12 weeks apart. 
The sample size was calculated to detect an effect size of VSG of 0.85 standard deviations (SD) from 
the mean VAS rating. With 15 patients in each group this was predicted to permit greater than 90% 
power to detecting significant differences at the p<0.05 level, using two tailed tests. The effects of 
sleeve gastrectomy on the study’s outcomes have never been examined before. Therefore, the effect 
size used in the power calculation was informed by similar experiments on patients after RYGB using 
the same behavioural testing methods at Imperial College London. 
Comparisons between and within groups were made using the Mann-Witney and Wilcoxon matched 
pairs test respectively. One-way ANOVA, within the surgical group was performed using repeated 
measures, Benferoni and the Friedman test respectively. Correlations were made using the 
Spearman non-parametric test, but the graphs include a parametric linear regression curve for visual 
comparison. The patient characteristic data were normally distributed and thus t-tests and ANOVA 
were used for within and between group comparisons for age and BMI, whilst gender comparisons 
were made with Fisher’s exact test. Results are expressed either as mean ±SEM or median 
(interquartile range). GraphPad Prism® version 5 was used for statistical comparisons and/or SPSS® 
v22 for the Two Way ANOVA data analysis. Statistical power and study size calculations were based 
on our previously published data (386).  
 
5.3 Results 
5.3.1 One Way ANOVA Statistical Analysis 
Table ‎5.3-1 shows the demographic characteristics of the participants. All eligible non-surgical 
participants were recruited and completed the study (n=10). In the surgical group 21 eligible patients 
were recruited (Figure  5.3.1-1, Figure  5.3.1-2), four patients chose not to complete the study and one 
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was excluded because of problems with his teeth as he couldn’t tolerate the sweets. Data from 
completers are reported (Figure  5.3.1-3). The age of VSG was 15.3±0.5 and the control group 
13.8±0.6. There was no bodyweight change in the control group between the two sessions. The BMI 
decreased in the VSG group as compared to pre-surgery, from 49.7±1.6 to 40.2±1.7 and  
31.4±1.0 kg/m2 at 12 weeks and 52 weeks respectively. There were no discrepancies between the 
numbers of reinforcers actually consumed (counted after the session) and the number predicted to 
have been consumed based on the software results for either the patient or control groups  
(Figure  5.3.1-4). 
 
Figure  5.3.1-1 Gender distribution in between the groups, VSG vs. Control 
 
 
 Graph plots the distribution of both male and female in between the groups, VSG vs. Control.  
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Figure  5.3.1-2 Matching Age for both groups, VSG vs. Control 
 
Graph plots the matching age for both groups, VSG vs. Control, they are matching. 
 
 
Figure  5.3.1-3 Change in Weight pre/post VSG 
 
Graph plots the changes in Weight through all three interval visits, baseline, 12 and 52 weeks post 
VSG. (A) * 12 weeks, and ** 52 weeks  are significantly decreased as compared to pre-op visit, +52 
weeks significantly decreased as compared to 12 weeks. (B) Control groups no changes between the 
two visits. 
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Figure  5.3.1-4 Change in BMI pre/post VSG 
 
 Graph plots the changes in BMI through all three interval visits, baseline, 12 and 52 weeks post VSG. 
(A) * 12 weeks, and ** 52 weeks  are significantly decreased as compared to pre-op visit, +52 weeks 
significantly decreased as compared to 12 weeks. (B) Control groups no changes between the two 
visits. 
 
Breakpoints as assessed by the number of mouse clicks in the last completed ratio of the test did not 
differ in the control group between the two sessions and there was a significant correlation between 
the breakpoints for sessions 1 and 2 for the control subjects (Figure  5.3.1-5). There was no difference 
in breakpoints between the control group and obese group at baseline.  However, there was more 
than 50% reduction in the median breakpoint of the VSG group at 12 weeks after surgery, which was 
maintained at 52 weeks (Figure  5.3.1-5). This was also the case for the median rewards  
(Figure  5.3.1-6). In addition, the postoperative decrease in weight correlated significantly with the 
decrease in breakpoint at 12 weeks (Figure  5.3.1-7, Figure  5.3.1-8). Hunger ratings did not change, 
whilst nausea ratings significantly increased in the VSG group at 12 weeks compared to pre-
operatively (Figure  5.3.1-9).  
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Figure  5.3.1-5 Change in Clicks in the last completed ratio pre/post VSG  
 
Box plot of breakpoint (i.e. Clicks in the last completed ratio) for M&M® crispies.  The median is the 
gray/black line inside the box.   * 12 weeks is significantly reduced as compared to pre-op visit. 
 
 
Figure  5.3.1-6 Change in Number of consumed candies pre/post VSG 
 
Box plot of the total Number of rewards for M&M® crispies. The median is the gray/black line inside 
the box. * 12 weeks is significantly reduced as compared to pre-op visit, ** 52 weeks is significantly 
reduced as compared to pre-op visit. 
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Figure  5.3.1-7 Correlation between change in Weight and BMI to examine the change in Total Clicks 
at 12 weeks 
 
The postoperative decrease in Weight and BMI in patients correlated with the decrease in breakpoint 
for M&M® crispies (chocolate) at 12 weeks. 
 
 
Figure  5.3.1-8 Correlation between change in Weight and BMI to examine the change in Total Clicks 
at 52 weeks 
 
The postoperative decrease in Weight and BMI in patients correlated with the decrease in breakpoint 
for M&M® crispies (chocolate) at 52 weeks. 
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Figure  5.3.1-9 Change in Nausea (before and after task) pre/post VSG 
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Graph plots the changes in Nausea levels in VAS before and after the experiment session through all 
three interval visits, baseline, 12 and 52 weeks post VSG. (B)*12 weeks is significantly increased as 
compared to pre-op visit, +52 weeks is significantly reduced as compared to 12 weeks visit. (A) No 
significant changes. 
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Table  5.3-1 One Way ANOVA Results 
Participant characteristics at baseline and summary of responses at the progressive ratio task (PRT) and visual analogue scale ratings (VAS) at baseline 
and follow up. Patients were tested 12, and 52 weeks after vertical sleeve gastrectomy (VSG), whilst comparator participants were tested 8-12 weeks 
apart. Results are expressed as mean SEM or median (interquartile range) depending on normality distribution. 
 
VSG 
Pre-op 
(N=16) 
VSG 
12 weeks 
post‐op 
(N=16) 
VSG 52 weeks 
post‐op 
(N=16) 
P value 
within VSG 
group 
Control 
Visit 1 
(N=10) 
Control 
Visit 2 
(N=10) 
P value 
within 
Control 
group 
P value 
between 
groups at 
baseline 
Participant characteristics  
Gender (M/F) 8/8 N/A N/A N/A 7/3 N/A N/A 1.00 
Age (years) 15.30.5 N/A N/A N/A 13.80.6 N/A N/A 0.07 
BMI (kg/m2) 49.71.6 40.21.7 31.41.0 *≤0.0001 34.73.0 34.73.0 1.00 *≤0.01 
Responses at the PRT  
Clicks in last completed ratio 320(160-640) 80(50-32) 160(80-560) *≤0.01 480(160-640) 640(280-640) 0.17 0.87 
Total rewards earned 6(5-7) 4(3-6) 5(4-7) *0.002 6(5-7) 7(6-7) 0.12 0.87 
Visual Analogue Scale ratings  
Hunger pre‐test (cm) 33.87.4 34.09.1 30.57.5 0.94 28.07.2 35.28.0 0.24 0.60 
Fullness pre‐test (cm) 60.37.0 56.79.4 69.16.5 0.54 49.79.2 58.69.6 0.33 0.36 
“Wanting” pre‐test (cm) 55.18.1 33.17.8 43.47.9 0.09 44.05.9 52.46.6 0.24 0.34 
Nausea pre‐test (cm) 15.06.3 44.110.3 14.27.2 *0.03 10.88.1 16.010.4 0.65 0.69 
Hunger post‐test 28.86.9 34.110.8 16.35.4 0.26 25.18.9 30.39.3 0.58 0.75 
“Sweetness” post‐test (cm) 69.77.9 59.29.1 77.46.3 0.15 67.510.9 76.46.9 0.28 0.87 
“Creaminess” post‐test (cm) 58.97.0 61.28.1 62.87.2 0.93 58.88.5 60.88.4 0.73 0.99 
“Liking” post‐test (cm) 61.99.8 47.19.3 61.39.2 0.39 63.010.7 73.19.1 0.18 0.94 
Nausea post‐test (cm) 27.08.4 68.49.4 25.69.0 *0.0006 10.07.1 7.76.5 0.18 0.17 
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5.3.2 Two Way ANOVA Statistical Analysis 
The 2-way repeated measures ANOVA used to study the comparison between groups  
(VSG vs. Control) and within Group comparisons to examine the Time effect (pre-op vs post-op) on 
the variables (Table  5.3-2). Post hoc effects of Time were illustrated within each group, according to 
the Time x Group interaction effect (Table  5.3-3). Changes in the appetitive behaviour was studied 
through PRT test that shows changes in the clicks in last completed ratio (breakpoints) that signifies 
changes in the reward value after surgery within the VSG adolescent patients as compared to the 
control group. Clicks in last completed ratio (breakpoints) were significantly decreased after  
12 weeks‎ in patients post VSG. The Overall repeated measures ANOVA: Group F(1,24)=2.9, p=0.10, 
Time F(1,24)= 0.03, p=0.85, Group x Time F(1,24)= 8.5, *p=0.008. (*p= 0.02) with post-hoc Bonferroni 
significant differences test (Figure ‎5.3.2-1). An interaction between Group and Time have also 
presented that the Total Rewards earned have reduced in number accordingly. Overall repeated 
measures ANOVA: No differences were shown between groups (VSG vs control), F(1,24)=1.8, p=0.18, 
as well as no differences between visits (Time), F(1,24)=2.8, p=0.10, but a significant interaction 
between Group and Time for visits was seen, F(1,24), *p=0.003. (*p ≤0.001) with post-hoc Bonferroni 
significant differences test (Figure ‎5.3.2-2). Nausea post-test measures at the VAS showed changes in 
patients post VSG. Overall repeated measures ANOVA: Group F(1,24)=14.3, *p ≤0.001, Time 
F(1,24)=7.5, *p ≤0.01, Group x Time F(1,24)=9.4, *p ≤0.005. (*p≤ 0.001) with post-hoc Bonferroni 
significant differences test (Figure  5.3.2-4). 
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Figure  5.3.2-1 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Clicks at the last completed ratio 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on clicks at the last ratio, showing the effects of Time within each group, 
according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
 
Figure  5.3.2-2 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Reward number 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on reward number (number of consumed candies), showing the effects of 
Time within each group, according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, 
***P≤0.001. 
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Figure  5.3.2-3 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Total Clicks  
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on total clicks, showing the effects of Time within each group, according to 
the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
 
Figure  5.3.2-4 Comparison between groups (VSG vs. Control) and within group to examine time 
effect (pre-op vs post-op) on Nausea post test  
 
Comparison between groups (VSG vs Control) and within group comparisons to examine the time 
effect (pre-op vs post-op) on Nausea post test, showing the effects of Time within each group, 
according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
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Table  5.3-2 Two Way ANOVA Results 
  
Two Way ANOVA results for Participant characteristics at baseline and 12 weeks. A summary of their response to sweet/fat tastant using the (PRT) after 
Vertical Sleeve Gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending on normality distribution. 
 
CONTROLS SLEEVE ANOVA 
PRE POST PRE POST GROUP TIME GROUP X TIME 
Number 10 10 16 16 F 
a
 P 
b
 F 
a
 P 
b
 F 
a
 P 
b
 
Participant characteristics  
Age (years) 13.80.6 N/A 15.30.5 N/A N/A N/A N/A N/A N/A N/A 
Height (m) 1.66±0.03 1.66±0.073 1.66±0.12 1.67±0.12 N/A N/A N/A N/A N/A N/A 
Weight (kg) 94.7±7.6 95.4±7.8 136.6±6.0 110.9±6.1 8.8 *0.007 88.0 *≤0.001 98.5 *≤0.001 
BMI (kg/m2) 34.7±2.4 34.7±2.5 49.7±1.9 40.2±1.98 10.8 *0.003 95.3 *≤0.001 95.3 *≤0.001 
Responses at the PRT 
 
Clicks in last completed ratio 465±107 658±146 420±84 201±115 2.9 0.10 0.03 0.85 8.5 *0.008 
Total rewards earned 5.8±0.5 6.3±0.6 6.0±0.4 4.5±0.4.0 1.8 0.18 2.8 0.10 11.3 *0.003 
Total Clicks 992±237 1369±292 966±187 456±230 2.3 0.13 0.2 0.65 9.3 *0.005 
Visual Analogue Scale pre-test 
 
Hunger pre‐test (cm) 28±8.6 35.2±10.3 33.8±6.8 34±8.2 0.06 0.80 0.2 0.65 0.17 0.67 
Fullness pre‐test (cm) 49.7±9.0 58.6±11.0 60.3±7.1 56.7±8.8 0.2 0.64 0.09 0.76 0.5 0.48 
“Wanting” pre‐test (cm) 44.0±8.9 52.4±8.8 55.1±7.0 33.1±7.0 0.2 0.62 0.8 0.37 4.1 0.055 
Nausea pre‐test (cm) 10.8±8.0 16.0±12.1 15.0±6.4 44.1±9.6 3.4 0.07 3.1 0.09 1.5 0.23 
Visual Analogue Scale post-test 
 
Hunger post‐test 25.1±8.8 30.3±12.2 28.8±7.0 35.1±9.6 0.11 0.74 0.45 0.50 0.001 0.99 
“Sweetness” post‐test (cm) 67.5±10.4 76.4±10 69.7±8.2 59.2±8.0 0.43 0.51 0.02 0.90 2.3 0.14 
“Creaminess” post‐test (cm) 58.8±8.8 60.8±9.5 58.9±7.0 61.2±7.5 0.001 0.98 0.1 0.74 0.001 0.98 
“Liking” post‐test (cm) 63.0±11.8 73.1±10.8 61.9±9.3 47.1±8.6 1.35 0.25 0.08 0.78 2.2 0.15 
Nausea post‐test (cm) 10.0±9.5 7.7±10.2 27.0±7.5 68.4±8.1 14.29 *≤0.001 7.49 *≤0.01 9.35 *0.005 
Data presented as mean ± SEM 
F
 a
 (1,24) for all ANOVA results. 
P
 b
 values for repeated measures ANOVA with Group as between subject factor and Time as within subject factor. 
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Table  5.3-3 Post hoc effects of Time within groups 
  
Post-hoc Bonferroni significant differences test with Two Way ANOVA results for participant characteristics at baseline and 12 weeks. A summary of 
response to sweet/fat tastant after Vertical Sleeve Gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending 
on normality distribution 
 
CONTROL VS. SLEEVE AT 
BASELINE 
CONTROL VS. SLEEVE AT 12 
weeks‎ 
CONTROL BASELINE VS. 12 weeks‎ SLEEVE BASELINE VS. 12 weeks‎ 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Participant Characteristics  
Age (years) N/A N/A N/A N/A N/A N/A N/A N/A 
Height (m) N/A N/A N/A N/A N/A N/A N/A N/A 
Weight (kg) -41.9±9.6 *≤0.001 -15.5±9.9 0.13 0.7±2.1 0.73 25.7±1.7 *≤0.001 
BMI (kg/m2) -15.0±3.1 *≤0.001 -5.5±3.2 0.097  0.01±0.8 1.0 9.5±0.6 *≤0.001 
Responses At The PRT  
Clicks in last completed ratio 45±137 0.74 457±186 *0.02 193±110.7 0.09 218.8±87.5 *0.02 
Total rewards earned -0.2±0.6 0.74 1.8±0.7 *0.02 0.5±0.5 0.29 1.5±0.4 *≤0.001 
Total Clicks 26±303 0.93 913±372 *0.02 377±227 0.11 510±180.1 *0.009 
Visual Analogue Scale Pre-Test  
Hunger pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Fullness pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
“Wanting” pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Nausea pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Visual Analogue Scale Post-Test  
Hunger post‐test N/A N/A N/A N/A N/A N/A N/A N/A 
“Sweetness” post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
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CONTROL VS. SLEEVE AT 
BASELINE 
CONTROL VS. SLEEVE AT 12 
weeks‎ 
CONTROL BASELINE VS. 12 weeks‎ SLEEVE BASELINE VS. 12 weeks‎ 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
“Creaminess” post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
“Liking” post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Nausea post‐test (cm) -17.0±12.0 0.17 -60.7±13.0 *≤0.001 2.3±11.2 0.83 41.4±8.9 *≤0.001 
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5.4 Discussion 
This study has shown that the appetitive reward value of a tastant high in sugar and fat decreased 
after VSG surgery in adolescents. Our data is consistent with the changes shown in rodents after VSG 
(529) and in adult patients after RYGB (386). Our method built on the literature involving the use of 
PRT in humans (386;590-596). 
One of the key merits of the PRT is that the assessment is based on the actual behaviour of the 
subject and is not burdened by interpretive limitations associated with verbal report or scaling 
procedures. Our study answered the question of how hard adolescents were willing to work for  
a given reinforcer that was high in sugar and fat.  Our model employed simple computer software, in 
which participants actually tasted the reinforcer during the task rather than postponing the 
consumption to the end. Thus, appetitive responsiveness was determined directly by the orosensory 
properties (e.g. taste) of the reward and did not rely on the association between a stimulus like  
a token, money or images with the reward. Completion of the schedule was not dependent on 
computer skills or the completion of an intellectually demanding task. In an attempt to minimise post-
ingestive effects, reinforcers were of minimal volume and calories. It is this property that makes the 
PRT ideal for studying changes in appetitive responsiveness after VSG so that ingestion of a food 
reward may not lead to premature satiation or satiety signals from the small bowel and interfere with 
its orally based evaluation.   Participants were briefed about the experiment by the investigator, who 
was absent from the room during the task itself, in order to minimise bias in the responses. The above 
methodological features differentiate our paradigm from others used in humans including reports on 
RYGB (269;275;279;362;373). Analytical taste and/or postingestive effects contribute to these effects 
on preference, which are often perceived as changing to more “healthy choices”  
(269;271;275;279;362;368;373;518;586). 
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In our previous study changes in breakpoints observed following RYGB matches the reports of 
reduced preference. As was noted within that study, the assessment was quantified on the basis of 
measurement of the objective behaviour of the subject. Our findings followoing VSG in adolescents 
are consistent with both those from the human study of RYGB (386)  and also those in animals 
followin VSG (529).  Using the same paradigm in rats after RYGB, we were not able to show a change 
in breakpoint (597).  This does raise the question of whether, despite best efforts, patients may still 
“behave” in a specific way to “please” the investigator, a problem that is not seen in rats.  Accepting 
the limitations of the VAS, and whilst the increase in nausea did not correlate with the reduction in 
breakpoint, the higher nausea ratings after VSG may reflect the presence of negative visceral signals 
contributing to conditioned taste avoidance; the subject gradually learns that a small amount of high 
fat and sugary food are still rewarding after surgery, but a larger amount may have to be avoided to 
prevent negative consequences. This is akin to patients with lactose intolerance still enjoying a small 
amount of milk, but learning to avoid large amounts of milk. Our results do not suggest that 
conditioned taste aversion took place, as all the subjects continued to exert some level of effort to 
achieve at least two candies 12 and 52 weeks after VSG.  If a true aversion had been present, they 
would likely not have exerted any effort in pursuit of the tastant. The breakpoints of the VSG and 
control group were similar at baseline, which is consistent with our previous findings in adults (386). It 
is thus tempting to speculate that obese adolescents and adults will not necessarily work harder than 
normal weight subjects for high fat and sugary foods if the environment can be structured in such  
a way as to require increasing effort to attain these obesogenic foods. This argument may support 
portion control as an effective measure to reduce the incidence of childhood obesity.  
Our study has certain limitations. The control group was lighter than the VSG group and was not 
studied one year after inclusion in the study. However, it was reassuring that the control group 
appetitive responses to the task remained stable over an 8-12 week period. Peri-operative dietary 
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advice may have prejudiced the patients against the consumption of food high in sugar and fat. 
Therefore, it's not possible to entirely exclude the possibility that subjects’ responses were influenced 
by their own cognitive expectations regarding how they thought they were expected to behave 
toward the reinforcer. However, this is an unavoidable limitation of any assessment of food 
preference and hedonics in an experimental setting.  It should be stressed that the subjects were 
clearly instructed that there was no right or wrong performance. Indeed, the small volumes of 
rewards ingested coupled with the simple response requirement associated with the task hopefully 
reduced the influence of cognitive factors on the outcome.  It is almost impossible to objectively 
assess a subject’s true intent, but instead of just relying on verbal or written ratings, it is at least 
possible to directly measure a subject’s behaviour; indeed in the context of this experiment, the 
behavioural outcomes correlated remarkably well with the changes in BMI and are consistent with 
the available reports in the literature regarding changes in food preferences and hedonics after VSG 
(529;577).  
 It was beyond the scope of this study to investigate the mediators of the change in appetitive 
behaviour after VSG. It is noteworthy that the responses of post-prandial anorexigenic gut hormones 
(glucagon-like peptide 1 (GLP-1) and peptide tyrosine tyrosine (PYY) are enhanced after both the VSG 
and RYGB, despite the anatomical differences between them. The administration of GLP-1 and PYY 
has been shown not only to increase fullness and decrease caloric intake, but also to reduce 
behavioural and brain reward system responses to energy-dense foods or cues in humans and 
rodents (598). Future work is necessary to investigate the role of gut hormones, alongside altered 
nutrient sensing in the gut and other physiological signals, in the reduction of the reward value of 
energy-dense food after both procedures.  
 In conclusion, using the progressive ratio task this study demonstrated a reduction in appetitive 
behaviour for a palatable energy-dense reward following VSG in obese adolescents. Direct 
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measurement of appetitive behaviour is therefore both possible and informative in humans after 
VSG. It is now possible to study the underlying mechanisms responsible for this change, both in 
animal and human experiments. By understanding the mechanisms by which VSG decreases 
consumption of high-calorie fat and sweet foods and alters taste responses, new and existing surgical 
and non-surgical therapies can be developed to reproduce these processes and so encourage safe 
and effective weight loss for adolescents.   
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CHAPTER 6  
CHANGES IN “FACIAL EXPRESSIONS” IN OBESE 
ADOLESCENTS WHEN REACTING TO TASTANT 
STIMULANTS AFTER VERTICAL SLEEVE GASTRECTOMY 
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6.1 Introduction 
The prevalence of overweight and obesity has increased considerably in children and adolescents in 
developed countries. In 2013, 23·8% and 22·6% of boys and girls were considered overweight or 
obese. The prevalence of overweight and obesity has also increased among the same age group in 
developing countries in 2013, from 8·1% to 12·9% among boys and from 8·4% to 13·4% among girls 
(18). The Middle Eastern countries of Egypt, Libya, Iran, Turkey, and the Gulf region, including Saudi 
Arabia (SA), are examples of countries with some of the highest prevalence rates of obesity in old 
and young people (18;25;26). In SA, cultural factors may contribute heavily to the extensive problem. 
Saudi Arabia, covers around two-thirds of the Arabian Peninsula, and has a population of 30.8 million 
people, of whom 20.7 million are Saudis (44).  According to a 2007 survey, 37% of the population are 
≤15 years (45).  The prevalence of overweight and obesity among young people ≤ 20 years old in 
Saudi Arabia has been estimated at 19.0% and 23.3% respectively.   More than 50% of children in SA 
between 14 and 18 years had weight above the 85th percentile in year 2010 (49).  
The best strategies and policies to control the epidemic of obesity have not been established yet 
(83).  Diet and exercise are examples from several strategies for obesity treatment, both considered 
useful for losing weight in adults with moderate obesity. However, it appears that even losing weight 
with these methods, most persons with obesity do not maintain weight loss for long periods (84). 
VSG is emerging as a standalone procedure (222).  From 1997 to 2003, the volume of adolescent 
bariatric surgery done in the United States was projected to have increased 5-fold, from 51 to 282 
(226).  Alongside this, data from a global survey have shown an increase in the use of VSG, from 0% 
of all procedures in 2003, to 5.4% in 2008 (170).  Al Qahtani has published recently updated data 
relating to 226 paediatric patients, concluding that VSG resulted in successful short-term weight loss. 
Furthermore, 90.3% of comorbidities remitted or improved, 64.9% of which did so within the first  
3 postoperative months. Although no further improvement or remission was observed beyond  
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2 years, there was no recurrence up to 3 years in patients who were seen in follow-up. The loss to 
follow-up, across each of 3 years of follow-up, was 4.2%, 7.6%, and 15.3%, respectively (237).  Long-
term data are needed for better understanding and evaluation of weight loss maintenance and 
maturation to adulthood (236;237).  The most recent study to date was published by Al Sabah et al. 
with a total of 135 adolescent patients, who underwent VSG, followed up for an average of twenty 
months. The patients had a median age of 19 years (range 12-21) and a mean BMI of 48.5 kg/m². The 
%EWL at 2 years for males and females was 84 and 77 %, respectively. All patients with type 2 
diabetes mellitus and 75 % of those with hypertension presented complete resolution at  
2 years (238). Human obesity and weight gain have been linked to an elevated preference for both 
sweet and/or high-fat diet  (355;356).  An increased appetite for sweet or high-fat foods may explain 
why people with obesity readily gain and subsequently regain body weight (357;358). For example; 
these two energy rich components account for around 60% of the daily energy content of the typical 
American diet (22%) from sugar and 37% from fats)  For example, these two energy rich components 
account for around 60% of the daily energy content of the typical diet in the United States (22% from 
sugar and 37% from fats) (468). Discrepancy exists between the published studies that have 
investigated whether people with obesity have a higher preference for sweet-tasting foods, or have a 
different threshold for sweetness compared to the non-obese (469-478). The common view about fat 
is comparable to that for sugar; it is presumed that obese people show a greater liking for high-fat 
foods (357;486;487). In these studies, mixing fat with other dietary components was of special 
interest for researchers. Drewnowski and his colleagues conducted a study that used dairy products 
(with diverse sugar and fat content) to study more about this mixture between fat and sugar and 
how palatable it might be. Their data showed that women with obesity preferred a higher ratio of fat 
to sweet than men, and that a mixture of sweet and fat offered a particularly palatable taste (357).  
In a study by Bartoshuk et al. data were collected using the general labeled magnitude scale (gLMS). 
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This group illustrated those individuals with obesity experience, not only a greater preference for 
sweet and high-fat foods in the first place, but also that their perception of sweetness is weaker than 
individuals who do not have obesity. Perhaps this will open the ‘synergism’ between fat and sweet 
sensations to a greater degree of understanding, and an expression of taste loss in the obese will 
offer researchers new ways to think concerning the increased liking for fat in the obese population. 
In sum, the research team have concluded that liking of both fat and sweet rises in line with 
increasing BMI (471).  It is not clear yet in the literature, why liking for sweet and fat tastes increase 
as BMI increases. It is established, though, that the relationship between orosensory experience and 
post-ingestive effects of sweet and fat foods contributes to liking (489) and, indeed that the 
hedonism associated with palatable foods is considered a significant factor in the increased 
prevalence of obesity. Taste detection thresholds are only one basic aspect of taste function and 
have been shown to vary as a function of genetics, pharmacological treatment, and neural 
manipulations (515). Taste hedonics and alterations in reward responses have not been fully 
explored as a potential mechanism for the development of obesity. The search for the neural basis of 
any behavioural or sensory process must begin with a clear articulation of the principles of function. 
With this in mind, there is ample evidence that the sense of taste serves several functions that can be 
experimentally classified into at least three general domains  (379): 
1-Stimulus identification is the detection or discrimination of sensory signals arising from taste cell 
activation in the oral cavity.   
2-Ingestive motivation refers to processes that promote or discourage ingestion of foods and fluids 
on the basis of taste input. Ingestive motivation can be further divided into two functional 
subclasses: Appetitive behaviour (“wanting”) and consummatory behaviour (“liking”)   
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3-Digestive preparation refers to physiological reflexes that fall into a general class referred to as 
cephalic phase responses, which are internal physiological events triggered by stimulus contact with 
any sensory receptor of the head (516). Bariatric surgery could be exerting its effects on food 
selection and preference through any one of these functional domains; sensory-discriminative  
(or stimulus identification), hedonic (or ingestive motivation) and the physiological (or digestive 
preparation) domains (379;380). Altered taste function in humans can be measured through various 
means. 
Sensory domain 
 Behaviour has previously been measured directly, using a constant stimuli method to determine 
detection thresholds on the sensory domain of sweet taste in patients who had undergone gastric 
bypass surgery for obesity (385).  This technique has also been used to measure taste sensitivity in 
animal models (385) After RYGB, patients’ sucrose detection threshold decreased (523)  and 
sensitivity increased, to this sweet stimulus, suggesting that surgery has consequences on the 
sensory processing of taste signals generated by sucrose (381).  
Reward domain: appetitive behaviour 
 Although there are suggestions in animal models that the rewarding and inhibiting properties of 
sweet and fat stimuli may change after RYGB  (263;381-385),  very little work has been undertaken in 
humans to determine whether there are any changes in the hedonic domain of taste function after 
other weight loss surgery, such as VSG. This has been addressed by the use of the progressive ratio 
schedule of reinforcement, an operant task first developed by Hodos 50 years ago (528) for use in 
animals. In our previous study we demonstrated that the change in breakpoints, observed following 
RYGB, matches anecdotal patient reports of reduced preference. 
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However, as noted within that study, the assessment was actually quantified on the basis of 
measurement of the objective behaviour of the subject, rather than reported behaviours (386). 
Reward domain: consummatory behaviour 
Another objective way to study human feeding behaviour, is taste reactivity as measured by “the 
involuntary, minute movements of the face in response to a stimulus” (531). These can be studied to 
enable an impression of the emotional state of an individual as a consequence of the applied 
stimulus. Taste reactivity studies using facial expression which looked at infants, apes, new world 
monkeys and rats concluded that there were two major reaction patterns seen: the positive, hedonic 
reaction - typically to sweet taste - was characterised by lip smacking, tongue protrusion and even  
a smile, while the negative (aversive) reaction to bitter taste involved grimacing, retracting of the 
lips, wrinkling of the nose and retraction of the head away from the food source. Other tastes, such 
as salt or sour, were found to produce responses with intermediate reactions between those 
described above (532-536). The use of taste reactivity to study the ingestive motivation, 
consummatory behaviour of taste in adult humans has been less well investigated. Previous work has 
shown that adults do demonstrate facial reactivity, with some promising results (533;535;537;538), 
though it was considered that adults may not be as accurate as a consequence of socialisation and 
voluntary or higher control (535;539). Taste reactivity has not previously been used for the study of 
consummatory reward in obese patients. The consequence of VSG on the complex central reward 
circuits has not been studied before. By understanding the mechanisms by which VSG decreases 
consumption of high-calorie fat and sweet foods and alters taste responses, new surgical and non-
surgical therapies could be developed that reproduce these processes and so encourage safe and 
effective weight loss. The aim of this study is to assess changes in consummatory behaviour after 
VSG in adolescents, as compared to the non-operated control group, by determining changes in 
“facial expressions” in adolescents when reacting to tastant stimulants after VSG. 
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 To study and evaluate oromotor reflexes as related to consummatory behaviour pre surgery, and 
after 10 days and 12 weeks‎, in adolescents after VSG. 
 
6.2 Methods 
Within this pilot study, five non-obese control subjects were examined twice, while the seven obese 
sleeve subjects were examined before surgery and twice (10 days and 12 weeks) after VSG. Written, 
informed consent was obtained from all the subjects. The study was approved by the Ethics 
Committee at KKUH (Reference E 13-932). Participants were instructed to come to the Clinic 
Research Centre CRC fasting overnight for the test. The same investigator was available throughout 
the experimental period and explained the experiment, provided the visual analogue sheets and 
assured the confidentiality of the recordings. A commercial chocolate milkshake Galaxy® was used 
(50 ml, 52 kcal), the camera was prepared to start recording, and the patient were asked to complete 
a VAS of hunger and fullness just before and after the experiment (Appendix 15). The investigator 
ensured that the milkshakes flowed directly and accurately into the subjects’ mouths by hanging the 
milkshake in a giving set bag from a 1.5-2 meters stand and thus using gravity to deliver a rate of 
25mL/minute (Appendix 15). Then simple written instructions were provided on paper detailing: 
“You will be filmed for two minutes whilst the milkshake is poured into your mouth. There are no 
right or wrong answers in this experiment. You will not put on weight as a result of this task. You can 
stop the infusion at any point, subjects were told.” A bowl was placed next to the subject to expel 
any potential excess milk shake into if they wish. The subject was also shown how to turn the 
infusion off and how to remove the straw from their mouth, in case they wished to do so during any 
part of the study. The investigator asked if the subjects had any questions. If not, the record button 
on the camera was pressed, the infusion began and the investigator left the room. After two minutes 
the investigator re-entered the room to stop the experiment. The patient was then asked to 
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complete the second VAS. Facial Expression Food Preference Rating Scale, Like vs. Dislike of 
Standardized Tastent was created and used based on a selection of the action Units (AUs) from the 
Facial Action Coding System (FACS) system (Appendix 15). The AUs that show most consistency in the 
literature with regard to the positive or negative affective value (599). 
The sample size was calculated to detect an effect size of VSG of 0.85 standard deviations (SD) from 
the mean VAS rating. With 15 patients in each group this was predicted to permit greater than 90% 
power to detecting significant differences at the p<0.05 level, using two tailed tests. The effects of 
sleeve gastrectomy on the study’s outcomes have never been examined before. Therefore, the effect 
size used in the power calculation was informed by similar experiments on patients after RYGB using 
the same behavioural testing methods at Imperial College London. 
Comparisons between and within groups were made using the Mann-Witney and Wilcoxon matched 
pairs test respectively. One-way ANOVA, within the surgical group was performed using repeated 
measures, Benferoni and the Friedman test respectively. Correlations were made using the 
Spearman non-parametric test, but the graphs include a parametric linear regression curve for visual 
comparison. The patient characteristic data were normally distributed and thus t-tests and ANOVA 
were used for within and between group comparisons for age and BMI, whilst gender comparisons 
were made with Fisher’s exact test. Results are expressed either as mean ±SEM or median 
(interquartile range). GraphPad Prism® version 5 was used for statistical comparisons, and/or SPSS® 
v22 for the Two Way ANOVA data analysis.   
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6.3 Results 
6.3.1 One Way ANOVA Statistical Analysis 
At this pilot study, Table ‎6.3-1 shows the demographics of the participants. In the surgical group  
7 eligible patients were recruited (Figure  6.3.1-1). Data from completers are reported for both 
surgical and non-surgical group. The age of the surgical group was 15.6 ±0.7 years, and for the non-
surgical group 14.4 ±0.7 years (p = 0.3) (Figure  6.3.1-2). BMI was 52.5 ±2.4 kg/m² and  
28.8 ±2.0 kg/m², respectively (p=0.003) (Figure  6.3.1-3). There was no bodyweight change in the non-
surgical group between the two sessions, but the VSG group reduced their weight from 144 ±8.9 kg, 
to 132.1 ±8.5 kg and 113.3 ±7.1kg at 10 days and 12 weeks (p=0.066) (Figure  6.3.1-4)‎.  
 
Figure  6.3.1-1 Gender distribution in between the groups, VSG vs. Control 
 
Graph plots the distribution of both male and female in between the groups, VSG vs. Control. 
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Figure  6.3.1-2 Matching Age for both groups, VSG vs. Control 
 
Graph plots the matching age for both groups, VSG vs. Control, they are matching. 
 
 
Figure  6.3.1-3 Change in BMI pre/post VSG 
 
Graph plots the changes in BMI through all three interval visits, baseline, 10 days and 12 weeks post 
VSG. (A) ** 12 weeks is significantly decreased as compared to pre-op visit.  (B) Control groups no 
changes between the two visits. 
 
Sleeve Control
0
2
4
6
8
10
12
14
16
18
Ag
e(
ye
ar
s)
Pre op  10 days 12 weeks
0
10
20
30
40
50
60
 **
B
M
I 
K
g
/m
2
Visit 1 Visit 2
0
10
20
30
40
50
60
B
M
I 
K
g
/m
2
(A) (B)
 181 
 
Figure  6.3.1-4 Change in Weight pre/post VS 
 
Graph plots the changes in Weight through all three interval visits, baseline, 10 days and 12 weeks 
post VSG. (A) No significant decrease was shown as compared to pre-op visit.  (B) Control groups no 
changes between the two visits. 
 
VAS did not change among both the surgical and non-surgical subjects though all visits (Table  6.3-1). 
The video analysis results are shown in (Table  6.3-1, Figure  6.3.1-5) for both negative and positive 
effective values (NEV, PEV). A significant increase was obesrved in NEV in the surgical group, from  
0.3 ±0.2 units at baseline (pre-op), to 9.9 ±4.9 units and 8.1 ±3.6 unit (p=0.02), 10 days and 12 weeks‎ 
post-operatively, respectively. PEV reduced significantly, from 7.0 ±2.2 unit at baseline,  
to 0.7 ±0.7 unit and zero units at 10 days and 12 weeks‎ respectively (p=0.03) . The non-surgical group 
showed no changes in either NEV or PEV (Figure  6.3.1-5). 
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Figure  6.3.1-5 Change in Positive Effective Behaviour and Negative Effective Behaviour pre/post 
VSG 
 
(A1) Changes in the Positive Effective Values (PEV) at baseline visit (pre-op), 10 days, and 12 post VSG 
(p=0.03). (A2) Changes in the Negative Effective Values (NEV) at baseline visit (pre-op), 10 days and 
12 post VSG (p=0.02). *Denotes a significant change from baseline to 10 days. (B1, B2) Control 
groups no changes between the two visits. 
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Figure  6.3.1-6 Correlation between change in Weight and BMI to examine the change in Ingestive 
Behaviour at 10 days 
 
The postoperative decrease in Weight and BMI in patients correlated with the changes (decrease) in 
ingestive behaviour at 10 days post-op. 
 
 
Figure  6.3.1-7 Correlation between change in Weight and BMI to examine the change in Ingestive 
Behaviour at 12 weeks 
 
The postoperative decrease in Weight and BMI in patients correlated with the changes (decrease) in 
ingestive behaviour at 12 weeks post-op.   
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Table  6.3-1 One Way ANOVA Results 
Participant characteristics at baseline, 12 and 52 weeks. A summary of response to sweet/fat tastant using facial expressions after vertical sleeve 
gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending on normality distribution. 
 
VSG 
Pre-op 
(N=7) 
VSG 
10 days 
post‐op 
(N=7) 
VSG 12 weeks 
post‐op 
(N=7) 
P value 
within VSG 
group 
Control 
Visit 1 
(N=5) 
Control 
Visit 2 
(N=5) 
P value 
within 
Control 
group 
P value 
between 
groups at 
baseline 
Participant characteristics  
Gender (M/F) 6/1 N/A N/A N/A 3/2 N/A N/A 0.38 
Age (years) 15.6±0.7 N/A N/A N/A 14.4±0.7 N/A N/A 0.34 
BMI (kg/m2) 52.5±2.4 48.1±2.2 40.9±1.8 *≤0.005 28.8±2.0 28.9±1.7 0.91 *0.003 
Video Facial Expression Analysis  
Food Preference Behavior 
        
General Behavior 8.4±2.5 8.0±2.0 7.4±2.0 0.61 9.4±1.4 6.4±1.6 0.13 0.93 
Negative Effective Value 0.3±0.2 9.9±4.9 8.1±3.6 *0.02 2.4±1.2 2.4±1.7 0.87 0.14 
Positive Effective Value 7.0±2.2 0.7±0.7 0.0±0.0 *0.03 14.6±2.7 11.8±4.1 0.34 0.07 
Behavior total raw score         
Visual Analogue Scale Ratings pre-
test 
 
Hunger pre‐test (cm) 53.0±9.3 62.7±14.8 45.1±10.6 0.55 51.2±21.1 66.4±6.8 1.0 1.0 
Fullness pre‐test (cm) 43.6±4.7 44.4±13.7 37.9±8.0 0.90 22.2±8.9 16.0±10.1 0.67 0.06 
“Wanting” pre‐test (cm) 32.7±15.0 56.3±14.9 41.7±17.0 0.72 51.6±14.7 53.0±9.8 1.0 0.59 
Nausea pre‐test (cm) 29±9.4 27.7±10.8 10.4±7.5 0.28 15.2±12.6 14.6±14.4 0.90 0.36 
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VSG 
Pre-op 
(N=7) 
VSG 
10 days 
post‐op 
(N=7) 
VSG 12 weeks 
post‐op 
(N=7) 
P value 
within VSG 
group 
Control 
Visit 1 
(N=5) 
Control 
Visit 2 
(N=5) 
P value 
within 
Control 
group 
P value 
between 
groups at 
baseline 
Visual Analogue Scale Ratings post-
test 
 
Hunger post‐test 44.9±11.1 22.7±6.5 29.9±9.1 0.31 50.0±16.7 57.0±12.5 0.67 0.9 
“Sweetness” post‐test (cm) 68.4±12.0 71.4±12.6 86.3±4.1 0.58 48.0±9.7 60.0±7.9 0.30 0.2 
“Creaminess” post‐test (cm) 39.0±11.4 55.4±9.5 66.3±5.6 0.24 59.2±6.4 65.8±8.4 0.91 0.3 
“Liking” post‐test (cm) 77.3±9.2 70.9±12.1 68.7±13.0 0.90 85.4±5.6 90.2±7.7 0.60 0.7 
Nausea post‐test (cm) 21.6±12.4 24.0±13.5 21.3±13.5 0.76 3.2±2.5 0.2±0.2 0.44 0.2 
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6.3.2 Two Way ANOVA Statistical Analysis 
The two-way repeated measures ANOVA (Table ‎6.3-2, Figure  6.3.2-1) was used to study the 
comparison between groups (VSG vs. Control), and within group comparisons to examine the timing 
effect (pre-op vs. post-op) on the variables. Given our a priori hypothesis of enhanced effects of time 
(post-op vs. pre-op) in VSG group, Post hoc effects of time were illustrated within each group, 
irrespective of the Time x Group interaction effect (Table ‎6.3-3, Figure  6.3.2-2) The facial expression 
PEVs showed significant differences between groups, and also according to the time effect for visits. 
Nonetheless, no Time x Group interaction was seen. The overall repeated measures ANOVA: Group 
F(1,10)=10.4, *p=0.009, Time F(1,10)= 9.4, *p ≤0.01, Group x Time F(1,10)= 1.7, p=0.21. (*p= 0.007) 
with post-hoc Bonferroni significant differences test. Facial expression NEV did not show any 
difference, either between groups F(1,10)=0.6, p=0.44, or according to the effect of time,  
F(1,10)= 2.6, p=0.13. No Group x Time interaction was seen F(1,10)= 1.7, p=0.21. (*p= 0.03) with 
post-hoc Bonferroni significant differences test. General Behaviour as response to the sweet/fat 
tastant in the Facial expression test for food preferences likes vs. dislikes did not change using the 
two-way ANOVA analysis. Group F(I,10)=0.001, p=0.99, no differences between visits F(1,10)= 1.1, 
p=0.32, and no interaction between Group and Time for visits, F(1,10)= 0.3, p=0.61.  
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Figure  6.3.2-1 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Positive Effective Behaviour 
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs. post-op) on Ingestive Behaviour (PEV), showing the effects of Time within each 
group, according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
 
 
Figure  6.3.2-2 Comparison between groups (VSG vs. Control) and within group to examine time 
effect on Negative Effective Behaviour  
 
Comparison between groups (VSG vs. Control) and within group comparisons to examine the time 
effect (pre-op vs. post-op) on Negative Effective Behaviour (NEV), showing the effects of Time within 
each groups, according to the Time x Group interaction effect. *P≤0.05, **P≤0.01, ***P≤0.001. 
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Table  6.3-2 Two Way ANOVA Results  
Participant characteristics at baseline and 12 weeks. A summary of response to sweet/fat tastant using facial expressions after vertical sleeve 
gastrectomy (VSG). Results are expressed as mean +/- SEM or median (interquartile range) depending on normality distribution. 
 
CONTROLS SLEEVE ANOVA 
PRE POST PRE POST GROUP TIME GROUP X TIME 
Number 5 5 7 7 F a P b F a P b F a P b 
Participant Characteristics  
Age (years) 14.4±0.7 N/A 15.6±0.7 N/A N/A N/A N/A N/A N/A N/A 
Height (m) 1.65±0.03 1.65±0.04 1.65±0.03 1.66±0.03 N/A N/A N/A N/A N/A N/A 
Weight (kg) 78.6±9.3 78.9±7.5 143.9±7.8 113.3±6.4 21.1 *≤0.001 53.8 *≤0.001 55.9 *≤0.001 
BMI (kg/m2) 28.8±2.5 28.9±1.9 52.5±2.1 40.9±1.6 39.5 *≤0.001 59.1 *≤0.001 60.4 *≤0.001 
Video Facial Expression Analysis  
Food Preference Behavior           
General Behavior 9.4±2.5 6.4±2.1 8.4±2.1 7.4±1.8 0.001 0.99 1.1 0.32 0.3 0.61 
Negative Effective Value 2.4±0.8 2.4±3.5 0.3±0.6 8.1±2.96 0.6 0.44 2.6 0.13 2.6 0.13 
Positive Effective Value 14.6±2.6 11.8±2.6 7.0±2.2 0.001±2.2 10.4 *0.009 9.4 *≤0.01 1.7 0.21 
           
Visual Analogue Scale pre-Test 
 
Hunger pre‐test (cm) 51.2±15.8 66.4±10.6 53.0±13.4 45.1±9.0 0.6 0.44 0.09 0.77 0.8 0.38 
Fullness pre‐test (cm) 22.2±7.1 16.0±9.8 43.6±6.0 37.9±8.2 5.97 *0.04 0.8 0.40 0.001 0.97 
“Wanting” pre‐test (cm) 51.6±16.6 53.0±16.7 32.7±14.1 41.7±14.1 0.6 0.44 0.2 0.63 0.1 0.73 
Nausea pre‐test (cm) 15.2±11.8 14.6±11.4 29.0±10.0 10.4±9.6 0.1 0.73 2.6 0.13 2.3 0.16 
Visual Analogue Scale post-Test 
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CONTROLS SLEEVE ANOVA 
PRE POST PRE POST GROUP TIME GROUP X TIME 
Number 5 5 7 7 F a P b F a P b F a P b 
Hunger post‐test 50.0±14.7 57.0±11.5 44.9±12.4 29.9±9.7 1.2 0.29 0.2 0.66 1.5 0.25 
“Sweetness” post‐test (cm) 48.0±12.6 60.0±6.3 68.4±10.6 86.3±5.3 5.0 *≤0.05 3.6 0.085 0.1 0.72 
“Creaminess” post‐test (cm) 59.2±11.2 65.8±7.4 39.0±9.5 66.3±6.3 1.3 0.28 3.5 0.09 1.3 0.27 
“Liking” post‐test (cm) 85.4±9.1 90.2±12.9 77.3±7.7 68.7±10.9 2.3 0.16 0.03 0.86 0.4 0.54 
Nausea post‐test (cm) 3.2±11.5 0.2±12.4 21.6±9.7 21.3±10.4 2.8 0.12 0.03 0.87 0.02 0.89 
Data presented as mean ± SEM 
F a (1, 10) for all ANOVA results. 
P b values for repeated measures ANOVA with group as between subject factor and time as within subject factor. 
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Table  6.3-3 Post hoc effects of Time within groups 
Post-hoc Bonferroni significant differences test with Two Way ANOVA results for participant characteristics at baseline and 12 weeks.  
A summary of response to sweet/fat tastant after using facial expressions Vertical Sleeve Gastrectomy (VSG). Results are expressed as mean +/- SEM or 
median (interquartile range) depending on normality distribution. 
 
CONTROL VS. SLEEVE AT 
BASELINE 
CONTROL VS. SLEEVE AT 12 
weeks‎ 
CONTROL BASELINE VS. 12 
weeks‎ 
SLEEVE BASELINE VS. 12 weeks‎ 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Participant Characteristics  
Age (years) N/A N/A N/A N/A N/A N/A N/A N/A 
Height (m) -0.003±0.05 0.95 -0.008±0.05 0.86 N/A N/A N/A N/A 
Weight (kg) -65.3±12.1 *≤0.001 -34.4±9.9 *0.006 0.3±3.2 0.92 30.6±2.7 *≤0.001 
BMI (kg/m2) -23.7±3.3 *≤0.001 -12.1±2.5 *≤0.001 0.06±1.1 0.95 11.5±0.96 *≤0.001 
Video Facial Expression 
Analysis  Food Preference 
Behaviour 
 
General Behaviour N/A N/A N/A N/A N/A N/A N/A N/A 
Negative Effective Value 2.1±0.99 0.059 -5.7±4.6 0.24   0.01± 3.7 1.0 7.9±3.1 *0.03 
Positive Effective Value 7.6±3.5 0.052 11.8±3.4 *0.006 2.8±2.4 0.27 7.0±2.1 *0.007 
Visual Analogue Scale Pre-
Test 
 
Hunger pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Fullness pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
“Wanting” pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Nausea pre‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
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CONTROL VS. SLEEVE AT 
BASELINE 
CONTROL VS. SLEEVE AT 12 
weeks‎ 
CONTROL BASELINE VS. 12 
weeks‎ 
SLEEVE BASELINE VS. 12 weeks‎ 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Mean 
Difference 
P Value 
Visual Analogue Scale Post-
Test 
 
Hunger post‐test N/A N/A N/A N/A N/A N/A N/A N/A 
“Sweetness” post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
“Creaminess” post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
“Liking” post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
Nausea post‐test (cm) N/A N/A N/A N/A N/A N/A N/A N/A 
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6.4 Discussion 
This pilot study is the first study to focus on facial expressions in obese adolescent VSG 
patients in response to food stimuli. The aim was to investigate whether facial expressions 
represent a suitable and accurate measure, by which to quantify food preferences in 
adolescent obese patients before and after VSG. Although caution should be applied to the 
interpretation of the results because of the small number of subjects, this study delivers 
certain insights that might be valuable for researchers who are studying obese patients' 
food preference changes after bariatric surgery. This study used the facial expression method to 
assess changes in the consummatory behaviour relating to a single, specific food item after VSG 
surgery. The results indicate that negative facial expressions for disliked sweet/fat stimuli are 
more often encoutered after VSG. Our hypothesis that negative expressions will increase, 
and positive expressions decrease for disliked stimuli, was conﬁrmed. In addition, facial 
expressions remained unchanged across a similar test-retest interval in non-surgical control 
subjects.  
Expressions that are evoked by foods, based on an emotion that is clearly food-related, 
include the expression of disgust (600).  When a stimulus is liked (i.e. sweet solution), 
infants will smile, which is a sign of happiness. However, although the liked stimuli in our 
pilot study evoked an expression of happiness in the subject, it was difficult to detect  
and distinguish them from the neutral facial expressions. It has been suggested that, since 
the foods that humans consume and accept tend to result in mild positive reactions (601);   
it may be difﬁcult to distinguish degrees of liking (food acceptance) based on facial 
expressions (599). Another group was able to conclude that facial expressions are suitable 
to measure dislike, but not suitable to measure several gradients of food acceptance in 
children aged 5–13 years. They felt that including drinks that are better-liked (possibly 
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milkshakes) than previously used juices and sweet solutions, might be preferable when 
studying positive facial expressions (599). Nevertheless, other studies indicate as well that 
the human system is much more responsive to potentially dangerous substances (disliked) 
than it is to safe, liked stimuli (602;603). One of the key merits of the task used here is that the 
assessment was based on the actual behaviour of the subject and was not burdened by some of the 
interpretive limitations associated with scaling procedures. Our study answered the question of 
whether an obese adolescent subject likes or dislikes the sweet/fat stimulus after VSG surgery. Our 
model comprised a simple piece of apparatus, which ensured that the milkshake flowed directly and 
securely into the subjects’ mouths as described above. Thus, consummatory responsiveness was 
determined directly by the orosensory properties (e.g. taste) of the sweet/fat stimuli. Effort was 
made to minimise post-ingestive effects, and the reinforcer was of limited volume and calories.  
 In this study, large differences were observed in the expressiveness of the seven VSG adolescents' 
patients and the non-surgical group of five. Some were very expressive and others hardly showed 
any facial responses. To capture the more subtle changes in the face, it may be useful to apply 
electromyogram (EMG) measurements in future studies. EMG  measurements  or  an automated 
scoring system, which can capture more subtle or humanly imperceptible changes in the face and 
would make the measurement of facial expressions more objective and more widely accessible as  
a research tool (604;605).  It is unclear how much masking and control occurs in response to food 
stimuli. Since masking and control inﬂuence the objectivity of facial expressions as a tool for 
measuring food preferences, future research should examine how much masking and control is 
present at various ages and how much between-subject variation is present concerning masking and 
controlling expressions (599). The use of facial expressions to study the consummatory reward 
function of taste in human adults has been less well investigated. Previous work has shown that 
adults do demonstrate a degree of facial reactivity, with some promising results (533;535;537;538)  
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However, it was considered that they may not be as accurate owing to a combination of socialisation 
and voluntary or higher control (535;539).  
Taste reactivity has not been used for the study of consummatory reward in obese adults as yet. The 
major limitation to the use of facial reactivity is the difficulty in interpretation of these often small 
and subtle movements (535).  A few studies have used Facial Action Coding System (FACS) with 
trained interpreters (606). However, recently new face recognition software packages have been 
developed that enable the more objective assessment of facial reactivity and the duration of the 
facial reaction, providing a better overall feedback on the emotional state of the subject (e.g. 
FaceReader™). This technology is promising and could be further improved in terms of specificity, 
sensitivity and adapted to cultural and social facial reactivity differences (607).  On the basis of the 
results of this pilot study VSG is implicated in changes in consummatory behaviour in adolescents, by 
determining changes in “facial expressions” when reacting to tastant stimulants. Additionally, facial 
expressions appear to be suitable to measure dislike, as well as various gradients of food acceptance 
in adolescents with obesity. Future studies with a larger number of VSG patients should be 
performed to conﬁrm these results. The literature regarding bariatric surgery from human and 
animal experiments has broadly described reduced preference for refined sugars and fat, without 
pinpointing taste and/or post-ingestive effects as the cause for this perceived migration toward 
foods often considered more “healthy choices” (269;271;275;279;362;368;373;518;586). 
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CHAPTER 7  
DISCUSSION   
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7.1 Discussion 
7.1.1 Most important findings 
In this study, no changes were demonstrated in taste threshold, but changes in appetitive and 
consummatory eating behaviour were apparent after VSG. Changes were related to food preference, 
eating behaviour and meal patterns after VSG in obese adolescents' patients. 
7.1.2 Strength: Eating behaviour and meal pattern 
7.1.2.1 Food preferences 
The studies described in Chapter 3 demonstrate for the first time the powerful effect of VSG surgery 
in altering food choice in adolescents, particularly by decreasing fat intake. These data provide 
another parallel between the effects of VSG and RYGB, suggesting that these two anatomically-
distinct procedures may share a common mechanism to induce their effects. Furthermore, this effect 
on food choice, along with many other effects of VSG and RYGB, is not shared with AGB, indicating 
that AGB is fundamentally different from the other two and does not fall into the category of 
metabolic surgery (529). 
7.1.2.2 Eating behaviour and attitude of eating 
Data in Chapter 3 also demonstrate that VSG changes eating behaviour and specifically leads to 
reduced meal size, meal duration and rate of eating when eating ad libitum. Emotional eating and 
unconditioned eating decreased postoperatively, while cognitive restraint increased. Possible 
mechanisms include changes in appetite regulatory hormones, leading to less hunger, which in turn 
may reduce eating rate and energy intake (292;293). Eating rate may also be reduced to attenuate 
the risk of dumping syndrome, which can occur when high glycaemic index carbohydrates rapidly 
reach the proximal small intestinal (608). Reports documenting gastric emptying following VSG are 
 197 
 
inconsistent (461;462), and it is also unclear how often VSG is associated with symptoms of dumping 
syndrome, but a recent study suggested that symptoms of dumping syndrome occur in almost half of 
patients  
6 weeks after VSG (572).  
7.1.3 Strength: Taste detection 
Using the same methodology, my data on sucrose detection threshold after VSG in adolescents were 
different to our previous data from adults after RYGB (381). The change in taste detection thresholds 
for sucrose after RYGB remain controversial (585), but most of the available evidence are consistent 
with our previous findings (381). Scruggs et al. reported a trend for sucrose detection and recognition 
thresholds to decrease after RYGB (524). The concentration at which the subjects could correctly 
identify the characteristic taste quality of the stimulus was considered the recognition threshold. This 
technique, however, only stimulates a limited number of taste buds. Burge et al. used a staircase 
method of stimulus presentation and found that sucrose recognition thresholds also decreased after 
RYGB (523). Taken together, these data suggest that RYGB has, if any, a small effect on the sensory 
domain of taste. Our results therefore suggest that adolescents after VSG behave in similar ways to 
some adult patients after RYGB. There are reasons other than potential changes in the sensory 
nature or unconditioned hedonic value of sweets as to why patients would avoid some sugary or 
fatty foods and fluids, e.g. learning from post-ingestive consequences and or nutritional counseling 
(269;271;275;368;518;586;587). 
7.1.4 Strength: Appetitive behaviour 
In this study I have shown that the appetitive reward value of a tastant high in sugar and fat 
decreased after VSG surgery in adolescents. My data is consistent with the changes shown in rodents 
after VSG (529) and in adult patients after RYGB (386). My method built on the literature involving 
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the use of PRT in humans (386;590-596). One of the crucial advantages of the task used here is that 
the assessment is based on the actual behaviour of the subject and is not loaded by some of the 
interpretive limitations associated with scaling procedures. Our study answered the question of how 
hard was an adolescent subject willing to work for a given reinforcer. The food reward system is 
 a complex neural system that can be divided both anatomically and operationally into several 
components. One reasonable and important operational difference has been to distinguish hedonic 
“liking” from “wanting” and learning as proposed by Berridge and Robinson (609).   
 
This differentiation is based on the simple fact that a food item that is liked is not essentially wanted 
at a given time, and that learning is needed to predict the reward value of a given food (610). 
Potential effects of bariatric surgery (RYGB and VSG), on brain areas involved in reward, cognitive, 
and emotional functions, contribute to the control of food intake, representing the expanded 
homeostatic system regulating energy balance. Changes in circulating hormones and metabolites, as 
well as changes in neuronal inputs from visceral afferents, may affect: (1) the processing of sensory 
information all along the specific input pathways, (2) reward computation in the mesocorticolimbic 
dopamine system, (3) emotional valence computation in the amygdala, (4) formation and 
modification of ‘food memories’ in the insular and prefrontal cortex and, (5) decision-making and 
executive control (611).  
Looking for possible neural mechanisms that underlie changes in ”wanting”, particularly changes in 
activation of components of the mesolimbic dopamine system, there is a growing literature base 
engaging functional magnetic resonance imaging, or fMRI. Specifically, fMRI studies from rodents 
show reduction in preference for sweet and fatty foods post RYGB or VSG. Correspondingly, while 
one recent study found RYGB patients to be less willing to work and exert effort for high-calorie food, 
there is no clear consensus about changes in the motivation to gain food rewards (“wanting”) and its 
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underlying mesolimbic dopamine system. Flow of information is hypothetically involved in the 
physiological and behavioural consequences of VSG and RYGB surgery. The primary surgical affront in 
the gut leads to progressive adaptive changes in structure (e.g., mucosal hypertrophy) and function 
(e.g., shift in microbiota composition, hormone release patterns, and bile-acid metabolism). These 
mutual changes signal to other organs, such as the liver, pancreas, adipose tissue, muscle, and brain, 
through either the circulatory or nervous system, and eventually lead to changes in energy intake, 
energy expenditure, and food choice. Alterations in signaling to the brain do not only affect food 
intake, but also autonomic nervous system and endocrine outflow back to the gut as well as to the 
other organs (577;611).   
7.1.5 Strength: Consummatory behaviour  
On the basis of my pilot study results, I demonstrated that VSG surgery made some 
changes in consummatory behaviour in adolescents, as compared to the pre-surgical 
phase, by determining direct measure changes in “facial expressions” in adolescents when 
reacting to tastant stimulants after VSG. Data also demonstrated that facial expressions are 
suitable to measure dislike, as well as various gradients of food acceptance in adolescent 
patients with obesity. The literature regarding bariatric surgery from human and animal 
experiments has broadly described the development of reduced food preference for 
refined sugars and fat, without pinpointing taste and/or post-ingestive effects as the cause 
for this change to more “healthy choices” (269;271;275;279;362;368;373;518;586). Studies 
from the literature designed to determine the neural component(s) accountable for these 
adaptive changes further propose that “liking” of not only high-fat, but also high-sucrose 
taste stimuli, is reduced post RYGB. However, whether this shift towards lower calorie-
density sweet and fatty stimuli is due to changes in taste acuity or more central 
components of taste processing is not yet clear and needs further investigation. Results 
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from my study may support the notion that this shift is related more to the central 
components of taste, such as the hedonic area in the brain, as well as the learning process, 
as a result of the post-ingestive effects of certain foods following VSG, a response that we 
may call “conditioned aversion”. A similar pattern was seen as that of high-fat diet-induced 
obese rats, which”like” high concentrations of sucrose and corn oil. Rats post RYGB shift 
”liking” from higher to lower concentrations of both sucrose and corn oil solutions, 
behaving similarly to lean rats using the taste reactivity test (384). And because restricted-
calorie diet-induced rats experienced the same shift, the mechanism appeared to depend 
on weight loss rather than some other effect of the surgery (384). In the literature on 
humans, liking has been measured questionnaires and the VAS (612). Like the findings in 
rats, RYGB patients preferentially reduced their liking of high-calorie food versus low-
calorie foods, as measured before and after surgery (613).  
Patients with obesity described higher hedonic hunger (361) and higher liking for a given sweetness 
(471), compared with normal weight patients. Remarkably, this occurs regardless of decreased 
perceived sweetness in patients with obesity (471). Consequently, as determined by Bartoshuk et al. 
(471), liking is increased as  a function of sweetness in patients and more as BMI increases, and for 
similar perceived sweetness, liking increases as BMI increases. Interestingly, my results have also 
shown a correlation between weight reduction and the ingestive effect, the more weight reduces the 
less the ingestive effect is. During the early postsurgical phase, as a large amount of weight loss 
occurs, aversive conditioning might play an important role in the reduction of food intake in both 
humans (614) and rats (383). During the later postsurgical phases, changes in circulating gut 
hormones acting on the brain are supposed to be the main candidates for reduced appetite and food 
intake (292).   
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7.1.6 Strength: Methodology 
One of the fundamental components of the task used is that the assessment is based on the actual 
behaviour of the adolescent subject and is not loaded by some of the informative limitations 
associated with scaling procedures. The strength of this study is that actual direct measures of 
portion size, meal duration and eating rate were possible, both preoperatively and up to 1 year 
postoperatively. Direct assessments of portion sizes are certainly preferable, even if it is possible to 
rationally estimate the meal size based on assumed energy requirements. Even more exciting is the 
meal duration and eating rate, which add new and potentially significant clinical knowledge that are 
both important for clinicians in the nutrition care process and for the patient in daily life. Our study 
also answered the question of how hard was an adolescent subject willing to work for a given 
reinforcer. Consummatory behaviour in adolescents, as compared to the pre-surgical phase, was 
determined using direct measure changes in “facial expressions” in adolescents when reacting to 
tastant stimulants after VSG. Our study proved that facial expressions might be suitable to measure 
dislike, as well as suitable to measure various gradients of food acceptance in adolescent obese 
patients. In contrast to earlier experiments, the method of constant stimuli was used, in which taste 
stimuli were presented randomly and performance was assessed across a set of concentrations, 
allowing for derivation of a psychometric function. Furthermore, adolescent subjects obtained 
feedback by receiving tokens for correct responses and losing tokens for incorrect responses, which 
seemed to keep subjects attentive and motivated in this game-like competitive setting. 
7.1.7 Limitation: Eating behaviour and meal pattern 
A limitation of this study is that the test meals were administered in a laboratory setting, which may 
not reflect habitual eating habits of patients. In human research, food choice is regularly assessed by 
having patients maintain a food diary for a period of time, then analysing their diet by categorising 
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foods in different ways. Whereas total calorie intake and macronutrient intake can be calculated in a 
straightforward method, there is no consensus for grouping foods into other categories. For 
example, ice cream is differentially classified in four different studies as “dessert”, “sweets”, “milk 
and ice cream”, and “energy dense”  (332; 362; 363; 368). In human research, there is a major need 
for the acceptance of a standardised classification of foods. This may help to stop categorisation and 
analysis according to the investigator’s interests, and would facilitate comparisons between studies. 
The limitations of the study include the relatively small sample size, for both VSG and control group 
of adolescents that may possibly affect the generalisability of the results. It was not easy to bring 
subjects of this age group for testing in the morning, missing classes at school, and this was the main 
limitation to getting the control group to attend for a 3rd visit, unlike the VSG subjects. This difficulty 
was despite attempting to match test visits with children’s surgical check-up appointment at the 
obesity clinic. Also, the current study lacks data on changes in physical activity and body composition 
after VSG surgery for this age group. This information may have increased our understanding of 
associations or a lack thereof, between changes in food weight, energy intake, energy density and 
weight loss after VSG surgery. In addition, it has not been possible to measure the effect of the 
pediatric obesity clinic routine preoperative dietary education for adolescents with obesity, which 
may have had diverse effects in different subjects on postoperative eating behaviour. One of the 
limitations of using visual analogue scales in single-meal studies is that they have a great inter-
individual variability. Nevertheless, this may be of less concern in this within-subject design.  
7.1.8 Limitation: Taste detection 
A limitation of this study was the age group (12-18 years). An age group including subjects of less 
than 15 years old is not recommended for this study design, because of the methods setting, 
including the duration, need to focus, engagement and fasting hours. Age group of (15-18) years is 
preferable and much easier for the investigator to deal with for such behavioural studies. Children’s 
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attention deficiency test screening is required for further studies of similar methodology for this age 
group. 
7.1.9 Limitation: Appetitive behaviour 
It's not possible to entirely dismiss the possibility that subjects’ responses were influenced by their 
own cognitive expectations regarding how they thought they were supposed to behave toward the 
reward stimuli. However, this is an inescapable limitation of any assessment of food preference and 
hedonics in an experimental setting. Teeth screening wasn’t included in the inclusion/exclusion 
criteria, which might affect the intake of the sweet/fatty candy.   
7.1.10 Limitation: Consummatory behaviour 
Limitations may include the participant’s own interpretation of their sensation and are thus subject 
to variation based on individual differences in prior sensory experience. The adolescent subjects 
maybe holding back their responses as they feel that there were video recordings and this may lead 
to false reporting. The major limitation to the use of facial reactivity is the difficulty in interpretation 
of these often small and subtle movements (535). A few studies have used the Facial Action Coding 
System (FACS) with trained interpreters (540). However, new face recognition software packages 
have recently been developed, which enable the more objective assessment of facial reactivity and 
the duration of the facial reaction, providing better overall feedback on the emotional state of the 
subject (e.g. FaceReader™). This technology is promising and could be further improved in terms of 
specificity, sensitivity and adapted to cultural and social facial reactivity differences. Another 
limitation of this study is its small sample size, both for VSG and control groups, which limits the 
generalisability of the results.  
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7.1.11 Limitation: Methodology  
A limitation of this study is that the test meals were administered in a laboratory setting, which may 
not reflect habitual eating habits of patients. Scaling procedures have their limitations, but are 
relatively easy, efficient and inexpensive to use. This is also applied to all dietary verbal 
questionnaires that depend on memory, reliability, and good skilled interviewer. Another limitation 
of the study was the age group (12-18), an age group less than 15 years old are not really 
recommended for some of the study objectives, because of the methods' setting itself. Age group of 
(15-18) years are preferable and easier to deal with for such behavioural studies.  
7.1.12 Findings Potential Interaction Discussion 
In additional to potential changes in the sensory nature or unconditioned hedonic value of sweets, 
there are other explanations for avoidance of some sugary or fatty foods and fluids after surgery. 
These include learning from post-ingestive consequences and nutritional counselling 
(269;271;275;368;518;586;587). Understanding behaviours, such as ingestive behaviour, is an 
essential developmental mechanism critically guided by the brain reward system. When defining the 
relationship between food reward and obesity it is not yet clear what comes first. Several human and 
rodent studies that state changes in food choices and preferences were recently reviewed 
(364;615;616). The common observation in human studies of a shift from sweet and fatty energy-
dense foods to less energy-dense foods (367), is comparable to rodent studies, which find a shift in 
preference from high-fat diets before surgery in the obese state, to a lower preference for such diets 
after both RYGB and VSG (303;383;464;529;617). The diminution of fat preference in response to 
intra-gastric infusions of sucrose and intra-lipid, following bariatric surgery, suggest that the effect of 
VSG surgery on meal size might result from increases in sensitivity toward the caloric content of  
a given food, rather than resulting in increased distension-related signals due to small stomach (577). 
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Thus, this could be a good correlate for meal termination (618). However, preference and reward 
pathways are possible products of a more complex pathway that contains higher forebrain circuits. 
The different postprandial hormone profiles post VSG might be related more to changes in nutrient 
delivery to the duodenum. Human data demonstrate that VSG significantly increases the gastric 
emptying rate (461;462;619) and transit (462), and, in RYGB subjects, transit is increased by the 
surgical construction of a gastric-jejunal anastomosis (620). A previous study showed that rats 
increased their carbohydrate intake relative to fat through food selection test (462;529), suggesting 
that patients who undergo VSG will also be less likely to select high fat foods. However, it has been 
shown that, even when rats are continued on a similarly high-fat diet to that used to make them 
obese before the surgery, VSG still results in great reductions in body fat. Such results may suggest 
that changes in food choice are not essential to reduce body weight after VSG. Nevertheless, it is 
possible that similar mechanisms that lead to body weight reduction, also act to alter food choice as 
well (577).   
Accelerating the transit of lipids into the distal gut could stimulate the release of supra-physiological 
levels of GLP-1, PYY, and insulin after these types of surgery (301;314;462;621;622). It could also limit 
the exposure of fat to lipases and the emulsification process, providing a potential reason for the 
observed increase in plasma bile acids after VSG (623) and RYGB (624), as well as reduction in fat 
preference. This hypothesis might explain the differences between VSG and restrictive procedures 
such as AGB, wherein gastric emptying rates are not increased (625;626), and postprandial hormone 
profiles are not changed (290;316). In previous studies it was shown that the effects of RYGB on food 
preferences have been attributed to the exclusion of the duodenum and proximal bowel. However, 
the profile produced by VSG rats, on dietary preferences for high-energy liquids and dietary fat, 
reveals that similar effects can be achieved without bypassing the intestine. It also shows that 
reduction of meal size after VSG is due to an activation of satiation pathways in response to 
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nutrients, and especially to fat content, rather than as a result of volume effects (577). These data 
support the hypothesis that the satiating effects of VSG are based upon changed perceptions and 
actions of calories, not altered perception of the volume, caused by mechanical restriction as 
suggested previously (577). 
The noticeable changes in ingestive behaviour, with smaller meals and shifts in preference, observed 
in humans and rodents after RYGB (244;263;367;384;616;627) suggest that learning mechanisms 
contribute, in order to avoid unpleasant gastrointestinal sensations such as fullness, nausea and pain 
when ingesting too much of certain foods. Bariatric surgery in humans often causes incidences of 
fullness, discomfort and nausea, sometimes even pain and vomiting, with differing intensity and 
frequency, depending on the type of bariatric procedures (628-632) and the occurrence of  
a complication. Furthermore, conditioned taste aversion to orally administered corn oil was 
demonstrated in rats after RYGB and VSG (383;529). Changes in attitudes to eating may also alter 
meal frequency, meal size, eating rate (547;573), and weight loss maintenance (574-576). Individuals 
may be influenced by psychosocial factors, such as, culture, dietary counselling, food preferences, 
previous experiences of dieting and emotional state (244). The changes in gastrointestinal physiology 
after VSG may begin with a cognitive process where the individual makes changes in their behaviour, 
or may try to avoid negative consequences of eating specific foods (633). This learning process may 
increase cognitive restraint, although the impact this may have is controversial (546).  
When bariatric surgery patients are asked to describe their eating experience using interpretative 
phenomenological analysis, self-control was the central theme permeating all areas of the interviews 
(634;635). Most of these patients have been struggling all their life with control over eating and 
successful surgery appeared to make control easier. Ogden et al. concluded that successful surgery 
without weight regain brings the patient’s mind ‘in gear’, while failed surgery is characterised by  
a continuing battle for control (635). While the liking and wanting systems generate incentive 
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salience and craving, the executive control system acts as a brake to align impulsive behaviour with 
longer-term goals. Inhibitory control is particularly important to resist allurement to eat as 
stimulated by pervasive food cues in the modern environment (610). It would appear then, that the 
success of bariatric surgery may be due, in part, to the post-operative ability of an individual to 
activate neural circuits involved in executive control (636). It is unclear whether executive functions 
are precisely impaired in obesity or preoperatively in RYGB patients and VSG. The level to which the 
hedonic value of a given food cue impacts executive control functions also remains to be 
determined. RYGB post-operative changes in food hedonics may also facilitate executive control 
functions (613), and this is maybe the case in VSG. If this is the case, then removing or reducing the 
hedonic value of notoriously high-calorie foods through RYGB and VSG would make it easier to self-
regulate their intake (610).   
Food preferences and choices are direct reflections of sensory hedonic responsiveness, a justification 
for research on orosensory acuity, “wanting” and “liking”. In spite of the limited and inconsistent 
evidence this may explain the variation in energy intakes or nutritional status. Additionally, an aim of 
numerous public health (and marketing) campaigns is to attempt to shift a consumer choice toward 
certain foods. This fact alone places the understanding and ability to guide food “likes” and “wants” 
as a dominant challenge to academic and industrial nutritionists and consumer research. As noted 
earlier, attention to the differences between “liking” and “wanting” was considered(637).   
Considerable attention has also been given to the insight of orosensory stimuli and explicit liking of 
foods; however variation in obesity is not yet evidently related to variation in the hedonic knowledge 
or pleasure of eating. This apparent inconsistency may be resolved by a growing body of behavioural 
and neurophysiological evidence that distinguishes “liking” and “wanting”, and suggests new insights 
for understanding (over-) eating and obesity and the mechanisms behind.  
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Does this have any real-world application?  It’s worth understanding “why we want to eat what we 
want to eat”. It’s important to know that at any given moment a conscious feeling of the desire to 
eat a specific food is the result of a balance of: (1) physiological state and signals (particularly, thirst 
and hunger); (2) anticipated pleasure of eating (mainly acquired from learned associations); and (3) 
external associations and signals (also mainly learned, with cognitive components as well as elements 
that may be unrecognized and unconscious)(637).  
Implications  
What are the implications of all this? And how can we benefit from this in public health? 
For investigation in food intake and appetite regulation, by putting emphasis on understanding the 
nature of externally signalled eating behaviour, and particularly the extent and reason of differences 
in sensitivity to this (together with cognitive restraint and dieting) and it’s mechanism. 
For investigation in sensory food science and food acceptance, this body of knowledge must be 
integrated with consideration of the dynamics of the acquisition and changes in “liking”, and 
“wanting”. 
For guidance in prevention and treatment of obesity, this may give description to methods 
emphasising environmental control, with structuring and limiting food stimulation. 
For commercial food developers, the challenge in relative to weight control remains to improve the 
quality and attractiveness of lower dense foods, and make sure they are not just “liked”, but also 
“wanted”. 
For commercial food marketers, understanding this area of research, might point on the role of 
environmental signals, which include food itself as stimulus to eat. Marketers must take 
 209 
 
responsibility to guarantee that they are not excessively adding to the environmental stimulation to 
eat inappropriately. 
The main challenge is to understand the taste mechanism, the orosensory acuity, “wanting” and 
“liking”, the drivers of variance in eating behavior and food preferences and choices, and to apply 
this knowledge to food development, marketing, and public health guidance in ways that make 
healthy, appropriate eating somewhat that is liked, wanted, and preferred, as a preventive measures 
and management tools for childhood and adult obesity. 
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SUMMARY  
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8.1 Summary 
In summary, food preferences reported by adolescent patients undergoing VSG suggest a shift in 
food preferences to healthier choices, a reduction in fat and high glycaemic index carbohydrates with 
an increase in low glycaemic index carbohydrates and unchanged protein intake after VSG. Patients 
reduced their ad libitum meal size, meal duration and eating rate. Habitual meal frequency tended to 
increase, with more meals consumed in the mornings. Emotional and unconditional eating 
decreased, while cognitive restraint increased after VSG. Besides a considerable reduction in overall 
energy intake, patients also reported decreased dietary energy density. Thus obese adolescents after 
VSG exhibit eating behaviour that might help in promoting and maintaining weight loss. 
 
Obesity is associated with complex alterations in food reward functions at the neural and 
behavioural level. Generally, obese subjects like and want palatable foods more than normal weight 
subjects. Thus, there is clear evidence that ingestive behaviour and food choice changes after 
bariatric surgeries (RYGB and VSG) and that eating ‘as usual’ can lead to discomfort and nausea. It is 
thus very reasonable that animals and humans learn to avoid these negative consequences and thus 
reduce food intake, a term that we call the “conditioned aversion” response. It may, therefore, be 
possible to take advantage of this system for the development of drug or behavioural therapies to 
restrain food intake without induction of nausea (610). 
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CHAPTER 9  
CONCLUSION AND FUTURE DIRECTIONS  
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9.1 Conclusion 
Adolescent patients after VSG showed a shift in food preferences to healthier choices, with 
considerable reduction in overall energy intake and decreased dietary energy density. Eating 
behaviour and meal pattern changed, patients reduced their ad libitum meal size, meal duration and 
eating rate, as well as changes in the attitude of eating. All together this might help in promoting and 
maintaining weight loss. Obesity is associated with complex alterations in food reward functions at 
the neural and behavioural level. VSG was able to determine changes in the hedonic value, the 
reward domain in the brain, by changing the appetitive and consummatory behaviour in response to 
sweet or fatty stimulants, and shows no effect on the sensory domain, sweet sensitivity, after 
surgery.   
 
9.2 Future work 
Throughout the past decade, there has been a flow in studies characterising the effects of bariatric 
surgery in humans and rodents. They have established many structural, functional and molecular 
changes in the gut, the brain and the other organs as well as alterations in energy metabolism, 
glucose homeostasis and behaviour. After going for the ‘low-hanging fruit’, it is now time to separate 
irrelevant changes from mechanistically relevant ones. The marked and constant body weight loss 
and attendant correction of much obesity-related impairment in metabolism and behaviour are well-
documented, while other effects that do not depend on the hypocaloric state and weight loss are 
variable and less clear.  
In general, while the constant body weight loss in humans is mainly elucidated by reduced energy 
intake, not increased energy expenditure, the key observation is that energy intake is not increased 
to regain lost body weight, though food intake can be doubled if properly stimulated. This proposes 
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the active defense of a new lower body weight level post-surgery. Therefore, explaining the potential 
mechanisms for this constant relative hypophagia is perhaps most crucial for future non-surgical 
treatments of obesity. Whereas a number of candidate mechanisms have been proposed on the 
basis of changes in gut hormone secretion, as well as changes in peripheral and central targets of 
such hormones, direct testing of individual signaling flows was unable to confirm any of these 
hypotheses so far. It was beyond the scope of this study to explore the mediators of the change in 
appetitive and consummatory behaviour after VSG. It is notable that responses of post-prandial 
anorexigenic gut hormones (glucagon-like peptide 1 (GLP-1) and peptide tyrosine tyrosine (PYY)) are 
enhanced after both the VSG and RYGB, in spite of the anatomical differences between both 
procedures. The administration of GLP-1 and PYY has been shown, not only to increase fullness and 
decrease caloric intake, but also to decrease behavioural and brain reward system responses to 
energy-dense food or cues in humans and rodents. Reports of changes in taste-guided behaviour and 
food choices after bariatric surgery in the literature are mixed. Studies including more direct 
measures of target behaviours may help explain whether changes in food selection and changes in 
taste function accompany the reduction in caloric intake and weight loss seen after bariatric surgery. 
This goal can possibly be achieved through the implementation of protocols similar to those used 
with animals in basic research. The application of these techniques may also facilitate translation 
between findings from rodent models, which are essential for explaining physiological and neural 
mechanisms, and clinical research regarding the effects of VSG on taste function and food selection 
in humans.  
The priority for future research that is aimed to: 
1-Studying the changes in dietary energy density after VSG and RYGB using direct measure 
methodology. A standardised ad libitum meal (lunch), in a buffet style, will be served to all 
participants, who will be free to choose and consume as much as they wish.  
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The energy intake (EI) and the dietary energy density (DED) of the food choice will be calculated after 
weighing the served food before and after the test meal. Meal patterns will also be measured using a 
standardised questionnaire for the analysis of meal frequency, dietary behaviour and temporal 
distribution over 24 hours, because the work showed changes in meal pattern and eating behaviour 
post VSG 
2- Studying the consummatory beahavior of taste in adolescent humans after it has showed some 
promising results using facial reactivity methods. The aim is to study the taste reactivity on a larger 
scale of subjects using the facial analysis softwear programs method such as the FaceReader® for 
more objective results.  
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Appendix 1 Review of studies from Saudi Arabia evaluating the prevalence of overweight and obesity among children (Adapted following permission from 
the author; Al-Dossary S.S.) 
Review of studies from Saudi  Arabia evaluating the prevalence of overweight and obesity among children 
Reference Region Target children No. Ages (years) Sex 
Overweight 
prevalence (%) 
Obesity prevalence 
(%) 
Present study Eastern province School children, Private hospital 7056 2-18 M, F 19 23.3 
Alarm, 2008 West Riyadh Elementary school 1072 8-12 F n/d 14.9 
Amin, 2008 Al Hassa Primary schools 1139 10-14 M 14.2 9.7 
Al-Hazzaa, 
2007 
Riyadh Primary schools 
1082 (1988) 
702 (2005) 
6-14 M  
3.4 (1988) 
24.5 (2005) 
Al Turki, 2007 Riyadh Primary care clinic 267 12-20 n/d 18.7 21.0 
Mahfouz, 
2007 
Abha city Schools 2696 11-19 M 11 5.0 
Farghal, 2007 Abha city Schools 767 7-20 M, F 11 15.9 
Al-Almaie, 
2005 
Al-Khobar 
Intermediate and all 3 grades of 
secondary school 
1766 14-19 M, F 
19.3(M) 
11.8(F) 
17.2(M) 
10.2(F) 
Al-Rukban, 
2003 
Riyadh 
Intermediate and secondary 
schools 
894 12-20 M 13.8 20.5 
Al-Saeed, 
2003 
Different provinces Primary and preparatory schools 2239 6-17 F 20 11.0 
El-Hamzi & 
Warsy, 2002 
Different provinces Household screening programme 12701 1-18 M, F 23.4 12.7 
El-Hamzi, 
2002 
Different provinces 
National epidemiological 
household 
12071 1-18 M, F 
10.7(M) 
12.7(F) 
6.0(M) 
6.7(F) 
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Abahussain, 
1999 
Al-Khobar city Adolescent girls 676 12-19 F 
 
              28 
(overweight obese) 
Al-Nuaim, 
1996 
Different provinces Schoolchildren 9061 6-18 M 11.7 15.8 
M = Male; F= Female 
n/d = not determined 
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Appendix 3 Meals distribution over the 24 hours (Chapter 3) 
 
Number of meals distributed over the 24 hours for VSG and control subjects 
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Appendix 4 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 
before test meal 
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Appendix 5 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 
immediately after test meal  
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Appendix 6 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 1 
hour after the test meal 
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Appendix 7 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 
before PRT test 
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Appendix 8 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 
after PRT test 
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Appendix 9 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 
before consummatory behaviour test 
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Appendix 10 Visual Analogue Scale Ratings for VSG and control subjects throughout interval visits 
after consummatory behaviour test 
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Appendix 11 Normal Zinc levels for VSG subjects at baseline 
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Appendix 12 Chapter 3 Infra structure 
Data Sheet – Eating behaviour and meal pattern study 
Name:                                                   Control   / Subject                                                    Code: 
 
Type of Food: 
1- Beryani with Chicken (330 g); (Pro:30 g, Fat:8 g, Carb: 63 g, Kcal: 450) 
2- Lasagne with meat (450 g); (Pro:32 g, Fat:13 g, Carb: 29 g, Kcal: 360)  
3- Beef Burger (280 g); (Pro: 33.6 g, Fat: 14 g, Carb: 47.6 g, Kcal: 448) 
4- Chicken Burger (265 g); (Pro: 34.5 g,Fat:15.9 g,Carb: 53 g, Kcal:503.5) 
5- Shawarma Beef (220 g); (Pro:24.2 g, Fat:8.8 g, Carb: 44 g, Kcal: 330) 
6- Shawarma Chicken (230 g); (Pro:25.3g,Fat:11.5g,Carb:48.3g,Kcal: 391) 
 
 
Visit 
 
Food  Wt 
Before 
 
Food  Wt 
After 
 
Start Time 
 
Finish Time 
 
Duration 
 
Date 
 
1st 
 
 
---------- gm 
 
---------- gm 
 
---:---  …m 
 
---:---  …m 
 
-------- min 
 
--/--/201 
 
2nd 
 
 
---------- gm 
 
---------- gm 
 
---:---  …m 
 
---:---  …m 
 
-------- min 
 
--/--/201 
 
3rd 
 
 
---------- gm 
 
---------- gm 
 
---:---  …m 
 
---:---  …m 
 
-------- min 
 
--/--/201 
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Meal Pattern lab setting pre-test 
 
 
Eaten Food on weighing scale pre-test vs post-test with duration 
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Initials ………………………….. Date ……. /……. /…… 
 
Visual Analogue Scale (pre-test) 
HOW MUCH DO YOU CRAVE FOR EATING JUST NOW? 
                            
        NOT AT ALL                                                        EXTREMELY 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
                           
        NOT AT ALL                                                     EXTREMELY 
HOW SATISFIED ARE YOU RIGHT NOW? 
                          
         NOT AT ALL                                                      EXTREMELY 
HOW MUCH FOOD COULD EAT RIGHT NOW? 
                          
            NOTHING A LARGE AMOUNT 
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Initials ………………………….. Date ……. /……. /…… 
 
Visual Analogue Scale (post- test immediately) 
HOW MUCH DO YOU CRAVE FOR EATING JUST NOW? 
                            
        NOT AT ALL                                         EXTREMELY 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
                            
       NOT AT ALL                                            EXTREMELY 
HOW SATISFIED ARE YOU RIGHT NOW? 
                           
        NOTHING A LARGE AMOUNT 
HOW MUCH FOOD COULD EAT RIGHT NOW? 
                           
        NOT AT ALL                                          EXTREMELY 
HOW GOOD WAS THE FOOD? 
                           
       NOT AT ALL                                                         EXTREMELY 
Why did you stop eating? 
                                                   I WAS FULL 
                                                   UNPLEASANT TASTE 
                   OTHER............................................................. 
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    Initials ………………………….. Date ……. /……. /…… 
 
Visual Analogue Scale (1 hour post- test) 
HOW MUCH DO YOU CRAVE FOR EATING JUST NOW? 
 
               NOT AT ALL                                                   EXTREMELY 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
 
               NOT AT ALL                                        EXTREMELY 
HOW SATISFIED ARE YOU RIGHT NOW? 
 
                NOT AT ALL                                       EXTREMELY 
HOW MUCH FOOD COULD EAT RIGHT NOW? 
 
                   NOTHING                                             A LARGE AMOUNT 
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TEFQ-R21 
This section contains statements and questions about eating habits and feelings of hunger.  
Read each statement carefully and answer by ticking the alternative that best applies to you. 
1. I deliberately take small helpings to control 
my weight 
7. When I feel tense or stressed, often feel I need 
to eat 
1  Definitely true 1  Definitely true 
2  Mostly true 2  Mostly true 
3  Most ly  fa l se  3  Most ly  fa l se  
4  Definitely false 4  Definitely false 
  
2. I begin eating when I feel anxious  
8. I often feel so hungry that my stomach feels 
like a bottomless pit 
1  Definitely true 1  Definitely true 
2  Mostly true 2  Mostly true 
3  Most ly  fa l se  3  Most ly  fa l se  
4  Definitely false 4  Definitely false 
  
3. Sometimes when I start eating, I just can't 
seem to stop 
9. I'm always so hungry that it's hard for me to 
stop eating before finishing all of the food on my 
plate 
1  Definitely true 1  Definitely true 
2  Mostly true 2  Mostly true 
3  Most ly  fa l se  3  Most ly  fa l se  
4  Definitely false 4  Definitely false 
  
4. When I feel sad, I often eat too much 10. When I feel lonely, I console myself by eating 
1  Definitely true 1  Definitely true 
2  Mostly true 2  Mostly true 
3  Most ly  fa l se  3  Most ly  fa l se  
4  Definitely false 4  Definitely false 
  
5. There are some foods I don't eat, because 
they make me fat 
11. I consciously restrict how much I eat during 
meals to avoid gaining weight 
1  Definitely true 1  Definitely true 
2  Mostly true 2  Mostly true 
3  Most ly  fa l se  3  Most ly  fa l se  
4  Definitely false 4  Definitely false 
  
6. Being with someone who is eating, often 
makes me also wants to eat 
12. When I smell appetizing food or see a 
delicious dish, I find it very difficult not to eat - 
even if I've just finished a meal 
1  Definitely true 1  Definitely true 
2  Mostly true 2  Mostly true 
3  Most ly  fa l se  3  Most ly  fa l se  
4  Definitely false 4  Definitely false 
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TEFQ-R21 
This section contains statements and questions about eating habits and feelings of hunger.  
Read each statement carefully and answer by ticking the alternative that best applies to you. 
13. I am always sufficiently hungry to eat at 
any time 
17.  How often do you avoid "stocking up" on 
temping foods? 
1  Definitely true 1  Almost never 
2  Mostly true 2  Rarely 
3  Most ly  fa l se  3  Usual ly  
4  Definitely false 4  Almost always 
  
14.  If I feel nervous, I try to calm myself down by 
Beating 
18.  How likely are you to make an effort to eat 
less than you want? 
1  Definitely true 1  Unl ike ly  
2  Mostly true 2  A l i t t le  l ike ly  
3  Most ly  fa l se  3  Somewhat likely 
4  Definitely false 4  Very likely 
  
15. When I see something that looks 
delicious, it often makes me feel so hungry 
that I have to eat right away 
19.  Do you go on eating binges even though 
You're not hungry? 
1  Definitely true 1  Never 
2  Mostly true 2  Rarely 
3  Most ly  fa l se  3  Somet imes  
4  Definitely false 4  At least once a week 
  
16. When I feel depressed, I want to eat 20. How often do you feel hungry? 
1  Definitely true 1  Only at mealtimes 
2  Mostly true 2  Sometimes between meals 
3  Most ly  fa l se  3  Often between meals 
4  Definitely false 4  Almost always 
 
21. On a scale from 1 to 8, where 1 means no restraint in eating and 8 means constant 
restraint, what number would you give yourself? 
Circle the number that best applies to you 
              1      2       3     4       5        6        7    8 
I eat 
whatever and 
whenever I  
want to 
     I am constantly 
limiting my  
food intake, never 
"giving in 
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24hrs recall methods Quetinnaire 
Name: ......................................................... 
Code: .......................................................... 
Date: ........................................................... 
Day: ............................................................ 
Time Food or Beverage consumed Amount 
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Food questionnaire (SOS) 
For each food type, fill in your daily or weekly intake. Answer daily or weekly, not both. Choose 
a daily category if you eat the food daily, choose a weekly category if you don't eat the food 
daily. You can go back and forth between daily and weekly categories as often as necessary. All 
of your answers should describe your eating habits during the last 12 weeks‎. 
  
VEGETARIAN/NON-VEGETARIAN? 
 
1.  
DO YOU EAT MEAT? YES NO   
2.  
DO YOU EAT FISH? YES NO   
3.  
DO YOU EAT MILK PRODUCTS? YES NO   
4.  
DO YOU EAT EGGS? YES NO   
Bread     
5.  
HOW MANY PIECES OF BREAD DO YOU EAT? Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)             number 
      
6.  HOW MANY PIECES OF CRISP BREAD DO YOU EAT? Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or    
 Per week (2)             number 
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7.  OUT OF 10 PIECES OF BREAD, ON HOW MANY DO YOU 
USUALLY TAKE CHEESE, MEAT, And SAUSAGE OF LIVER 
PÂTÉ ETC.? 
    
 Fill in 0 for toppings that you don't use     
 Cheese (1)  number 
 Cottage cheese or Cheese spread (2)             number 
 Meat, sausage or liver pâté                                                                                 (3)  number 
 Swedish caviar, sardines, fish                                                                             (4)             number 
 Jam (5)             number 
 Vegetables (6)             number 
 Nothing (7)             number 
  The sum should be: 10 
8.  HOW MUCH OF THE FOLLOWING DO YOU EAT? GIVE 
THE AMOUNT IN NUMBER OF "NORMAL TOPPINGS 
ON ONE SANDWICH" 
    
 
1) Cheese   
Fill in one alternative 
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
2) Cottage cheese or cheese Spread 
   
 Per day (1)             number 
 Or    
 Per week (2)             number 
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3) Meat, sausage or liver pâté                                                                   
   
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
4) Swedish caviar, sardine, fish                                                                 
   
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
5) Marmalade 
   
 Per day (1)             number 
 Or    
 Per week (2)             Number 
9.   OUT OF 10 PIECES OF BREAD, HOW MANY ARE:     
 Fill in 0 for toppings that you don't use     
 Rye, whole-wheat, or other                                                                         (1)             number 
 Sweet Swedish bread (2)             number 
 White bread                                                                                                 (3)             number 
  The sum should be: 10 
10.  HOW THICK ARE YOUR PIECES OF BREAD?  
 
1) Brown bread                                                                                               
fill in a cross 
               Thinner than 1 cm                                                                                              (1) number  
 Approximately 1 cm (2) (2)             number  
               Thicker than 1 cm (3)             number  
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2) Sweet, Swedish bread                                                                                  
fill in a cross 
               Thinner than 1 cm                                                                                              (1) number  
 Approximately 1 cm (2) (2)             number  
               Thicker than 1 cm (3)             number  
 
3) White bread                                                                                                  
fill in a cross 
               Thinner than 1 cm                                                                                              (1) number  
 Approximately 1 cm (2) (2)             number  
               Thicker than 1 cm (3)             number  
11.  MUCH FAT DO YOU USUALLY SPREAD ON YOUR 
SANDWICHES? 
fill in a cross 
 Nothing (1)             number  
 A thin layer                                                                                                 (2)  number  
 Normal layer                                                                                               (3)             number  
 Thick layer                                                                                                  (4)             number  
 Very thick layer                                                                                          (5)  number  
      
12.  OUT OF 10 PIECES OF BREAD, ON HOW MANY YOU 
USE: 
Fill in 0 for the alternative you don't use 
 Butter                                                                                                       (1)            number  
 A mixture of butter and oil                                                                        (2)  number  
 Margarine   (3)             number  
 Low fat margarine                                                                                     (4)  number  
  No fat at all (5)             number  
  The sum should be: 10 
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13.  HOW MUCH OF THE FOLLOWING DO YOU EAT? GIVE 
THE AMOUNT IN NUMBER OF "NORMAL TOPPINGS 
ON ONE SANDWICH" 
    
 
6) Cheese   
Fill in one alternative 
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
7) Cottage cheese or cheese Spread 
   
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
8) Meat, sausage or liver pâté                                                                   
   
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
9) Swedish caviar, sardine, fish                                                                 
   
 Per day (1)             number 
 Or    
 Per week (2)             number 
 
10) Marmalade 
   
 Per day (1)             number 
 Or    
 Per week (2)             Number 
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14.   OUT OF 10 PIECES OF BREAD, HOW MANY ARE:     
 Fill in 0 for toppings that you don't use     
 Rye, whole-wheat, or other                                                                         (1)             number 
 Sweet Swedish bread (2)             number 
 White bread                                                                                                 (3)             number 
  The sum should be: 10 
15.  HOW THICK ARE YOUR PIECES OF BREAD?  
 
4) Brown bread                                                                                               
fill in a cross 
               Thinner than 1 cm                                                                                              (1) number  
 Approximately 1 cm (2) (2)             number  
               Thicker than 1 cm (3)             number  
 
5) Sweet, Swedish bread                                                                                  
fill in a cross 
               Thinner than 1 cm                                                                                              (1) number  
 Approximately 1 cm (2) (2)             number  
               Thicker than 1 cm (3)             number  
 
6) White bread                                                                                                  
fill in a cross 
               Thinner than 1 cm                                                                                              (1) number  
 Approximately 1 cm (2) (2)             number  
               Thicker than 1 cm (3)             number  
 
 
    
16.  MUCH FAT DO YOU USUALLY SPREAD ON YOUR 
SANDWICHES? 
fill in a cross 
 Nothing (1)             number  
 A thin layer                                                                                                 (2)  number  
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 Normal layer                                                                                               (3)             number  
 Thick layer                                                                                                  (4)             number  
 Very thick layer                                                                                          (5)  number  
      
17.  OUT OF 10 PIECES OF BREAD, ON HOW MANY YOU 
USE: 
Fill in 0 for the alternative you don't use 
 
 Butter                                                                                                       (1)            number  
 A mixture of butter and oil                                                                        (2)  number  
 Margarine   (3)             number  
 Low fat margarine                                                                                     (4)  number  
  No fat at all (5)             number  
  The sum should be: 10 
BEVERAGES     
18.  HOW MUCH DO YOU CONSUME OF THE 
FOLLOWING? (INCLUDING MILK PRODUCTS ON 
CEREAL) 
Fill in 0 per week for those you don't use 
 
1) Whole milk                                                                                            
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 
2) Low fat milk (1%)   
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
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3) Skim milk 
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 
4) Yoghurt/fermented milk (whole) 
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 
5) Low fat yoghurt 
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 
6) Juice   
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 
7) Fruit drink, soft drink                                                                              
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 Or     
 Bottles/Cans per day (3)             number  
 Or     
 Bottles/Cans per week (4)             number  
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8) Alcohol-free beer                                                                                   
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 Or     
 Bottles/Cans per day (3)             number  
 Or     
 Bottles/Cans per week (4)             number  
 
9) Energy Drinks 
Fill in one alternative                                             
 Glass (250ml) per day (1)             number  
 Or     
 Glass (250ml) per week (2)             number  
 Or     
 Bottles/Cans per day (3)             number  
 Or     
 Bottles/Cans per week (4)             number  
FRUITS     
19.  HOW MUCH CITRUS FRUIT (ORANGES, LEMONS, 
TANGERINES, AND GRAPEFRUITS) DO YOU EAT?                                                          
Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
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20.  HOW MANY APPLES/PEARS DO YOU EAT?                                 Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
      
21.  HOW MANY BANANAS DO YOU EAT?                                            Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 
Per week 
 
(2)             number  
22.  HOW MANY PORTIONS OF GRAPES DO YOU EAT?  
(One portion of about 15-20 grapes are approx. 
100g)                                    
Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
      
23.  HOW MANY PLUMS DO YOU EAT? Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 
Per week 
 
(2)             number  
24.  HOW MANY PORTIONS OF MELON DO YOU EAT PER 
WEEK? 
 
 Per week                                                                                                                          number of portions 
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25.  HOW MANY PEACHES/NECTARINES YOU EAT?    
 
Per week       
                                                                                                                  
 number  
26.  HOW MANY PORTIONS OF EXOTIC FRUITS (KIWI, 
PAPAYA, MANGO, and PINEAPPLE) DO YOU EAT? 
 
 Per week                                                                                                                         number of portions 
CAKES AND COOKIES     
27.  MANY (LIST OF SEWDISH NAMES FOR HIGH-FAT, 
HIGH SUGAR CAKES) DO YOU EAT?                                                                         
Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
      
28.  HOW MANY SWEET BUNS AND (SWEDISH NAMES) 
FOR SWEDISH CAKE DO YOU EAT?   
Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
29.  HOW MANY COOKIES AND BISCUITS AND SUCH 
DO YOU EAT?         
Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
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DESSERTS AND SNACKS 
 
30.  HOW MANY FRUIT DESSERTS DO YOU EAT?                            Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
31.  HOW MUCH ICE CREAM DO YOU EAT?                                   Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
32.  HOW MUCH PIE, PUDDING, CHOCOLATE MOUSSE, 
AND SUCH DO YOU EAT? 
    
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
 
EGGS  
33.  HOW MANY EGGS DO YOU EAT? Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number 
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PORRIDGE GRUEL AND BREAKFAST CEREAL 
34.  HOW MANY PORTIONS OF PORRIDGE DO YOU 
EAT?            
Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
35.  HOW MANY PORTIONS OF GRUEL DO YOU EAT?                    Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
36.  HOW MANY PORTIONS OF CEREAL DO YOU EAT?               Fill in one alternative                                             
 Per day                                                                                                             (1)             number  
 Or     
 Per week (2)             number  
LIGHT MEALS     
With light meals we mean omelet's, soup, salad, cottage cheese, hot sandwiches etc. Do not include 
cereals and full lunches here. 
32a.  HOW MANY LIGHT MEALS DO YOU EAT?                     Fill in one alternative                                             
 Per day                                                                                                             (1)            number  
 Or     
 Per week (2)             Number  
OTHER FAST FOODS 
32b. HOW MANY HAMBURGERS, HOT DOGS WITH 
BREAD OR FRIES DO YOU EAT?   
Fill in one alternative                                             
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 Per week (1)             number  
32c. HOW MANY PIZZAS DO YOU EAT?     
 Per week (1)             Number  
MAIN MEALS 
‘Main meals’ refer to hot lunches, dinners, or any main meal, even if eaten during a night shift). 
EXAMPLE OF PROTION SIZES 
Attention! Do not include porridge, light meals or pizza here, since you have already described them. 
 
              Portion A                   Portion B                              Portion C 
 
33. HOW MANY SUCH MEALS DO YOU EAT ON 
MONDAY, TUESDAY, WEDNESDAY AND 
THURSDAY? 
Fill in one alternative 
 Main meals per day (1)             number  
 OR     
 Main meals per 4 days (2)             number  
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Look at the picture on the previous page. As you see they are various sizes describe your 
own portion sizes in relation to the picture. You can choose potatoes from one portion, 
meat from another and vegetable from a third. 
1) Potatoes, rice, spaghetti etc. in your main meals on Mondays -Thursdays?  Check 
the alternative that best describes the average portion size on most days. 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)   
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)
 Between portion B and C                                                                                                        (6)   
 Same as Portion C                                                                                                                   (7)
 Twice as much as portion C                                                                                                    (8)   
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
      
2) Meat, Fish, fowl, and seafood on average on Mondays -Thursdays if you are a 
vegetarian relate the meat portion shown here to your vegetarian alternatives (soy 
beans, lentils, beans etc.) 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)   
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)
 Between portion B and C                                                                                                        (6)   
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 Same as Portion C                                                                                                                   (7)
 Twice as much as portion C                                                                                                    (8)   
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
      
3) Vegetables on average per main meal Monday-Thursday 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)   
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)
 Between portion B and C                                                                                                        (6)   
 Same as Portion C                                                                                                                   (7)
 Twice as much as portion C                                                                                                    (8)   
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
 
34. 
 
HOW MANY MAIN MEALS DO YOU EAT ON FRIDAYS? 
Main meals on Fridays                                                                        number 
 
 
Describe the size of your main meal on Friday in relation to the pictures.    
…………………………… 
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1) Potatoes, rice, spaghetti etc. in your main meals on Mondays -Thursdays?  Check 
the alternative that best describes the average portion size on most days. 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)  
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)  
 Between portion B and C                                                                                                        (6)  
 Same as Portion C                                                                                                                   (7)   
 Twice as much as portion C                                                                                                    (8)  
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
      
2) Meat, Fish, fowl, and seafood on average on Mondays -Thursdays if you are a 
vegetarian relate the meat portion shown here to your vegetarian alternatives (soy 
beans, lentils, beans etc.) 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)  
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)  
 Between portion B and C                                                                                                        (6)  
 Same as Portion C                                                                                                                   (7)   
 Twice as much as portion C                                                                                                    (8)  
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 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
 
3) Vegetables on average per main meal Monday-Thursday 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)  
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)  
 Between portion B and C                                                                                                        (6)  
 Same as Portion C                                                                                                                   (7)   
 Twice as much as portion C                                                                                                    (8)  
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
      
35. HOW MANY COOKED MEALS DO YOU EAT ON 
SATURDAY AND SUNDAY? 
    
 total of all main meals during these 2 days                                                              number   
 
Describe your main Saturday and Sunday meal sizes in relation to the pictures. 
 
…………………………… 
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1) Potatoes, rice, spaghetti etc. in your main meals on Mondays -Thursdays?  Check 
the alternative that best describes the average portion size on most days. 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)  
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)  
 Between portion B and C                                                                                                        (6)  
 Same as Portion C                                                                                                                   (7)   
 Twice as much as portion C                                                                                                    (8)  
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
      
2) Meat, Fish, fowl, and seafood on average on Mondays -Thursdays if you are a 
vegetarian relate the meat portion shown here to your vegetarian alternatives (soy 
beans, lentils, beans etc.) 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)  
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)  
 Between portion B and C                                                                                                        (6)  
 Same as Portion C                                                                                                                   (7)   
 Twice as much as portion C                                                                                                    (8)  
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 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
      
3) Vegetables on average per main meal Monday-Thursday 
  ONE CROSS   
 I don't eat it                                                                                                                              (1)  
 Half of portion A                                                                                                                                       (2)  
 Same as Portion A (3)    
 Between portion A and B           (4)    
 Same as Portion B                                                                                                                  (5)  
 Between portion B and C                                                                                                        (6)  
 Same as Portion C                                                                                                                   (7)   
 Twice as much as portion C                                                                                                    (8)  
 Three times as portion C                                                                                                        (9)  
 Four times as portion C                                                                                                         (10)  
36. IMAGINE 10 CONSECUTIVE MAIN MEALS APPROXIMATELY HOW MANY CONSIST 
OF THE FOLLOWING? 
 Fill in 0 for food types that you don't use    no. of meals 
 Soy burgers, lentils, beans etc.                                                                   (1)  
 Beef, ground meat, pork chop, filet, chicken, other 
fowl, game               
 
(2) 
 
 
 Fish, seafood                                                                                              (3)  
 Salted pork, bacon, sausage, other Fatty meals                                         (4)  
  The sum should be: 10 
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37. IMAGINE 10 CONSECUTIVE MAIN MEALS 
APPROXIMATELY HOW MANY OF THESE MEALS ARE: 
 
no. of meals 
 Boiled (1)   
 Fried (2)    
  The sum should be: 10 
38. IMAGINE 10 KG OF FAT USED IN YOUR HOUSEHOLD 
FOR COOKING (EXCLUDING SANDWICH SPREAD) HOW 
DO THESE 10 KILOS DIVIDE OUT? 
    
 Fill in 0 for cooking fat that you don't use no. of Kg 
 Butter (1)    
 A mixture of butter and oil (2)    
 Margarine     (3)    
 light margarine                                                                                            (4)    
 Oil (5)    
  The sum should be: 10 
Candy     
39. HOW MANY CHOCOLATE BARS (NORMAL SIZE 100g) 
DO YOU EAT? 
Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)  number 
40. HOW MANY LARGE CHOCOLATE BARS (250g) DO YOU 
EAT? (same size as cooking chocolate bars)                                                                                                         
Fill in one alternative 
 Per day                                                                                                             (1)  number 
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 Or     
 Per week (2)  number 
41. HOW MANY CHOCOLATE BARS (MARS, SNEAKERS 
ETC.) DO YOU EAT?   
Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)  number 
42. HOW MANY PIECES OF CHOCOLATE (BOX-TYPE) YOU 
EAT? 
Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)  number 
43. MANY NON-CHOCOLATE SWEETS DO YOU EAT?   Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)  number 
44a. HOW MANY CANDIES OR EQUIVALENTS DO YOU EAT?    Fill in one alternative 
 100 g per day                                                                                                                     (1)  number 
 Or     
 100 g per week                                                                                                                   (2)  number 
 Or     
 small bag daily                                                                                                                  (3)  number 
 Or     
 small bag weekly                                                                                                               (4) number 
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 Or     
 big bag daily                                                                                                                      (5)  number 
If we have not included all types of candies that you eat, fill in the category (39-44) that is 
the most similar in such a way that that the total number of candies eaten per day or 
week is approximately correct. 
45. HOW MANY NUTS, PRETZELS DO YOU EAT?                         Fill in one alternative 
 Small bag of (approx. 125g) per day                                                                                           (1) number
 Small bag of ( approx. 125g) per week                                                                              (2) number 
 big bag of (approx. 130g) per day                                                                                 (3)  number 
 big bag of (approx. 125g) per week                                                                               (4)  number 
46. HOW MANY CHIPS CHEESE PUFFS ETC. DO YOU EAT?      Fill in one alternative 
 1 large bag per day                                                                                                    (1)  number 
 Or     
 1 large bag per week                                                                                                  (2)  number 
 Or     
 1 small bag per day                                                                                                      (3) number 
 Or     
 1 small bag per week                                                                                                  (4) number 
COFFEE, TEA, HOT (OR COLD) CHOCOLATE DRINK 
      
47. HOW MANY CUPS OF COFFEE DO YOU DRINK?       Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)             number 
 How many sugar cubes do you use in a cup of coffee?   number  
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 Do you put anything else on your coffee? ONE CROSS   
  No (1)    
  yes, whipping cream (2)    
 yes, half and half (3)    
  yes, milk (4)    
      
48. HOW MANY CUPS OF TEA DO YOU DRINK?                     Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)             number 
 
How many sugar cubes do you put in a cup of tea? 
 
 number  
49. HOW MANY CUPS OF HOT (OR COLD) CHOCOLATE DO 
YOU DRINK? 
Fill in one alternative 
 Per day                                                                                                             (1)  number 
 Or     
 Per week (2)             number 
 Which liquids do you use for making chocolate drink? ONE CROSS   
 Water (1)    
 Milk (2)    
 cream and water (3)    
 cream and milk (4)    
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Appendix 13 Chapter 4 Infra structure  
 
Taste Detection test lab setting 
 
 
Taste Detection preparation phase 
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PRESENTATION ORDER (Disterbution of stemulants and water in cups in 8 blocks randomly) 
B 1 
(T1-14) 
S6 S1 w S5 w S3 w S4 w S2 W w S7 w 
B 2 
(T15-28) 
S6 w w S4 w S3 w S7 w S5 S1 w S2 w 
B 3 
(T29-42) 
W S7 w w S2 S5 S6 w S4 w W S3 S1 w 
B 4 
(T43-56) 
S3 w S2 S6 w W S7 w w w S1 w S4 S5 
B 5 
(T57-70) 
W S3 S2 w S1 S7 w S5 S6 w S4 w w w 
B 6 
(T71-84) 
W S6 w S5 w S4 S1 w w w S7 w S3 S2 
B 7 
(T85-98) 
W S5 w w S2 W S3 w S6 S1 W S4 w S7 
B 8 
(T99-112) 
S1 S6 w S5 S7 W w w w S2 S3 w S4 w 
A. The probability of receiving a water trial is 0.5. Thus half of the cups will contain 
water. 
B. Each taste compound will be tested in 12 blocks (B1-B12). A block of trials will consist 
of 7 tastes (S1-S7) and 7 distilled water trials (w) presented in random order without 
replacement.  Each concentration (from 7) will be presented once within a block. 
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Appendix 14 Chapter 5 Infra structure 
 
Lab setting and Sleeve subject performing the PRT test (consent obtained) 
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Progressive Ratio Task Program (Test screen) 
 
 
Progressive Ratio Task Program (Termination test screen) 
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Initials …………………………..                                 Date ……. /……. /…… 
 
Visual Analogue Scale (pre – test) 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
 
NOT AT ALL EXTREMELY 
HOW FULL DO YOU FEEL RIGHT NOW? 
 
NOT AT ALL EXTREMELY 
HOW MUCH DO YOU WANT THE M&M? 
 
NOTHING              A LARGE AMOUNT 
HOW SICK/NAUSEATED DO YOU FEEL? 
 
NOT AT ALL EXTREMELY 
What did you have for breakfast and how much? 
...................................................................................................... 
...................................................................................................... 
 
 
  
 332 
 
Initials …………………………..                            Date ……. /……. /…… 
 
Visual Analogue Scale (post – test) 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
 
NOT AT ALL EXTREMELY 
HOW SWEET WAS THE M&M? 
 
NOT AT ALL EXTREMELY 
HOW FATTY/CREAMY WAS THE M&M? 
 
NOTHING    A LARGE AMOUNT 
HOW MUCH DID YOU LIKE THE M&M? 
 
NOT AT ALL EXTREMELY 
HOW SICK/NAUSEATED DO YOU FEEL? 
 
NOT AT ALL EXTREMELY 
WHY DID YOU STOP PRESSING THE BUTTON? 
FEEL FULL UNPLEASANT TASTE FEEL SICK 
     OTHER         ................................................................................... 
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Appendix 15 Chapter 6 Infra structure  
 
Setting and preparation of Consummatory behaviour test with control volunteer picture (consent 
obtained) * Permission was obtained from the child’s parents to show his eyes. 
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Initials ………………………….. Date ……. /……. /…… 
 
Visual Analogue Scale (Pre-test) 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
                
NOT AT ALL EXTREMELY 
HOW FULL DO YOU FEEL RIGHT NOW? 
              
NOT AT ALL EXTREMELY 
HOW MUCH DO YOU THINK YOU COULD EAT RIGHT NOW? 
             
NOTHING A LARGE AMOUNT 
HOW SICK/NAUSEATED DO YOU FEEL? 
               
NOT AT ALL EXTREMELY 
What did you have for breakfast and how much? 
...................................................................................................... 
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Initials …………………………..                                  Date ……. /……. /…… 
 
Visual Analogue Scale (Post-test) 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
                  
 NOT AT ALL EXTREMELY 
HOW SWEET WAS THE MILKSHAKE? 
                  
 NOT AT ALL EXTREMELY 
HOW FATTY/CREAMY WAS THE MILKSHAKE? 
                   
   NOTHING          A LARGE AMOUNT 
HOW MUCH DID YOU LIKE THE MILKSHAKE? 
                   
NOT AT ALL EXTREMELY 
HOW SICK/NAUSEATED DO YOU FEEL? 
                  
 NOT AT ALL EXTREMELY 
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 ___________________________________________________________________________ 
Facial Expression Food Preference Rating Scale, Like vs. Dislike of Standardized Tastent 
___________________________________________________________________________ 
Directions: Rate the following items according to the frequency of occurrence. Use the following 
guidelines for your ratings:  
0 Never observed-You have never seen the individual behave in this manner. 
1 Seldom Observed-Individual behaves in this manner for about (1-2) of the time. 
2 Sometimes Observed-Individual behaves in this manner for about (3-4) of the time. 
 3 Frequently observed-Individual behaves in this manner for about (≥ 5) of the time. 
Circle the number that best describes your observations of the individual's typical behaviour under 
this certain circumstances.  Remember to rate every item, If you are uncertain about how to rate an 
item delay the rating and repeat and pause the video. REMEMBER, EVERY ITEM SHOULD RECEIVE A 
SCORE. 
Food Preference Behaviour 
N
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Frequency 
General Behaviours 
-Body movement 0 1 2 3  
-Hand movement 0 1 2 3  
-Head movement 0 1 2 3  
-Eye movement 0 1 2 3  
-Up 0 1 2 3  
-Down 0 1 2 3  
-Right 0 1 2 3  
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-Left 0 1 2 3  
-Looking to the stimuli 0 1 2 3  
-Turn off the stimuli flow 0 1 2 3  
-Overall calmness 0 1 2 3  
Facial Expression: Positive Or Negative Effective Values 
Negative effective values: 
Upper Face: 
-Inner eyebrows raised 0 1 2 3  
-outer eyebrows raised 0 1 2 3  
-Browed pulled together and lowered 0 1 2 3  
-Nose wrinkle 0 1 2 3  
-eye closed 0 1 2 3  
-blink 0 1 2 3  
-Cheek raiser(neutral) 0 1 2 3  
Lower Face: 
-Upper lip raiser 0 1 2 3  
-Lip corner depressor 0 1 2 3  
-Lip stretch 0 1 2 3  
-Lip pressed 0 1 2 3  
-Lips part 0 1 2 3  
-Gape 0 1 2 3  
Positive effective values: 
Upper Face: 
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-Smile with cheeks raised 0 1 2 3  
-Cheek raise (neutral) 0 1 2 3  
Lower Face: 
-Lip corner puller 0 1 2 3  
-Smile with open mouth 0 1 2 3  
-Lip smack 0 1 2 3  
-Chin raiser (neutral) 0 1 2 3  
-Lip pucker (neutral) 0 1 2 3  
Gross Behaviour: 
Neutral face (neutral) 0 1 2 3  
Lip bite (neutral) 0 1 2 3  
Head shake (negative) 0 1 2 3  
Head nod (positive) 0 1 2 3  
Tongue protrusion (positive) 0 1 2 3  
Cheek sucking (positive) 0 1 2 3  
Subtotals 
_  
+ 
_  
+ 
_  
+ 
_  
+ 
 
   Behaviours Total Raw Score 
                                  
